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Abstract
In this thesis, we present methods and results for the estimation of diagnosis incep-
tion rates for Critical Illness Insurance (CII) claims in the UK by cause. This is the
first study which provides a stochastic model for the diagnosis inception rates for
CII. The data are supplied by the UK Continuous Mortality Investigation and relate
to claims settled in the years 1999 - 2005. First, we develop a model for the delay
between dates of diagnosis and settlement of claims in CII using a generalised-linear-
type model with Burr errors under both Bayesian and maximum likelihood approach.
Variable selection using Bayesian methodology to obtain the best model with differ-
ent prior distribution setups for the parameters is applied. For comparison purposes,
a lognormal model and frequency-based model selection techniques are also consid-
ered. The non-recorded dates of diagnosis and settlement have been included in the
analysis as missing values using their posterior predictive distribution and Markov
Chain Monte Carlo methodology. Missing dates of diagnosis are estimated using the
parsimonious claim delay distribution. With this complete data set, diagnosis incep-
tion rates for all causes (combined) and for specific causes are estimated using an
appropriate claim delay distribution where the observed numbers of claim counts are
assumed to have a Poisson distribution. To model the crude rates, a generalised linear
model with Poisson errors and log-link function is used.
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Chapter 1
Introduction
1.1 Critical Illness Insurance
Critical Illness Insurance (CII) is a type of long term insurance that provides a lump
sum on the diagnosis of one of a specified list of critical illnesses within the policy
conditions. CII first came to the scene in South Africa early in the 1980s under
the name of Dread Disease Insurance. However, before this, in the USA, Japan and
Israel some life insurance policies were extended to cover cancer (Dash and Grimshaw,
1993).
CII has been very popular in the UK. Although CII policies have been issued since
the 1980s in the UK, the number of policies increased dramatically in the early 1990s.
From then on, it continued growing. While there were 100000 new sales in 1990, this
figure increased almost 7 times to 700000 new CI policies sold in 1998 (Dinani et
al., 2000). More recent sales figures reveal that more than one million new policies
were issued in 2002 (CMI WP 50, 2011). The data we are using throughout the thesis
cover the period between 1999 and 2005 and the inforce figures also indicate a positive
growth during the period, however with a smaller rate.
There are some particular aspects of CII which make this type of policy attractive,
e.g. the lump sum benefit is payable on diagnosis regardless of the duration of the
illness. This can make CII more popular than permanent health insurance. Moreover,
a single person who has no dependants would probably prefer CII instead of buying
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conventional life assurance in order to meet the high expenses of serious illness (Dash
and Grimshaw, 1993). There is no restriction on how to spend the CII benefit. Most
of the CII policies in the UK are linked to mortgages as this is a considerable financial
commitment and diagnosis with a critical illness could affect the individual’s ability
to repay the mortgage.
In the UK, there are two types of CI policy: Full Accelerated (FA), which covers both
critical illness and death, and Stand Alone (SA), which covers only critical illness.
Most of the policies are accelerated policies and they are attached to life insurance,
term insurance or endowments (see WP 50 (2011)). Typically, regular premiums are
payable throughout the term while the policy is in force.
CII coverage includes, but is not limited to, cancer, heart attack, stroke, coronary
artery by-pass graft (CABG), kidney failure, major organ transplant (MOT) and
multiple sclerosis (MS). Most policies include total and permanent disability (TPD)
for completeness, essentially to cover disability arising from other reasons which might
not be covered explicitly by other causes. These 8 diseases and death form more than
90% of the claims. However the CII market in the UK is very competitive so that
insurance companies may increase the number of illnesses covered in an attempt to
increase their market share.
One feature of CII is that it has mostly clear and understandable definitions of what
constitutes a claim. In the UK, the Association of British Insurers (ABI) has defined
the illnesses covered by CII. These definitions are presented in ABI (2006) and for most
of the illnesses are accepted as a standard guide by the insurance companies. However,
unlike most of the other causes covered by CII, TPD has a vague definition (e.g ‘own
or any occupation’ statement) and this leads to some problems such as rejection of
many claims as valid or long waiting periods until the settlement of a claim. To reduce
the ambiguity in these claims and raise the understanding of consumers, recently, the
ABI set some specific model definitions using their past experience. These definitions
are explained in detail in ABI (2010). However note that the data used in this thesis
do not cover these recent definitions.
In general, CII is subject to long delays between the dates of diagnosis and settlement,
which in some cases can be measured in years rather than in weeks or months, and
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this leads to some problems such as incurred but not settled (IBNS) claims. This
is an important problem, as not allowing for this in the modelling will distort the
results by exposure year (because of the removal of claims settled in the exposure
year but diagnosed in earlier years and addition of claims diagnosed in the exposure
year but settled in later years). This issue is also raised by the Continuous Mortality
Investigation (CMI) (see WP 14 (2005), WP 28 (2007) and WP 33 (2008)).
The CMI is a research body organised by the Actuarial Profession in the UK. It
collects data from contributing life insurance offices and carries out research on all
main life insurance branches including critical illness. It publishes the research in
reports and working papers. The data we used in this thesis were supplied by the
CMI and they include claims settled between 1999 and 2005. We were provided with
a large set of claims data and the associated in force data collected from contributing
life insurance offices in the UK. This data set represents about one half to one third
of the CII policies sold in the UK for that period (WP 50, 2011). The data will be
explained in more detail in Chapter 2.
1.2 Overview of past results
Our ultimate aim in this thesis is modelling diagnosis inception rates for CII using
appropriate statistical methodology. The cost of CII based on the UK data was
modelled by Dash and Grimshaw (1993) and some incidence rates for heart attack,
stroke, and cancer were produced for full accelerated policies. A base table called IC94
was produced by the Working Party of the Society of Actuaries in Ireland (1994). In
that table the rates were mostly derived from population data in the UK, however the
data were adjusted for Ireland and insured lives. The rates were produced for different
ages and sex but not for smoker status. The CI market in the UK between 1991 and
1998 is examined by Dinani et al. (2000) and a base table, CIBT93, was published,
mostly from English population data between 1993-1994. The data were obtained
from the Office of National Statistics, Hospital Episodes Statistics and Morbidity
Statistics from General Practice. Incidence rates were calculated for the core diseases
and they were applicable to both full accelerated and stand alone policies for different
sexes and ages. The incidence rates for the full accelerated policies were calculated
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using Dash and Grimshaw’s (1993) model for the UK population. This base table
was updated in 2006 by the CI Trends Research Group with the 1999-2002 experience
using the same data source and the CIBT02 base table was produced. This base table
was also for the UK population. As for CIBT93, the rates were age and sex specific
but they did not differ by smoker status. CIIT00 which was produced by GenRe
in 2007 was an attempt to construct a table using insured lives data. Basically the
population incidence rates from CIBT02 base table were rescaled using the 1999-2002
insured experience of the CMI because they mention that the size of the insured data
set was not sufficient to construct a new table. Different incidence rates for smokers
and non–smokers were provided in this table. Two recent studies by the CMI give
CI inception rates in the UK, namely WP 43 (2010) and WP 50 (2011). These rates
are based on insured data from the UK. These two studies will be discussed in more
detail here, as a more comprehensive point of view is provided compared to the other
studies. Nevertheless, none of the incidence rates for CII produced so far depends on
a statistical model.
In this thesis we first model the delay between diagnosis and settlement of claims as
this delay can be very long and subject to uncertainty in CII. These long delays lead
to problems of incurred but not reported (IBNR), incurred but not settled (IBNS) and
reported but not settled (RBNS) claims. This issue is also mentioned by the CMI (in
WP 14 (2005), WP 28 (2007) and WP 33 (2008)) and the necessity of an adjustment
factor to avoid the understatement of the experience is stressed. This factor is ex-
pected to be dependent at least on office as well as other characteristics of the claim,
such as cause of claim, smoker status, policy duration. Here, we consider a generalised
model setting with a three-parameter Burr distribution to model the claim delays and
estimate parameters under both a classical approach and a Bayesian approach using
Markov Chain Monte Carlo (MCMC). The three-parameter Burr distribution has
many applications in actuarial science due to its high flexibility in modelling heavy
tails. Beirlant et al. (1998) extended the Burr distribution to a regression model by
allowing either one of its shape parameters or the scale parameter to vary with the
covariates. In their paper, they estimated the parameters by using a maximum likeli-
hood approach. Following this, Beirlant and Guillou (2001) considered extreme value
methods for Pareto-type distributions under censoring, and discussed maximum likeli-
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hood estimates of the extreme value index of the Burr distribution, which is defined in
terms of shape and scale parameters. Explanatory variables are also regressed on this
index by Beirlant and Goegebeur (2003) and maximum likelihood estimates are given.
Regression-type models with heavy-tail errors are considered in a Bayesian context by
Antonio and Beirlant (2008) and Frees and Valdez (2008). MCMC methodology for
actuarial related problems using the Burr distribution is discussed by Scollnik (2001).
In order to obtain the most suitable model for describing and predicting the delay
between diagnosis and settlement of claims, we also investigate Bayesian variable
selection among the available claim-related factors in this study. Different prior dis-
tribution settings for the model parameters are considered employing methodology
introduced by Dellaportas et al. (2002), Ntzoufras (2002, 2009) and Ntzoufras et al.
(2003).
One of the biggest difficulties the CMI encountered in providing inception rates is
that of non-recorded dates of diagnosis. In WP 14 (2005) and WP 28 (2007) the
investigation period is 1999-2002 and only 56% of the claims have the date of diagnosis
recorded. The number of recorded dates of diagnosis increased to 70% in 2003 and
reached 75% in 2004 according to WP 33 (2008). Eventually in WP 50 (2011) it is
mentioned that, for the period between 2003 and 2006, approximately 80% of the
claims have date of diagnosis available.
Inception rates were smoothed by the CMI for CII and the results were presented
in the CMI’s WP 43 (2010) and WP 50 (2011). These two studies are the most
relevant ones to our work. The CMI’s methodology to produce diagnosis inception
rates is explained in WP 43 (2010) where the 1999-2004 experience is used. In both
of these working papers, an initial set of rates is adjusted using the CIBT02 base
table to obtain the inception rate. Nonetheless, not using adequate mathematical
modelling techniques creates difficulties. One of the problems with this method is
that it is applied to subsets of the data. When the volume of the data is not enough,
the rates for that subgroup can not be derived. Therefore the analyses of the rates
in these working papers are limited to full accelerated policies only. The rates can
only be produced for some combinations of sex, smoker status and policy duration.
The number of combinations is increased in WP 50 (2011) which uses the 2003-2006
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experience and it is mentioned that the data are more stable in this period. In WP
43 (2010), cause-specific rates (only for cancer, heart attack, death, stroke, CABG
and TPD) are presented for male, non–smokers, curtate policy durations 0 (duration
of policy is less than a year) to 5+ (duration of policy is more than 5 years). Since
the method used there is highly data-intensive, the rates are not reliable outside the
age range 25-65 for the all-cause rates while it is restricted to 30-60 for cause-specific
rates. Also, as the data have a significant amount of missing dates of diagnosis, the
claims are matched to exposure, according to their year of settlement (not diagnosis).
In addition to these disadvantages, another, and probably more serious, problem with
this non-statistical method is that no confidence intervals can be given for the rates
because it is not possible to calculate a standard deviation with this method.
In graduating claim diagnosis rates, we use a similar model to that described in Forfar
et al. (1988). A good discussion of smoothing rates can be found in this paper where
the 1979-1982 mortality experience is used for the UK.
1.3 Stochastic modelling for inception rates
Regardless of the insurance type, insurance companies need to assess the diverse range
of risks they face as this will affect their evaluation of future cash flows, premium cal-
culations and policy values in order to be solvent and meet the capital requirements.
Morbidity is one of the risks for health related policy products that insurance com-
panies have to manage effectively.
The occurrence and amount of liabilities are the inherent uncertainties about mor-
bidity. The risk can be reduced if claim inception rates are modelled suitably and
therefore it is important to develop a stochastic model of morbidity risks. Some fac-
tors such as age, sex or smoker status are most likely to have an effect on morbidity
rates. Also, consequences of different benefit amounts, years of diagnosis or policy
durations can be investigated. Depending on the insurance type, there might be other
factors as well. For example, for CII, policy type (full accelerated/stand alone) could
be an important factor in terms of claim inception rates. Apart from these, different
offices might experience different morbidity rates due to their underwriting proce-
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dures, market coverage (different target of socio-economic groups) or interpretations
of cause of claims. On the other hand, external factors such as medical advances (new
treatments, new diagnostic techniques that may cause illness definitions to change)
or changes in lifestyles (social, behavioural) are difficult to represent mathematically.
In this thesis we will apply statistical methodology to estimate the claim inception
rates for CII by date of diagnosis and by cause. This will be the first statistical model
for the diagnosis inception rates for CII.
We consider 8 causes of claims and death. All other causes are collected under a cat-
egory comprising ‘Other’ causes which corresponds to 6.6% of the data (details about
grouping illnesses are discussed in Chapter 2). Considering all of the CI causes we
have covered, we have 11 possible states for considered policyholders, including the
healthy state. A policyholder is supposed to be healthy at the time of the commence-
ment of the policy and he/she stays in this state until at some future time he/she
transits to one of the 10 possible exit states. These states and the possible transitions
are represented in Figure 1.1.
As mentioned in Section 1.1, a CII ceases on the payment of the lump sum. Therefore
all CI cause states are absorbing states. Since transitions between these states are
not possible in both directions, the model, can be considered as a multiple decrement
model (see Waters (1984)).
In Figure 1.1, the transition intensities are denoted by λc(x;θ) where c = {CABG,
Cancer, Heart Attack, Kidney Failure, MOT, Multiple Sclerosis, Stroke, TPD, Other,
Death} and they are allowed to depend on the policyholder’s attained age (x) as
well as other characteristics (e.g. sex, smoker status, policy type, office). These
characteristics are denoted by a vector, θ. Here, we emphasize that different incidence
rates may depend on different subsets of θ since covariates are selected to provide the
most appropriate model for each transition. This will be discussed later in Chapter 8
when we model the incidence rates for individual causes.
In Chapter 7 we will model the incidence rates for ‘all-causes’, λ(x;θ), where
λ(x;θ) ≈
∑
c
λc(x;θ).
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We do not use a strict equal sign in this equation, as the equivalence is relative
to different exposures, as will be discussed in Chapter 8. In our model, maximum
likelihood estimation of the intensity under the Markov model provides the same
estimates as when the observed claim numbers, N(x;θ), are assumed to follow a
Poisson(λ(x;θ)E∗(x;θ)) distribution for known exposure (here E∗(x;θ) can be re-
garded as ‘adjusted exposure’ where the cdf of the appropriate claim delay distribu-
tion (CDD) is used as an adjustment factor). Detailed explanation and the estimation
procedure can be found in Macdonald (1996a, b, c). Therefore in Chapters 7 and 8
we will assume that the observed number of claims has a Poisson distribution. This
will facilitate the use of a generalised linear model (GLM) for smoothing the inception
rates.
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Figure 1.1: A multi-state model for specific causes for CII.
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1.4 Outline of the thesis
The layout of the thesis is as follows:
The data we used are described in Chapter 2. The information available for each
observation is presented and the grouping of the CI causes is described. This grouping
is based on core illnesses defined by the ABI and on CMI experience.
In Chapter 3 the modelling of the claim delay distribution (CDD) without considering
business growth and missing observations is presented. As the Burr is not a member of
the exponential family of distributions, a generalised-linear-type model (GL-type) is
fitted, where claim-related factors possibly affecting the delay are linked to the mean
of the distribution. The method we use to estimate the CDD gives us an opportunity
to estimate the claim delays for various characteristics in a single model and calculate
the probability of settling a claim using an appropriate CDD.
When modelling the claim delays in Chapter 4, changes in the volume of CI busi-
ness are taken into consideration for each office; the growth rates differ significantly
between individual offices.
The most suitable CDD is chosen in Chapter 5 after variable selection using both
Bayesian methodology under different prior distribution setups and frequency-based
model selection techniques. First, claim specific covariates are selected for the models
without considering the growth rates, and the selection is then repeated for the model
which includes growth rates.
Although the number of submitted dates of diagnosis is increasing over time, the
number of missing cases is still significant considering that date of diagnosis is accepted
as the ‘date of claim’. Excluding these claims from the analyses might lead to biased
estimates, especially if these missing dates are not random (e.g. depending on office
or cause). In this thesis we use a Bayesian approach as this incorporates missing
or unobserved information in a natural manner. Under a Bayesian setting missing
data are treated as additional parameters that are estimated in the analysis through
imputation of their values in a MCMC scheme in Chapter 6. The missing values are
estimated using the median of the most suitable CDD obtained in this chapter and
this complete data set is used when the diagnosis inception rates are modelled.
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The estimation of diagnosis inception rates for all-causes (combined) is presented in
Chapter 7. An appropriate CDD is used to adjust the exposures in order to eliminate
the effects of long delays between dates of diagnosis and settlement of claims (e.g.
IBNS). The number of claims is assumed to have a Poisson distribution and diagnosis
inception rates are smoothed using a similar model to that described in Forfar et
al. (1988). Diagnosis inception rates are smoothed using three different subsets of
covariates. In the first model, we used the best model after variable selection. To
compare our rates with CMI rates (in WP 43 (2010)) we also used the best model
which includes the CMI variables and the model which only uses the CMI variables.
Here, CMI variables refer to policy type, sex, smoker status and policy duration
variables. Also, in this chapter, the effect of using the median of the CDD obtained in
Chapter 6 to estimate the missing dates on the diagnosis inception rates is investigated
by a sensitivity analysis.
Diagnosis inception rates are modelled for specific causes and results are compared
with all-cause rates in Chapter 8.
Finally, our conclusions together with some discussions and ideas for further research
are presented in Chapter 9.
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Chapter 2
Data
Our aim is to develop models for critical illness insurance for providing diagnosis
inception rates by determining the effects of various risk factors on diseases and death.
To do this, we use the claims data and corresponding inforce data supplied by the
CMI in the UK. The CMI collects data from contributing offices on critical illness
business on a calendar year basis. Since CI policies can have long periods between
the dates of diagnosis and settlement, it is not practical for the CMI to wait until
all the diagnosed claims in a particular year have been settled. Hence, the CMI asks
for the submission of the settled claims during the year only (see e.g. CMI WP 33
(2008)). The data with which we are provided relate to claims inforce and/or settled
in the years 1999 - 2005.
Each observation in the data set has various characteristics. These can be listed as
(a) Sex: female, male are coded as F and M, respectively
(b) Smoker status: non-smoker, smoker, undifferentiated are coded N, S and U,
respectively
(c) Record year: taking values from 1999 to 2005
(d) Benefit type: full accelerated, stand alone are coded as F and S, respectively
(e) Office number: coded anonymously from letter A to letter S. If the office has
changed its portfolio of policies during its contribution period, this is shown by
a suffix (e.g. A becomes A2 and then A3)
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(f) Territory: the UK, Eire are coded as 1 and 2 (all of the claims have code 1),
respectively
(g) Policy type: joint or single life are coded as J and S, respectively
(h) Sales channel: bancassurer, direct sales, IFA, other, unknown are coded as B,
D, I, O and U, respectively
(i) Benefit amount: in GBP
(j) Submission group: coded from 1 to 15 to show the contribution period of an
office (see Table 2.1 for details)
(k) Date of birth: in DDMMYYYY format
(l) Date of commencement (of the policy): in DDMMYYYY format
For the claims data, we are also provided with
(m) Type of claim: death, critical illness are coded as D and C, respectively
(n) Cause of critical illness claim: there are 54 different critical illnesses and death
giving cause of claim in the data set.
Moreover for each claim, contributing offices are asked to provide 4 dates which are
(o) Date of diagnosis: in DDMMYYYY format
(p) Date of notification: in DDMMYYYY format
(q) Date of claim admission: in DDMMYYYY format
(r) Date of settlement: in DDMMYYYY format.
However these dates are not always completed by the offices and sometimes they show
inconsistencies (e.g. date of notification is earlier than date of diagnosis).
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Table 2.1: Details of the submission groups.
Group Years of submission
1 Data submitted consistently throughout 1999-2005
2 Data submitted consistently throughout 1999-2002
3 Data submitted consistently throughout 2003-2005
4 Data submitted consistently throughout 2003-2004
5 Data submitted for 2005 only
6 Data submitted consistently throughout 1999-2003
7 Data submitted for 2004 only
8 Data submitted consistently throughout 1999-2001
9 Data submitted consistently throughout 2000-2005
10 Data submitted consistently throughout 2000-2004
11 Data submitted for 1999 only
12 Data submitted consistently throughout 2000-2002
13 Data submitted for 2002 only
14 Data submitted consistently throughout 2000-2003
15 Data submitted consistently throughout 2004-2005
These submission groups enable us to determine details of the policies inforce at the
start and at the end of each of the seven years of the investigation period. This
information is needed to calculate exposure - see Chapter 7.
Another point to mention is that we have not used ‘Sales Channel’ in our analyses since
it is highly related to ‘Office’. Of the 13 offices we have considered in our analyses, 6
offices use only one sales channel among four known channels. The numbers of sales
channels used by the offices are given in Table 2.2. One of the offices uses only the
‘Unknown’ sales channel, thus it is not shown in the table. Since offices use specific
sales channels, office and sales channel are highly related and therefore one of these
two variables is unnecessary in the analyses.
Table 2.2: Number of offices and number of sales channels.
No. sales channels
1 2 3 4
No. offices 6 3 1 2
The claims file contains records of 27244 claims settled in the seven year period from
1999 to 2005. Of these claims, a total of 8117 (29.8%) were omitted from our analysis
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of the claim delay distribution for one of the following reasons:
(i) One of the offices provided both dates of diagnosis and settlement for only
235 claims out of 4426 and all of them are death claims. This caused many
computational problems when including the missing values as we do not have
sufficient information for the other causes for this office. (4426)
(ii) Both date of diagnosis and date of settlement are missing (some offices have
never provided both dates of diagnosis and settlement). (3585)
(iii) Smoker status is not recorded. (61)
(iv) Date of commencement is the same as date of diagnosis. (42)
(v) Date of commencement is the same as date of birth. (1)
(vi) Date of commencement is the same as date of notification. (1)
(vii) Date of commencement is the same as date of settlement. (1)
As a result we ended up with 19127 claims. In the data, 9.2% of these claims have
no date of diagnosis which we use as date of claim. We need the date of claim to
calculate the duration of the policy and policyholder’s age at the time of claim. By
defining the date of claim, claims will be assigned to a particular year’s experience.
If the aim is to produce claim diagnosis rates, the date of diagnosis seems suitably to
represent the claim date, as the claim will have been incurred in the insurance period
but not necessarily reported or settled in the same year. In this respect, it reflects
the true cost to the insurer (CMI WP 14, 2005; CMI WP 33, 2008).
On the other hand, claims are submitted to the CMI according to their settlement
year and 7.9% of the data have no date of settlement. Out of 19127 claims settled in
the period 1999 - 2005, only 15860 have both dates of diagnosis and settlement. This
corresponds to 82.9% of the whole claims data set. The observed intervals between the
four dates relate to each claim and the missing figures for these delays are summarised
in Table 2.3.
To summarise the data, the number of claims and percentages by various factors
are given in Table 2.4. The identity of each contributing office is confidential so this
characteristic was recorded as a code. Our data originated from 13 different offices, not
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Table 2.3: Average observed delays between dates of diagnosis, notification, admission
and settlement (in days).
Diagnosis to Notification to Admission to Diagnosis to
Notification Admission Settlement Settlement
Mean delay 93 80 18 185
No. observations 15585 9190 9752 15860
% of observations
having both dates 81% 48% 51% 83%
all of which contributed data in each of the seven years. In terms of the percentage
of the total claims, the largest contribution was 27.5%, the smallest 0.1% and the
median was 3.0%.
Table 2.4: Number of claims and percentages by various factors.
Benefit Type Critical Illnesses
Full Accelerated 16875 (88.2%) CABG 393 (2.1%)
Stand Alone 2252 (11.8%) Cancer 9381 (49.0%)
Deaths 3371 (17.6%)
Joint/Single Life Heart Attack 2220 (11.6%)
Joint Life 9743 (50.9%) Kidney Failure 110 (0.6%)
Single Life 9384 (49.1%) Major Organ Transplant 36 (0.2%)
Multiple Sclerosis 825 (4.3%)
Gender Other 1265 (6.6%)
Female 8173 (42.7%) Stroke 1027 (5.4%)
Male 10954 (57.3%) Total and Permanent Disability 499 (2.6%)
Smoker Status Type of Claim
Non-Smoker 14129 (73.9%) Claim (Critical Illness) 15756 (82.4%)
Smoker 4998 (26.1%) Death 3371 (17.6%)
Most of the policies (88%) are covering death as well as critical illness, i.e. full
accelerated policies. The greater proportion of claimants are non-smokers; the non-
smoker/smoker split (75%/25%) is approximately the same as in the general UK
population. We have a good representation for females and males. Joint life and
single life policies are almost equally split.
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CII policies cover a great number of illnesses, but eight illnesses – cancer, heart attack,
stroke, CABG, MOT, kidney failure, MS and TPD – and death form 93.4% of the
total cases. All other causes are grouped in the ‘Other’ claim cause category which
includes 6.6% of the data. In total, 10 causes of claims are taken into consideration
in our analyses. These diseases and relevant groupings are explained in detail later in
this section.
Grouping the critical illness causes
There are 55 different cause codes in the claims data, most of which are types of
cancer. Among the specified cancer types, the biggest group is female breast cancer
with 1838 claims. Since we have a significant amount of data for this cancer type
we wanted to analyse it as a separate cause. However cancer claims include ‘site
not specified’ which, in fact, includes the biggest number of claims with 4363 claims
out of a total 19127 claims (and corresponds to 22.3% of all claims and 45.4% of all
cancer claims). We are told by the CMI that ‘site not specified’ group includes female
breast cancer claims as well as other cancers. This means that analysing cancer types
individually will underestimate the true rates. Therefore we do not subdivide cancer
into categories and analyse cancer as a single cause. This issue is also mentioned by
the CMI in WP 43 (2010, page 38).
The 55 causes of claim and the groups used in the analyses are given in Table 2.5.
In the table, the number of claims for each cause is also presented. We reduce the
number of causes for analysis by grouping some of the less frequent causes mostly
depending on the ABI definition of ‘core’ conditions (ABI, 2005) and on the grouping
which the CMI uses in its working papers (this is explained in CMI WP 14 (2005,
Appendix C)).
Cancer, heart attack and stroke are the major causes of claim as they are always cov-
ered under a critical illness policy. According to the ABI (2005), other core conditions
are CABG, kidney failure, MOT and MS. Apart from these diseases we treat TPD as
a separate group following CMI practice. All the other causes merged into the ‘Other’
cause group (unlike the CMI’s WP 43 (2010), we group terminal illness and unknown
in other causes. Later in WP 50 (2011), unknown claims are combined with the other
17
causes by the CMI). These 9 categories together with death form our cause variable
throughout the thesis.
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Table 2.5: Grouping cause of claim.
CMI Cause Coded as No. Claims
1 Coronary Artery Bypass Graft (CABG) CABG 393
2 Cancer - site not specified Cancer 4363
3 Hodgkin’s disease Cancer 60
4 Leukaemia Cancer 201
5 Malignant melanoma of skin Cancer 285
6 Malignant Neoplasm (MN) of oesophagus Cancer 29
7 MN - multiple sites Cancer 19
8 MN of bladder Cancer 56
9 MN of bone and articular cartilage Cancer 12
10 MN of bone, connective tissue, skin and breast - unspec. Cancer 16
11 MN of brain Cancer 128
12 MN of colon Cancer 286
13 MN of digestive organs and peritoneum - unspec. Cancer 44
14 MN of female breast Cancer 1838
15 MN of genitourinary organs - unspec. Cancer 78
16 MN of kidney and other urinary organs Cancer 111
17 MN of larynx Cancer 40
18 MN of lip, oral cavity and pharynx Cancer 37
19 MN of liver Cancer 46
20 MN of lymphatic and haematopoietic tissue Cancer 279
21 MN of other sites Cancer 302
22 MN of ovary and uterine adnexa Cancer 229
23 MN of pancreas Cancer 63
24 MN of prostate Cancer 199
25 MN of rectum, rectosigmoid junction and anus Cancer 8
26 MN of respiratory and intrathoracic organs - unspec. Cancer 11
27 MN of small intestine including duodenum Cancer 18
28 MN of stomach Cancer 64
29 MN of testis Cancer 361
30 MN of trachea, bronchus and lung Cancer 228
31 Myeloid leukaemia Cancer 8
32 Other MN of skin Cancer 22
33 Deaths Death 3371
34 Heart Attack (HA) HA 2220
35 Kidney Failure (KF) KF 110
36 Major Organ Transplant (MOT) MOT 36
37 Multiple Sclerosis (MS) MS 825
38 Alzheimers Disease Other 8
39 Angioplasty Other 131
40 Aorta Graft Surgery Other 15
41 Benign Brain Tumour Other 278
42 Blindness Other 7
43 Coma Other 74
44 Deafness Other 1
45 Heart Valve Replacement / Repair Other 151
46 Loss of limbs Other 5
47 Motor Neurone Disease Other 42
48 Other Other 208
49 Paralysis / Paraplegia Other 47
50 Parkinsons Disease Other 66
51 Terminal Illness Other 6
52 Third Degree Burns Other 5
53 Unknown Other 161
54 Stroke Stroke 1027
55 Total Permanent Disability (TPD) TPD 499
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Chapter 3
Modelling CDD I: Without
considering the missing values and
growth rates
3.1 Introduction
The aim of this chapter is to model the delay between diagnosis and settlement dates.
Both classical methods and Bayesian methods are employed. The classical method
is based on maximum likelihood estimation. The coefficients are obtained by max-
imising the likelihood with a Newton-Raphson iterative approach using R software
(R Development Core Team, 2009). In Bayesian analyses we consider the posterior
distribution, which is given in terms of the likelihood function and the prior distribu-
tion. However, in some cases these posterior distributions might be too complex to be
derived analytically. In these cases, MCMC methods can be used to integrate over the
high dimensional posterior distribution and make inferences about model parameters
(Gilks et al., 1996). Bayesian methodology is quite natural for interpreting statistical
conclusions and its flexibility allows complex data sets to be managed (Gelman et
al., 2000). Moreover, MCMC methodology allows us to apply Bayesian analysis to
the complex data sets considered here and also to include missing observations in
later chapters. Bayesian methods and MCMC techniques are used with the help of
the WinBUGS software package (Spiegelhalter et al., 2003). In this chapter, we only
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consider claims where both dates of diagnosis and settlement are known. There are
15860 such cases out of 19127 which corresponds approximately to 83% of the data.
Later, in Chapter 6, we also include unobserved dates in the analysis.
Some features of the observed delay between the dates of diagnosis to settlement are
given in Section 3.2. In Section 3.3, we present the results assuming the contributing
offices do not grow within successive years. In Section 3.4, prediction results are given
for some hypothetical scenarios.
3.2 The observed delay
Before we start modelling we would like to give some features of the delay between
the dates of diagnosis and settlement. The mean delay between these two dates is 185
days whereas the median is 111 days and the maximum delay is 3980 days. Figure
3.1 shows the distribution of the duration of the delay for these claims, measured in
days. Although in theory it is not likely to be diagnosed and settled in the same day,
some claims have zero days between these two dates. Since we are told by the CMI
that these claims are genuine claims and there are no known mistakes, we kept these
39 claims in the analyses by adding 0.5 days to delay due to the calculation problems
(logarithmic transforms and distributions defined only for strictly positive values).
Most of these claims (31) are death claims with 4 cancer, 3 TPD and 1 other causes
claims.
Without any modelling, the box plot of the delay by cause on a logarithmic scale is
shown in Figure 3.2. The interquartile range of TPD is the widest. The median of the
delay of death claims is 78 days and it is smaller than the medians of other causes.
The minimum delay of MOT is the longest one with 24 days.
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Figure 3.1: Histogram of claim settlement delay (in days).
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Figure 3.2: Box plots of observed delay by cause (in days).
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3.3 Modelling under the assumption of no growth
within offices
Without subdividing the data set by different risk factors, parametric models are fitted
to 15860 claims where we have dates of both diagnosis and settlement. Considering the
shape of the histogram in Figure 3.1, the data are positively skewed which is common
for waiting time data, especially in insurance. Commonly, standard 2-parameter
distributions such as the lognormal, Pareto and Gamma are employed in insurance
data problems, partly because of their straightforward use. Here the distribution of
the observed data suggests that a 3-parameter distribution may be more suitable due
to its flexibility in modelling heavy-tails. We note that the Pareto distribution is a
special case of the Burr distribution when one of the shape parameters is equal to 1.
We use a 3-parameter Burr model and compare our main findings with results ob-
tained using the more commonly used lognormal distribution. We treat all unknown
coefficients and parameters appearing in the model as random quantities and we assign
to them prior distributions to complete the Bayesian setting.
The Burr model
The delay for claim i is denoted by a random variable Di and under the assumed
Burr(α, τ, λ) model, its probability density function is given by
f(di;α, τ, λ) =
ατλαdτ−1i
(λ+ dτi )
α+1
, i = 1, . . . , n, (3.1)
for di, α, τ, λ > 0, where α and τ represent shape parameters, λ is a scale parameter
(Hogg and Klugman, 1984) and n is the number of claim delays.
Here we consider an alternative Burr parameterisation (Dutang et al., 2008), by defin-
ing a new scale parameter s = λ1/τ . This parameterisation was chosen mainly in order
to improve the efficiency of the MCMC estimation algorithm. The density function
is now given as
f(di;α, τ, s) =
ατ(di/s)
τ
di[1 + (di/s)τ ]α+1
, i = 1, . . . , n,
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for di, α, τ, s > 0. Under this setting, the distribution function is
FD(d) = 1−
(
sτ
sτ + dτ
)α
with kth moment given by
E(Dk) = skΓ
(
α− k
τ
)
Γ
(
1 +
k
τ
)
/Γ (α) , (3.2)
for ατ > k, or ∞ otherwise.
In a GL-type setting, we regress covariates of interest on the mean of the distribution
and use a logarithmic link since the mean duration should be strictly positive. This
gives
E(Di) = exp(ηi) i = 1, . . . , n (3.3)
where η = Xβ, with η n × 1, X the n × (p + 1) design matrix and β denoting the
(p+1)× 1 coefficient vector. Here p is the number of covariates which are given later
in Table 3.3.
To associate the mean of the delay distribution with the explanatory variables, we
consider (3.2) and use the link function in (3.3) to obtain the Burr GL-type model
Di ∼ Burr(α, τ, si)
with
E(Di) = exp(ηi)
= si
Γ(α− 1/τ)Γ(1 + 1/τ)
Γ(α)
(3.4)
which implies that
si =
Γ(α)
Γ
(
α− 1
τ
)
Γ
(
1 + 1
τ
) exp(ηi).
Note that si = λ
1/τ
i . To facilitate the fitting of this non-standard model, we consider
expressing the Burr distribution as a mixed hierarchical model comprising a Weibull
and a gamma component. This is particularly useful as the WinBUGS software (used
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here for MCMC estimation) does not include the Burr distribution in its standard
models. An alternative option, to explicitly define the Burr likelihood function in the
WinBUGS code, proved to be very inefficient (Spiegelhalter et al., 2003) and led to
computational problems especially when we introduced missing values to the problem.
Using the parameterisation given in (3.1), the mixed model is given as
Di|θi ∼ Weibull(τ, θi)
θi ∼ Gamma(α, λi)
(3.5)
for i = 1, . . . , n and τ , θi, α, λi > 0. This can be shown by first noticing that the
marginal density function of di under (3.5) is
f(di) =
∫ ∞
0
f(di|θi)h(θi)dθi
with f(.) and h(.) being the probability density functions of di and θi. Here
f(di|θi) = τθidτ−1i exp(−θidτi ) and
h(θi) =
λαi θ
α−1
i exp(−λiθi)
Γ(α)
.
This gives
f(di) =
τdτ−1i λ
α
i
Γ(α)
∫ ∞
0
θαi exp(−θi(λi + dτi ))dθi
and by integrating over θi
f(di) =
τdτ−1i λ
α
i
Γ(α)
Γ(α+ 1)
(λi + dτi )
α+1
which implies that the marginal density of di is
f(di) =
ατλαi d
τ−1
i
(λi + dτi )
α+1
i.e. di|α, τ, λi ∼ Burr(α, τ, λi).
In the following sections we consider prior distributions for the model parameters
under the Bayesian model. For the classical analysis, we maximised the following
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log-likelihood function
l = log(f(D|α, τ, β)) =n log(α) + n log(τ) + α
∑
i
log(λi) + (τ − 1)
∑
i
log(di)−
(α+ 1)
∑
i
log(λi + d
τ
i ).
(3.6)
The LN model
The probability model used for a lognormal GLM is
Di ∼ LN(µi, σ2) i = 1, . . . , n
µ = η =Xβ
(3.7)
where µ being n× 1 vector. The log-likelihood is
l = log(f(D|σ2, β)) = −n
2
log(2pi)− n log(σ)−
∑
i
log(di)−
∑
i (log(di)− µi)2
2σ2
.
3.3.1 The null model
First consider the null model, i.e. the model with
E(Di) = exp(ηi) = exp(η) = exp(β0), i = 1, . . . , 15860.
This is equivalent to the GL-type model in (3.4) with
E(Di) = sG(α, τ)
where G(α, τ) = Γ(α−1/τ)Γ(1+1/τ)
Γ(α)
. By setting s = (G(α, τ))−1 exp(β0) we have
β0 = log(s) + log(G(α, τ)).
In order for the mean E(Di) to be defined, we need ατ > 1 and therefore we impose a
restriction on the prior distribution of τ . Censoring is denoted here using the notation
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I(lower, upper). We therefore assign the following non-informative prior distributions
α ∼ Gamma(0.001, 0.001)
τ ∼ Gamma(0.001, 0.001) I
(
1
α
,∞
)
s ∼ Gamma(1, 0.01).
The likelihood of this model is
f(D|α, τ,β) = αnτn
n∏
i
(
(G(α, τ))−1 exp(β0)
)ατ
dτ−1i
[(
(G(α, τ))−1 exp(β0)
)τ
+ dτi
]−(α+1)
.
(3.8)
Model parameters are estimated by using MCMC methodology in WinBUGS and
by maximising the likelihood given in (3.8) in R software. To obtain the Bayesian
estimates, 10000 iterations were performed after 4000 burn-in values. Chain traces
and low MC errors showed that convergence was satisfied after burn-in.
Table 3.1 shows posterior estimates and ML estimates of the model parameters and
also the mean, median, standard deviation and the log-likelihood value of the fitted
Burr and lognormal distributions. Bayesian estimation and classical analysis give very
close results. The mean delay under the Burr distribution is longer than with the
lognormal model whereas the median delay of the fitted Burr distribution is shorter.
This is because the Burr distribution is more skewed to the right due to its longer
tail. For the Burr distribution, the condition of the existence of the second moment
given in (3.2) is not satisfied, i.e. ατ 6> 2. So, the second moment of this distribution
is not defined, giving infinite variance.
Also note that the estimate of τ under the Burr distribution (around 2.3 with 0.028
standard deviation) shows that the parameter is significantly greater than 1. Since
Burr(α, 1, λ) ≡ Pareto(α, λ), the estimate of τ suggests that a Pareto distribution
would not be appropriate.
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Table 3.1: Posterior and ML estimation under the null model.
Burr LN
Mean SD Mean SD Mean SD Mean SD
MCMC MCMC MLE MLE MCMC MCMC MLE MLE
α 0.7784 0.0191 0.7764 0.0193 µ 4.7516 0.0075 4.7516 0.0075
τ 2.2290 0.0282 2.2324 0.0275 σ 0.9434 0.0053 0.9434 0.0053
s 95.7123 1.6505 95.5588 1.6867
Mean 193.26 2.9842 193.21 - 180.67 1.6202 180.66 -
Median 112.59 0.7548 112.59 - 115.77 0.8640 115.77 -
SD ∞ - ∞ - 216.47 3.3465 216.40 -
LogL -96135.3 -96133.8 -96941.4 -96940.4
To compare the Burr and lognormal models, we use the deviance information criterion
(DIC) under the Bayesian methodology (Spiegelhalter et al., 2002) and Bayesian
information criterion (BIC) under the classical analysis (Schwarz, 1978). To calculate
the DIC, the effective number of parameters, pD is used. This is given as the difference
between the posterior mean of the deviance, D¯ = ̂−2 logL(θ), and the deviance
calculated at posterior means of the parameters, Dˆ = −2 logL(θˆ). Then, DIC =
D¯ + pD. BIC can be calculated as BIC = −2 logL(θˆ) + k log(n) where k is the
number of estimated parameters. The lower criteria values of the Burr distribution
(see Table 3.2) imply a better fit of this model when covariates are not considered.
Table 3.2: Information criteria under the null model.
Burr LN
BIC (MLE) 192296.5 193900.1
D¯ = ̂−2 logL(θ) 192270.53 193882.86
Dˆ = −2 logL(θˆ) 192267.51 193880.82
pD 3.02 2.04
DIC (MCMC) 192273.55 193884.90
Figure 3.3 shows a comparison of the empirical cdf of observed duration and the fitted
distribution using posterior estimates of the parameters under the Burr and lognormal
distributions. When data are not subdivided, the cdf of the observed duration is very
close to the cdf of the fitted Burr distribution. All comparisons of cdfs, log-likelihood
values and information criteria suggest that the Burr distribution gives a considerably
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better fit than the lognormal distribution.
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Figure 3.3: CDF of the diagnosis – settlement interval.
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3.3.2 Analysis with covariates
To model the delay, 10 covariates are used, namely age, sex, benefit type, smoker
status, joint/single life, settlement year, benefit amount, policy duration, office and
cause of claim. Details of these covariates are given in Table 3.3. The office covariate
with 13 levels and cause of claim with 10 levels are taken as categorical variables. To
compare office and cause effects with the corresponding mean level effect, a sum-to-
zero constraint is used for these variables, whereas standardised values are used for
other variables.
Table 3.3: Definitions of the covariates.
Covariate Number of Levels Additional Information
x1 Age Numerical age last birthday at date of diagnosis
x2 Sex 2 (F & M) F is the base category
x3 Benefit type 2 (FA & SA) FA is the base category
x4 Smoker status 2 (N & S) N is base category
x5 Policy type 2 (Joint/Single life) J is the base category
x6 Settlement year Numerical record year
x7 Benefit amount Numerical
x8 Policy duration Numerical duration between dates of diagnosis and
commencement of the policy
x9 Office 13
x10 Cause of claim 10 1.CABG
2.Cancer
3.Death
4.Heart Attack
5.Kidney Failure
6.Major Organ Transplant
7.Multiple Sclerosis
8.Other
9.Stroke
10.Total and Permanent Disability
The Burr model
We regress the covariates on the mean of the Burr distribution and use the logarithmic
link in (3.4) where
ηi = β0 +
8∑
j=1
βjzij + β9,Officei + β10,Causei (3.9)
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for i = 1, . . . , 15860,Officei = 1, . . . , 13,Causei = 1, . . . , 10.
Here zij = (xij− x¯j)/sd(xj) are the standardised observations with xij being the orig-
inal observations, β0 and βj (j = 1, . . . , 8) are the standardised intercept term and
coefficients respectively and β9,1, . . . , β9,13, β10,1, . . . , β10,10 are the coefficients corre-
sponding to the different levels of the office and cause factors. The coefficients on the
original scale for the linear covariates, bj, and the intercept term, b0, can be calculated
by bj = βj/sd(xj) and b0 = β0 −
∑8
j=1 bjx¯j.
We assign the following non-informative prior distributions to the model parameters.
α ∼ Gamma(0.001, 0.001)
τ ∼ Gamma(0.001, 0.001) I( 1
α
,∞)
βj ∼ N(0, 1000), j = 0, . . . , 8
β9,k ∼ N(0, 1000), k = 2, . . . , 13
β10,l ∼ N(0, 1000), l = 2, . . . , 10
with
13∑
k=1
β9,k = 0 and
10∑
l=1
β10,l = 0.
(3.10)
The likelihood of this model can be given as
f(D|α, τ,β) = αnτn
n∏
i
((G(α, τ))−1 exp(ηi))
ατdτ−1i
[
((G(α, τ))−1 exp(ηi))
τ + dτi
]−(α+1)
where ηi is in (3.9) and the joint posterior density has the form
p(α, τ,β|D) ∝ f(D|α, τ,β)pi(α)pi(τ)pi(β) (3.11)
where pi(α), pi(τ), pi(β) are the prior densities given in (3.10).
Posterior estimates and the ML estimates of the model parameters are presented in
Table 3.4. The graphical representation of the posterior estimates with their 95%
credible intervals can be seen in Figure 3.6. Bayesian estimates are obtained after
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34000 iterations where the first 4000 iterations are considered as a burn-in process.
MC errors for all estimated parameters were relatively small and are not presented
here. Convergence of the algorithm was also checked by inspecting the chain trace
of the parameters, which indicated that the Markov chains converged after 4000 it-
erations. ML estimates of the mean and standard deviation of the coefficients are
very close to the Bayesian estimates. This is because we have a large amount of data
and we use uninformative priors for the model parameters. Note that after including
the covariates in the model, estimated means, standard deviations and 95% credible
interval of τ suggest once again that τ is significantly different from one and thus a
Pareto distribution does not fit the data.
Based on this model, the settlement year, policy duration, office, death and stroke
have stronger effects on the delay. The data suggest that the delay between diagnosis
and settlement in CII is shorter for stand alone policyholders (β3) and smokers (β4)
whereas it is longer for younger ages (β1), single life policyholders (β5) and for more
recent settlement years (β6). The benefit amount (β7) has a negative effect on the
delay. The delay gets shorter as the time since the policy was effected gets longer
(β8). Office (β9) also affects the time between diagnosis and settlement with different
administrative procedures changing the diagnosis – settlement period among offices.
The cause of claim (β10) has a big impact on the delay. For CABG or cancer claims
the delay is shorter than average while the shortest delay is associated to death claims.
The definition of multiple sclerosis, given by the ABI, states that the symptoms of
this disease should be persistent for a continuous period of at least 6 months (ABI,
2006). When there is this kind of waiting period, the delay until the date of settlement
increases significantly. Other diseases such as stroke or major organ transplant also
have a positive effect on the length of the delay. Note that the negative estimate of
coefficient β2 implies a shorter delay for males. However, the 95% credible interval
suggests that there is high posterior probability that there is no effect of gender on
the delay distribution.
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Table 3.4: Coefficients of the Burr model without growth rate.
MCMC MLE
Parameter Mean SD 2.5% 50% 97.5% Mean SD
β0 5.2970 0.0289 5.2430 5.2970 5.3560 5.2938 0.0280
β1 -0.0207 0.0073 -0.0347 -0.0207 -0.0065 -0.0205 0.0070
β2 -0.0131 0.0066 -0.0256 -0.0132 0.0001 -0.0129 0.0067
β3 -0.0285 0.0060 -0.0403 -0.0284 -0.0166 -0.0284 0.0061
β4 -0.0190 0.0064 -0.0317 -0.0189 -0.0062 -0.0189 0.0064
β5 0.0329 0.0063 0.0203 0.0328 0.0454 0.0333 0.0063
β6 0.1149 0.0075 0.1000 0.1149 0.1293 0.1152 0.0073
β7 -0.0373 0.0066 -0.0503 -0.0371 -0.0241 -0.0375 0.0066
β8 -0.1164 0.0077 -0.1313 -0.1166 -0.1011 -0.1168 0.0078
β9,1 0.2352 0.0245 0.1866 0.2354 0.2828 0.2365 0.0239
β9,2 0.1287 0.0234 0.0826 0.1291 0.1741 0.1295 0.0218
β9,3 -0.2016 0.0605 -0.3249 -0.1996 -0.0853 -0.1944 0.0611
β9,4 0.1271 0.0521 0.0276 0.1284 0.2263 0.1313 0.0495
β9,5 -0.1365 0.0369 -0.2085 -0.1369 -0.0642 -0.1402 0.0368
β9,6 -0.5209 0.0818 -0.6747 -0.5255 -0.3627 -0.5338 0.0830
β9,7 -0.2960 0.1282 -0.5191 -0.3150 -0.0177 -0.2997 0.1223
β9,8 0.0733 0.0233 0.0238 0.0745 0.1159 0.0748 0.0217
β9,9 -0.2040 0.0275 -0.2599 -0.2034 -0.1532 -0.2023 0.0267
β9,10 0.2224 0.0315 0.1584 0.2229 0.2826 0.2245 0.0328
β9,11 -0.0836 0.0212 -0.1261 -0.0833 -0.0434 -0.0825 0.0196
β9,12 0.1927 0.0260 0.1424 0.1929 0.2451 0.1948 0.0259
β9,13 0.4632 0.0772 0.3114 0.4629 0.6166 0.4613 0.0777
β10,1 -0.1325 0.0418 -0.2144 -0.1327 -0.0513 -0.1318 0.0414
β10,2 -0.0895 0.0194 -0.1267 -0.0898 -0.0506 -0.0889 0.0205
β10,3 -0.4787 0.0275 -0.5324 -0.4791 -0.4247 -0.4784 0.0281
β10,4 0.0256 0.0242 -0.0209 0.0254 0.0743 0.0259 0.0245
β10,5 0.0762 0.0818 -0.0841 0.0775 0.2334 0.0832 0.0803
β10,6 0.2541 0.1232 0.0038 0.2562 0.4950 0.2445 0.1218
β10,7 0.1031 0.0346 0.0360 0.1028 0.1720 0.1032 0.0343
β10,8 0.0156 0.0284 -0.0404 0.0162 0.0708 0.0163 0.0286
β10,9 0.2412 0.0287 0.1854 0.2411 0.2973 0.2414 0.0290
β10,10 -0.0150 0.0566 -0.1250 -0.0137 0.0940 -0.0155 0.0604
α 0.6200 0.0150 0.5917 0.6195 0.6513 0.6176 0.0168
τ 2.6290 0.0333 2.5580 2.6280 2.6920 2.6371 0.0383
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Model fit under the Burr distribution
To explore the model fit, residuals can be used giving the discrepancy between ac-
tual data and model fitted values. For model adequacy, deviance residuals, rD, are
calculated as follows
rDi = sign(di − dˆi)
√
2(ldi − ldˆi)
where d and dˆ are the actual and fitted delays, respectively with l being the log-
likelihood value corresponding to them (McCullagh and Nelder, 1989).
Under the parameterisation given in (3.1), both α and τ are the same for each ob-
servation in the saturated likelihood but λ is allowed to vary with observations (see
(3.6)). So the saturated log-likelihood is maximised when dl/dλi = 0. This gives
dl
dλi
=
α
λi
− α+ 1
λi + dτi
. (3.12)
Equating (3.12) to 0, we get
λi = αd
τ
i (3.13)
The deviance can be obtained by substituting (3.13) into the saturated log-likelihood
ldi = log(α) + log(τ) + α log(αd
τ
i ) + (τ − 1) log(di)− (α+ 1) log(αdτi + dτi )
ldˆi = log(α) + log(τ) + α log(αdˆ
τ
i ) + (τ − 1) log(di)− (α+ 1) log(αdˆτi + dτi )
and subtracting one from the other gives
ldi − ldˆi = ατ log(di/dˆi)− (α+ 1) log
(
αdτi + d
τ
i
αdˆτi + d
τ
i
)
. (3.14)
A plot of deviance residuals against the fitted delays is given in Figure 3.4. For
convenience of plotting, logarithms of the fitted delays are shown in the figure. The
graph shows no significant patterns in deviance residuals. The straight lines at the
bottom of the figure correspond to the claims with 0.5, 1.5 and 2.5 days delay. This
is both because of the log-linear structure of the model and the discrete nature of the
response variable.
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Figure 3.4: Deviance residuals of the Burr model without growth rate.
The LN model
The probability model used for a lognormal GLM is given as
Di ∼ LN(µi, σ2)
µi = ηi = β0 +
8∑
j=1
βjzij + β9,Officei + β10,Causei , i = 1, ..., 15860
(3.15)
with prior distributions for the β coefficients given in (3.10) and
σ2 ∼ IGa(0.001, 0.001).
Here IGa refers to ‘Inverse Gamma’ distribution. Therefore the likelihood can be
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expressed as
f(D|σ2,β) =
(
1√
2piσ2
)n n∏
i
1
di
exp
(
−
∑
(log(di)− ηi)2
2σ2
)
,
and the joint posterior density is
p(σ2,β|D) ∝ f(D|σ2,β)pi(σ2)pi(β).
where pi(σ2) is the gamma prior density for σ2. Posterior and ML estimates of the
model parameters are given in Table 3.5 for the LN model. Posterior estimates and
their 95% credible intervals are graphically represented in Figure 3.6. The two meth-
ods give very close estimates for the mean and standard deviation of all the coefficients.
Here we note that MCMC convergence under this model is satisfied faster than for
the Burr model.
Under the LN model, non-smokers (β4), younger ages (β1), single life policyholders
(β5) face longer diagnosis – settlement delays. This duration is shorter for the pol-
icyholders who have stand alone policies (β3) and for earlier settlement years (β6).
Increasing benefit amount (β7) and longer policy duration (β8) leads to shorter delays
until settlement. Office 4 (β9,4) has the longest delay whereas Office 6 (β9,6) has the
shortest. Major organ transplant (β10,6) has the strongest positive effect on the delay
among causes. Since we have fewer data for this cause, it has a wide credible interval.
Stroke comes next (β10,9) with a shorter credible interval. The only covariate which
has high posterior probability that there is no effect on the delay distribution is gender
under this model.
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Table 3.5: Coefficients of the LN model without growth rate.
MCMC MLE
Parameter Mean SD 2.5% 50% 97.5% Estimate SD
β0 4.7660 0.0273 4.7120 4.7660 4.8180 4.7628 0.0273
β1 -0.0294 0.0081 -0.0454 -0.0294 -0.0133 -0.0294 0.0081
β2 -0.0097 0.0077 -0.0249 -0.0097 0.0055 -0.0096 0.0077
β3 -0.0389 0.0073 -0.0534 -0.0389 -0.0248 -0.0390 0.0073
β4 -0.0256 0.0074 -0.0400 -0.0257 -0.0112 -0.0255 0.0074
β5 0.0315 0.0073 0.0171 0.0315 0.0459 0.0315 0.0074
β6 0.1272 0.0084 0.1106 0.1271 0.1434 0.1273 0.0084
β7 -0.0509 0.0073 -0.0652 -0.0509 -0.0365 -0.0509 0.0073
β8 -0.1755 0.0088 -0.1926 -0.1755 -0.1583 -0.1756 0.0087
β9,1 0.1688 0.0291 0.1124 0.1686 0.2270 0.1701 0.0293
β9,2 0.0763 0.0262 0.0250 0.0759 0.1281 0.0779 0.0266
β9,3 -0.1772 0.0690 -0.3099 -0.1774 -0.0406 -0.1791 0.0687
β9,4 0.3469 0.0509 0.2472 0.3464 0.4477 0.3492 0.0517
β9,5 -0.1668 0.0439 -0.2538 -0.1666 -0.0820 -0.1655 0.0436
β9,6 -0.7012 0.0889 -0.8694 -0.7038 -0.5217 -0.6956 0.0866
β9,7 -0.4013 0.1661 -0.7349 -0.4026 -0.0732 -0.4180 0.1629
β9,8 0.0397 0.0263 -0.0120 0.0397 0.0916 0.0409 0.0265
β9,9 -0.0709 0.0308 -0.1308 -0.0711 -0.0101 -0.0693 0.0305
β9,10 0.2475 0.0399 0.1698 0.2473 0.3253 0.2494 0.0398
β9,11 0.0005 0.0235 -0.0448 0.0000 0.0477 0.0022 0.0235
β9,12 0.3048 0.0297 0.2468 0.3047 0.3633 0.3067 0.0296
β9,13 0.3330 0.0978 0.1288 0.3361 0.5223 0.3311 0.1027
β10,1 -0.1365 0.0477 -0.2306 -0.1361 -0.0438 -0.1355 0.0475
β10,2 -0.0939 0.0218 -0.1369 -0.0936 -0.0520 -0.0922 0.0223
β10,3 -0.5986 0.0296 -0.6577 -0.5984 -0.5411 -0.5975 0.0299
β10,4 0.0031 0.0270 -0.0509 0.0035 0.0551 0.0043 0.0274
β10,5 0.1283 0.0865 -0.0425 0.1295 0.2965 0.1272 0.0851
β10,6 0.2631 0.1350 0.0040 0.2616 0.5315 0.2536 0.1407
β10,7 0.0497 0.0369 -0.0227 0.0498 0.1220 0.0512 0.0368
β10,8 -0.0164 0.0317 -0.0783 -0.0163 0.0449 -0.0145 0.0321
β10,9 0.2205 0.0327 0.1557 0.2208 0.2841 0.2217 0.0327
β10,10 0.1807 0.0436 0.0969 0.1802 0.2674 0.1818 0.0440
σ2 0.7981 0.0090 0.7807 0.7980 0.8159 0.7979
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The plot of deviance residuals against the logarithms of the fitted delays is given
in Figure 3.5. The graph shows no significant patterns in deviance residuals. The
straight lines at the bottom appear under the lognormal model corresponding to 0.5,
1.5 and 2.5 days of delay as well. This is, again, due to the log-linear structure of
the model and the discrete nature of the response variable. Note that 3.8% of the
residuals lie outside [-2,2].
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Figure 3.5: Deviance residuals of the LN model without growth rate.
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Comparison of Burr and LN models
To compare the Burr and lognormal models, the corresponding estimates of DIC and
BIC are given in Table 3.6. The lower values of information criteria of the Burr model
suggests that the fit is better under this distribution.
Table 3.6: Values of information criteria of the models without growth rate.
D¯ = ̂−2 logL(θ) Dˆ = −2 logL(θˆ) pD DIC BIC
Burr 190348.2 190316.7 31.5 190379.7 190626.0
LN 192150.8 192120.3 30.5 192181.3 192420.1
Figure 3.6 shows a comparison between the posterior estimates and 95% credible
intervals of the coefficients under both models. All the coefficients have the same
direction of effect on the delay when they are significant under the two models. How-
ever magnitudes of the effects are changing significantly for some coefficients, such as,
policy duration (β8), death (β10,3), TPD (β10,10) or Office 4, Office 9 and Office 12
(β9,4, β9,9 and β9,12). The first two have stronger negative effect and the latter ones
(except Office 9) have stronger positive effect under the LN model compared to the
Burr model. The negative effect of Office 9 is stronger under the Burr distribution.
These covariates/levels might be the most affected covariates by the shape (e.g. long
tail) of the distributions.
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Figure 3.6: Comparison of posterior estimates of the coefficients under Burr (black
line) and LN (red line) model. Bars show 95% credible intervals and bullets show
posterior means.
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3.4 Prediction under the two models
We now consider 17 scenarios for different risk types, as shown in Table 3.7. Note
that benefit amounts in the table are in thousands and the currency is GBP. The
first scenario is formed using the average values of the numerical covariates and the
levels of the factors where we have most of the data. The other scenarios show how
the delay changes when claim-related factors are altered. The changing variables are
shown in bold font in the table. Selected estimates of the predicted posterior delay of
the scenarios are given in Table 3.8 under the Burr and LN model. Also, 95% credible
intervals of the predicted posterior means of the scenarios are shown in Figure 3.7 for
both models.
Posterior estimates of the means show that the mean delays are longer under the Burr
distribution for almost all of the cases. Considering the longer tail of the distribution
(see the upper bounds of the credible intervals in Table 3.8), this result is expected.
Nevertheless these differences are not significant for some scenarios as the credible
intervals of the means of the scenarios are overlapping substantially under the two
models.
The mean delay of the typical scenario (Scenario 1) is 149 days under the Burr dis-
tribution and 140 days under the LN model (these are shown with vertical lines in
Figure 3.7). For settlement year 1999 (2005) (Scenarios 8 and 9) these delays are
changing to 123 days (181 days) under the Burr model and 113 days (173 days) under
the LN model.
In the typical case, the policy duration is taken as 4 years. Increasing this period to
10 years (Scenario 13) decreases the mean delay to 114 days under the Burr model
and 93 days under the LN model. The estimated delay is 101 days (95 days under the
LN model) for the death claims (Scenario 16). These two scenarios (Scenarios 13 and
16) are also the only scenarios where the 95% credible intervals of the means under
the two models do not overlap at all. For Scenario 17, holding the other covariates
constant, for TPD claims the delay between dates of diagnosis and settlement is longer
under the LN model (185 days) than the Burr model (161 days). However we note
that the coefficient of TPD (β10,10) is not significant under the Burr model. Scenarios
13, 16 and 17 are related to policy duration, death and TPD. In the previous section,
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it is mentioned that these variables might be more sensitive to the structure of the
distribution.
The credible intervals of the Scenarios 15 and 17 are wider than the others. Among
these scenarios, Scenario 14 (for Office 6) gives the shortest mean delay with 95 days
(70 days for the LN model).
Table 3.7: Scenarios for prediction of the CDD.
Scenario (Scn) 1 2 3 4 5 6 7 8 9
Sex M F M M M M M M M
Benefit Type FA FA SA FA FA FA FA FA FA
Smoker Status NS NS NS S NS NS NS NS NS
Policy Type J J J J S J J J J
Age 45 45 45 45 45 20 65 45 45
Settlement Year 2002 2002 2002 2002 2002 2002 2002 1999 2005
Benefit Amount 50 50 50 50 50 50 50 50 50
Policy Duration 1460 1460 1460 1460 1460 1460 1460 1460 1460
Office Code 11 11 11 11 11 11 11 11 11
Cause of Claim Cancer Cancer Cancer Cancer Cancer Cancer Cancer Cancer Cancer
Scenario 10 11 12 13 14 15 16 17
Sex M M M M M M M M
Benefit Type FA FA FA FA FA FA FA FA
Smoker Status NS NS NS NS NS NS NS NS
Policy Type J J J J J J J J
Age 45 45 45 45 45 45 45 45
Settlement Year 2002 2002 2002 2002 2002 2002 2002 2002
Benefit Amount 10 250 50 50 50 50 50 50
Policy Duration 1460 1460 365 3650 1460 1460 1460 1460
Office Code 11 11 11 11 6 10 11 11
Cause of Claim Cancer Cancer Cancer Cancer Cancer Cancer Death TPD
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Table 3.8: Posterior estimates of mean delays for the scenarios in Table 3.7 for the
Burr and LN model (days).
Burr Model LN Model
Mean SD 2.5% 50% 97.5% Mean SD 2.5% 50% 97.5%
Mean.Scn1 148.9 3.6 142.0 148.8 156.2 140.1 2.8 134.6 140.0 145.7
Mean.Scn2 152.8 3.6 145.8 152.7 160.2 142.8 2.7 137.5 142.8 148.3
Mean.Scn3 136.5 4.2 128.2 136.5 144.8 124.2 3.6 117.2 124.1 131.4
Mean.Scn4 142.5 3.8 135.4 142.5 150.2 132.1 3.1 126.2 132.1 138.3
Mean.Scn5 159.1 3.9 151.9 158.9 167.4 149.2 3.1 143.2 149.2 155.5
Mean.Scn6 157.3 5.1 147.5 157.2 167.6 151.4 4.7 142.6 151.3 160.8
Mean.Scn7 142.5 3.8 135.1 142.4 150.4 131.7 3.3 125.3 131.6 138.4
Mean.Scn8 122.5 3.5 116.0 122.4 129.3 113.1 3.0 107.4 113.1 119.2
Mean.Scn9 181.0 4.6 172.1 180.9 190.6 173.4 3.9 165.8 173.4 181.2
Mean.Scn10 152.9 3.7 145.9 152.9 160.6 145.2 3.0 139.3 145.1 151.2
Mean.Scn11 130.2 4.5 121.6 130.1 139.3 117.2 3.8 109.9 117.1 124.9
Mean.Scn12 170.4 4.0 162.7 170.4 178.8 171.6 3.5 164.8 171.6 178.6
Mean.Scn13 113.6 3.9 106.5 113.4 121.5 93.3 3.0 87.7 93.3 99.3
Mean.Scn14 94.6 9.1 75.5 94.6 111.7 69.8 6.8 58.0 69.2 84.3
Mean.Scn15 201.4 8.0 186.3 201.2 217.9 179.4 7.4 165.5 179.2 194.5
Mean.Scn16 101.1 3.2 95.0 101.0 107.6 84.6 2.5 79.7 84.6 89.5
Mean.Scn17 161.4 10.1 141.0 161.4 180.3 184.5 8.5 168.6 184.2 202.0
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Figure 3.7: Comparison of posterior estimates of the mean delay under different
scenarios using the Burr (black line) and LN model (red line). Bars show 95% credible
intervals and bullets show posterior means. Vertical lines show the posterior means
of the first scenarios under the two models.
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Chapter 4
Modelling CDD II: Without
considering the missing values and
taking growth rates into account
4.1 Introduction
In this chapter, we relax the assumption of no growth rate within each office. Changes
in the business are taken into consideration for each office. The CMI’s data for CII
is growing mainly because of two reasons; new offices and new business. Since the
office codes are given in the data set, growth arising from new offices is handled in
the model. On the other hand, growth within each office between successive years
should be taken into account as this is the effect of new business. Table 4.1 shows
growth rates (based on changes in average inforce figures) and growth factors for each
office in each contribution year. As stated before, the data relate to claims where
the settlement years are between 1999 and 2005. This is also the maximum period of
the given inforce data for an office. If an office partly contributed within this period,
e.g. from 1999 to 2002, the inforce data for that office is limited to that period.
So, the average number of inforce is used to calculate the growth rate for each office
between successive years. However, some of the claims’ diagnosis dates lie before that
office’s first contribution year. For those claims, growth rates should be estimated
from the known observations. Here, modelling the growth rates is not reasonable
44
because there is lack of observed growth rates for each office and they are generally
very volatile. Rather, we preferred to use the earliest growth rate for the ones we
should estimate. Based on this estimation, the average inforce and the growth factors
can be calculated. In Table 4.1, the estimated figures are in bold font. Results,
considering the growth rates, are presented in Section 4.2. In Section 4.3, prediction
results are given for the same hypothetical scenarios introduced in Chapter 3. Model
coefficients and prediction results are also compared when the growth rate is ignored
or taken into account in the models.
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Table 4.1: Growth rates from the inforce data for offices between successive years.
Office Year Growth Growth Office Year Growth Growth
Rate (GR) Factor (GF) Rate (GR) Factor (GF)
1 2001 1.5390 8 2000 0.9147 4.0000
1 2002 0.1305 1.3613 8 2001 0.6676 2.3987
1 2003 0.1305 1.2041 8 2002 0.7589 1.3638
1 2004 0.1305 1.0651 8 2003 0.2443 1.0960
1 2005 0.0651 1 8 2004 0.1460 0.9564
8 2005 -0.0436 1
2 1997 15.4865
2 1998 0.4357 10.7870 9 1993 1.2275
2 1999 0.4357 7.5136 9 1994 0.0337 1.1875
2 2000 0.4357 5.2336 9 1995 0.0337 1.1488
2 2001 0.8013 2.9055 9 1996 0.0337 1.1113
2 2002 0.7720 1.6396 9 1997 0.0337 1.0751
2 2003 0.3811 1.1872 9 1998 0.0337 1.0400
2 2004 0.1386 1.0426 9 1999 0.0337 1.0061
2 2005 0.0426 1 9 2000 0.0337 0.9733
9 2001 0.0337 0.9416
3 1997 14.3470 9 2002 -0.0119 0.9530
3 1998 0.8440 7.7804 9 2003 -0.0276 0.9801
3 1999 0.8440 4.2193 9 2004 -0.0205 1.0006
3 2000 0.8440 2.2881 9 2005 0.0006 1
3 2001 0.5942 1.4353
3 2002 0.4353 1 10 1997 2.4990
10 1998 0.1932 2.0944
4 1994 0.3618 10 1999 0.1932 1.7554
4 1995 -0.0499 0.3808 10 2000 0.1932 1.4712
4 1996 -0.0499 0.4008 10 2001 0.1082 1.3276
4 1997 -0.0499 0.4219 10 2002 0.0964 1.2108
4 1998 -0.0499 0.4441 10 2003 0.0807 1.1204
4 1999 -0.0499 0.4674 10 2004 0.1235 0.9972
4 2000 -0.0499 0.4920 10 2005 -0.0028 1
4 2001 -0.1039 0.5490
4 2002 -0.1438 0.6413 11 1995 3.8674
4 2003 -0.1503 0.7547 11 1996 0.2193 3.1717
4 2004 -0.1405 0.8780 11 1997 0.2193 2.6011
4 2005 -0.1220 1 11 1998 0.2193 2.1332
11 1999 0.2193 1.7495
5 2000 6.0575 11 2000 0.2193 1.4348
5 2001 1.8617 2.1167 11 2001 0.1655 1.2311
5 2002 0.5098 1.4020 11 2002 0.1390 1.0808
5 2003 0.1988 1.1695 11 2003 0.0810 0.9998
5 2004 0.0970 1.0661 11 2004 0.0214 0.9788
5 2005 0.0661 1 11 2005 -0.0212 1
6 1998 15.1923 12 1993 0.5080
6 1999 0.2089 12.5667 12 1994 0.0001 0.5079
6 2000 0.2089 10.3949 12 1995 0.0001 0.5078
6 2001 0.2089 8.5985 12 1996 0.0001 0.5077
6 2002 0.7340 4.9586 12 1997 0.0001 0.5077
6 2003 0.7422 2.8462 12 1998 0.0001 0.5076
6 2004 0.7862 1.5934 12 1999 0.0001 0.5075
6 2005 0.5934 1 12 2000 0.0001 0.5074
12 2001 0.0001 0.5074
7 2003 6.4257 12 2002 -0.1129 0.5719
7 2004 1.5349 2.5349 12 2003 -0.1875 0.7039
7 2005 1.5349 1 12 2004 -0.1730 0.8512
12 2005 -0.1488 1
8 1994 197.0800
8 1995 0.9147 102.9308 13 1999 2.3283
8 1996 0.9147 53.7586 13 2000 0.3047 1.7846
8 1997 0.9147 28.0770 13 2001 0.3047 1.3679
8 1998 0.9147 14.6640 13 2002 0.3679 1
8 1999 0.9147 7.6587
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4.2 Modelling when the business growth is taken
into account
The Burr model
As we only have the settled claims in the data set, recent claims have shorter delays
whereas earlier claims show the real delay structure with longer delays. However when
the growth rate is positive, the earlier observations are under-represented as they are
fewer in number. The average inforce numbers for the offices are changing across
years. This means that the number of claims would have been different, if there had
been the current amount of CI business in earlier years. Therefore we assign claims
office-specific weights according to their year of diagnosis. For example for Office 10
claims are weighted by 0.9972 if their year of diagnosis is 2004. This is because of the
negative growth (-0.28%) between 2004 and 2005. Likewise, the claims are given a
weight equal to 2.4990 weights if they are diagnosed in 1997 for this office. All claims
diagnosed in the latest year of contribution of an office have unit weights. For some
offices, growth rates are very large for earlier years. However these are relatively small
offices and the corresponding very large growth rates do not have a significant effect
on the modelling.
It is known that for estimation weights can be used in the model through the variance
of the estimates (e.g. as in common least squares estimation or weighted least squares),
i.e. weights can be inversely proportional to the variance (Greene, 1990). The variance
of the Burr distribution can be written in the following form
V (D) = s2
Γ(α)Γ(α− 2/τ)Γ(1 + 2/τ)− (Γ(α− 1/τ))2(Γ(1 + 1/τ))2
(Γ(α))2
. (4.1)
The growth factors (GF) in Table 4.1 show weights assigned to each office between
successive years. To introduce weights in the variance
sw = s/
√
GF
is used in the models.
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So, the probability model for a Burr GL-type model without missing values can be
given in the following way
Di ∼ Burr(α, τ, λwi), i = 1, . . . , 15860 (4.2)
where λwi = (swi)
τ with swi = si/
√
GFi and si = (G(α, τ))
−1 exp(ηi), G(α, τ) is as
defined in Section 3.3.1. Here we define GFi as the GF for observation i. We also
assign prior distributions
α ∼ Gamma(0.01, 0.01)
τ ∼ Gamma(0.01, 0.01) I
(
1
α
,∞
)
βj ∼ N(0, 1000), j = 1, . . . , 8
β9,k ∼ N(0, 100), k = 2, . . . , 13
β10,l ∼ N(0, 100), l = 2, . . . , 10
with
13∑
k=1
β9,k = 0 and
10∑
l=1
β10,l = 0.
(4.3)
The log-likelihood function of this model can be written in the following form
l = log(f(D|α, τ, β)) =n log(α) + n log(τ) + α
∑
i
log(λwi) + (τ − 1)
∑
i
log(di)−
(α+ 1)
∑
i
log(λwi + d
τ
i ).
(4.4)
The joint density function has exactly the same form as in (3.11) where pi(α), pi(τ),
pi(β) are the prior densities given in (4.3). By maximising (4.4), estimates of the
standardised coefficients and their standard deviations can be obtained. These are
given in Table 4.2 together with the posterior estimates. Posterior estimates are
obtained by using MCMC. A total of 30000 iterations are performed after a 4000
iteration burn-in process. Here, we see again that the ML estimates of the parameters
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are very close to those estimated using Bayesian methodology. The posterior estimates
and their 95% credible intervals are graphically represented in Figure 4.4.
Table 4.2: Coefficients of the Burr model with growth rate.
MCMC MLE
Parameter Mean SD 2.5% 50% 97.5% Mean SD
β0 5.4400 0.0293 5.3840 5.4400 5.4960 5.4351 0.0304
β1 -0.0200 0.0074 -0.0343 -0.0200 -0.0058 -0.0199 0.0072
β2 -0.0132 0.0069 -0.0267 -0.0131 0.0000 -0.0127 0.0068
β3 -0.0221 0.0063 -0.0344 -0.0220 -0.0100 -0.0221 0.0063
β4 -0.0177 0.0065 -0.0307 -0.0178 -0.0045 -0.0175 0.0065
β5 0.0374 0.0066 0.0244 0.0374 0.0503 0.0374 0.0065
β6 0.0167 0.0077 0.0015 0.0169 0.0315 0.0169 0.0077
β7 -0.0358 0.0066 -0.0488 -0.0358 -0.0231 -0.0354 0.0068
β8 -0.0996 0.0078 -0.1152 -0.0995 -0.0845 -0.0994 0.0079
β9,1 0.3021 0.0240 0.2555 0.3021 0.3494 0.3043 0.0246
β9,2 0.2489 0.0224 0.2054 0.2486 0.2926 0.2510 0.0229
β9,3 -0.1870 0.0627 -0.3081 -0.1865 -0.0641 -0.1794 0.0640
β9,4 -0.2605 0.0518 -0.3604 -0.2603 -0.1581 -0.2616 0.0514
β9,5 -0.0577 0.0393 -0.1347 -0.0576 0.0213 -0.0551 0.0380
β9,6 -0.1582 0.0917 -0.3400 -0.1604 0.0168 -0.1544 0.0925
β9,7 -0.0886 0.1297 -0.3522 -0.0843 0.1573 -0.1144 0.1258
β9,8 0.1432 0.0216 0.1010 0.1429 0.1869 0.1455 0.0225
β9,9 -0.3057 0.0275 -0.3593 -0.3058 -0.2514 -0.3042 0.0275
β9,10 0.2305 0.0324 0.1672 0.2307 0.2944 0.2346 0.0337
β9,11 -0.1064 0.0198 -0.1435 -0.1066 -0.0674 -0.1041 0.0203
β9,12 -0.1691 0.0261 -0.2200 -0.1684 -0.1192 -0.1675 0.0268
β9,13 0.4085 0.0764 0.2504 0.4109 0.5489 0.4054 0.0803
β10,1 -0.1353 0.0423 -0.2182 -0.1350 -0.0531 -0.1340 0.0422
β10,2 -0.0828 0.0199 -0.1214 -0.0825 -0.0446 -0.0806 0.0208
β10,3 -0.4685 0.0275 -0.5249 -0.4685 -0.4152 -0.4682 0.0287
β10,4 0.0248 0.0248 -0.0222 0.0247 0.0727 0.0265 0.0250
β10,5 0.1100 0.0822 -0.0506 0.1112 0.2710 0.1067 0.0820
β10,6 0.2497 0.1215 0.0166 0.2452 0.4911 0.2451 0.1228
β10,7 0.1024 0.0345 0.0360 0.1017 0.1689 0.1049 0.0352
β10,8 0.0210 0.0289 -0.0355 0.0207 0.0790 0.0227 0.0292
β10,9 0.2479 0.0288 0.1898 0.2480 0.3047 0.2489 0.0296
β10,10 -0.0692 0.0631 -0.1924 -0.0691 0.0526 -0.0720 0.0607
α 0.5879 0.0144 0.5596 0.5883 0.6142 0.5847 0.0158
τ 2.6170 0.0355 2.5570 2.6170 2.6970 2.6287 0.0387
The estimates of most of the coefficients are very similar when compared with the
estimates under the assumption of no growth rate within the offices (see Figure 4.2 for
the comparison between including and excluding growth rate in the Burr model). One
of the most affected coefficients is the office (β9), the other one is the settlement year
(β6). Positive effects of Office 4 (β9,4) and Office 12 (β9,12) on the delay distribution
change to negative after we considered the business growth in the model. These two
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offices are the only ones which are getting smaller during their contribution period.
The strong positive effect of the settlement year on the delay distribution is signif-
icantly reduced. Since we allow for the business growth within each office between
successive years, these results are expected.
A plot of deviance residuals against the logarithms of the fitted delays is given in
Figure 4.1 to assess the model fit. From Table 4.1, it is seen that most of the offices
have a positive growth rate during the period. Therefore, the claims diagnosed in
earlier years have larger weights than the claims diagnosed in later years which means
that they have smaller variances. This effect can be seen in Figure 4.1: the deviance
residuals are getting slightly narrower for longer delays.
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Figure 4.1: Deviance residuals of the Burr model with growth rate.
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Figure 4.2: Comparison of the posterior estimates of the coefficients under the Burr
model with and without growth rate.
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The LN model
Taking the business growth into account, the probability model under the lognormal
model becomes,
Di ∼ LN(µi, σ2wi)
σ2wi = σ
2/GFi
µi = ηi = β0 +
8∑
j=1
βjzij + β9,Officei + β10,Causei
(4.5)
for i = 1, . . . , 15860. The β coefficients have the same prior distributions given in
(4.3). For σ2 we use the prior
σ2 ∼ IGa(0.01, 0.01).
The likelihood can be expressed as
fw(D|σ2,β) =
(
1√
2pi
)n n∏
i
1√
σ2widi
exp
(
−
∑
(log(di)− ηi)2
2σ2wi
)
and the joint posterior density is
pw(σ
2,β|D) ∝ fw(D|σ2,β)pi(σ2)pi(β).
ML estimates are obtained by maximising the likelihood given above whereas Bayesian
estimates are acquired after 34000 iterations where the first 4000 iterations are con-
sidered as a burn-in process. Parameter estimates are given in Table 4.3. Similarly
to the other models, the ML estimates are very close to the Bayesian estimates. The
coefficients of the office are affected under the LN model when the growth is taken
into account (see Figure 4.3). However, the change of this variable on the delay
distribution is not as significant as in the Burr model.
This can also be said for the coefficient of the settlement year (β6). It is not affected
from the inclusion of the growth rate in the model as much as it was under the Burr
model (see Figure 4.4). The reason is that the growth rates are mostly affecting the
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earlier claims and the longer delays are associated with the earlier claims. Therefore,
while they are modelled better under the Burr distribution (as it is quite flexible in
modelling the tail), the shorter tail of the LN distribution is not sufficient to model
them.
Offices 4 and 12 (β9,4 and β9,12) affect the delay distribution in opposite ways under
the Burr and LN model. The same conclusion can be derived for Office 11 (β9,11) and
for TPD (β10,10). However, in these two cases, the 95% credible interval suggests that
the effects of these variables on the delay are not significant under the LN model and
Burr model, respectively.
Table 4.3: Coefficients of the LN model with growth rate.
MCMC MLE
Parameter Mean SD 2.5% 50% 97.5% Mean SD
β0 4.7990 0.0273 4.7450 4.7990 4.8510 4.7963 0.0271
β1 -0.0301 0.0082 -0.0462 -0.0301 -0.0140 -0.0302 0.0082
β2 -0.0160 0.0078 -0.0313 -0.0160 -0.0007 -0.0159 0.0078
β3 -0.0221 0.0069 -0.0357 -0.0220 -0.0087 -0.0221 0.0069
β4 -0.0482 0.0076 -0.0631 -0.0483 -0.0335 -0.0482 0.0076
β5 0.0316 0.0075 0.0168 0.0316 0.0464 0.0316 0.0075
β6 0.1046 0.0075 0.0899 0.1046 0.1192 0.1048 0.0075
β7 -0.0613 0.0074 -0.0757 -0.0613 -0.0469 -0.0613 0.0074
β8 -0.1794 0.0096 -0.1981 -0.1795 -0.1606 -0.1796 0.0096
β9,1 0.1798 0.0295 0.1222 0.1795 0.2384 0.1813 0.0295
β9,2 0.1528 0.0236 0.1066 0.1526 0.1996 0.1545 0.0238
β9,3 -0.1440 0.0594 -0.2599 -0.1442 -0.0270 -0.1440 0.0593
β9,4 0.1850 0.0686 0.0525 0.1842 0.3201 0.1863 0.0699
β9,5 -0.1842 0.0409 -0.2650 -0.1840 -0.1054 -0.1823 0.0408
β9,6 -0.3214 0.0495 -0.4183 -0.3220 -0.2247 -0.3192 0.0492
β9,7 -0.4302 0.1497 -0.7277 -0.4319 -0.1421 -0.4481 0.1468
β9,8 -0.0258 0.0245 -0.0737 -0.0258 0.0224 -0.0243 0.0246
β9,9 -0.1077 0.0323 -0.1710 -0.1079 -0.0439 -0.1059 0.0320
β9,10 0.2043 0.0395 0.1265 0.2041 0.2812 0.2062 0.0392
β9,11 0.0288 0.0227 -0.0154 0.0287 0.0740 0.0306 0.0226
β9,12 0.1703 0.0356 0.1013 0.1702 0.2403 0.1726 0.0351
β9,13 0.2924 0.1062 0.0726 0.2968 0.4958 0.2923 0.1087
β10,1 -0.1639 0.0503 -0.2626 -0.1635 -0.0658 -0.1632 0.0503
β10,2 -0.1007 0.0231 -0.1456 -0.1007 -0.0556 -0.0995 0.0233
β10,3 -0.5631 0.0318 -0.6257 -0.5631 -0.5007 -0.5623 0.0320
β10,4 0.0209 0.0284 -0.0352 0.0211 0.0760 0.0219 0.0286
β10,5 0.1131 0.0874 -0.0570 0.1137 0.2848 0.1119 0.0870
β10,6 0.1047 0.1475 -0.1821 0.1037 0.3964 0.0981 0.1509
β10,7 0.1012 0.0371 0.0282 0.1014 0.1737 0.1023 0.0370
β10,8 0.0379 0.0317 -0.0238 0.0378 0.0991 0.0395 0.0318
β10,9 0.2551 0.0337 0.1890 0.2551 0.3211 0.2560 0.0336
β10,10 0.1947 0.0459 0.1050 0.1945 0.2854 0.1953 0.0463
σ2 1.0100 0.0114 0.9878 1.0100 1.0320 1.0097
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Figure 4.3: Comparison of posterior estimates of the coefficients under the LN model
with and without growth rate.
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Figure 4.4: Comparison of posterior estimates of the coefficients under the Burr and
LN models.
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A plot of deviance residuals against the logarithms of the fitted delays is given in
Figure 4.5. A total of 3.9% of the residuals lie outside the interval [-2,2].
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Figure 4.5: Deviance residuals of the LN model without missing values and with
growth rate.
Comparison of Burr and LN models
To compare the Burr and LN models the corresponding estimates of DIC (from
MCMC) and BIC (from MLE) are given in Table 4.4. Again, the Burr model has a
better fit than the LN model when the growth rate is included in the models.
Table 4.4: Values of information criteria of the models with growth rate.
D¯ = ̂−2 logL(θ) Dˆ = −2 logL(θˆ) pD DIC BIC
Burr 191228.3 191196.5 31.9 191260.2 191505.7
LN 194324.4 194293.4 31.0 194355.4 194593.2
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4.3 Prediction
Table 4.5 shows the posterior estimates of the mean delay for each of the scenarios
described in Table 3.7 under the Bayesian estimation procedure with the Burr and
the LN model. The posterior estimates of the means and their 95% credible intervals
are compared in Figure 4.6. According to these, the mean delay of a typical scenario
(Scenario 1) is 178 days under the Burr model and 167 days under the LN model (these
are shown with vertical lines in Figure 4.6). Since the typical scenario’s 95% credible
interval (169-187 days) substantially overlaps with the credible intervals of Scenarios 2
(174-192 days), 4 (162-181 days), 6 (176-201 days) & 7 (161-181 days) and 8 (163-184
days) & 9 (174-193 days), it can be said that their estimated mean delays are not
significantly different from the mean of the typical scenario under the Burr model.
These scenarios correspond to changing sex, smoker status, age and settlement year
in the typical case. The importance of these covariates will be explored in Chapter
5. For the LN model, this is true for only Scenario 2, i.e. the estimated mean of the
typical scenario of 167 days lies within the 95% credible interval of Scenario 2. On
the other hand, changing office to Office 10 (Scenario 15) increases the mean delay
to 249 days (199 days under the LN model) whereas death claims are settled only in
121 days (105 days under the LN model). For the policies which are in effect for 10
years (Scenario 13), the estimated mean delay is 141 days with the Burr model and
110 days with the LN model.
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Table 4.5: Posterior estimates of mean delay for the scenarios in Table 3.7 for the
Burr and LN model with growth rate (days).
Burr Model LN Model
Mean SD 2.5% 50% 97.5% Mean SD 2.5% 50% 97.5%
Mean.Scn1 178.0 4.7 169.3 177.8 187.4 166.6 3.5 160.0 166.6 173.5
Mean.Scn2 182.8 4.8 173.9 182.7 192.4 172.1 3.4 165.5 172.1 178.9
Mean.Scn3 166.2 5.4 156.3 166.1 177.4 155.6 4.5 147.0 155.6 164.6
Mean.Scn4 171.0 4.9 162.1 170.9 180.8 149.3 3.6 142.4 149.3 156.6
Mean.Scn5 191.9 5.1 182.2 191.8 202.2 177.5 3.9 170.2 177.4 185.2
Mean.Scn6 187.7 6.4 175.5 187.4 200.8 180.4 5.6 169.7 180.3 191.7
Mean.Scn7 170.7 5.0 161.3 170.6 180.6 156.4 4.1 148.6 156.3 164.6
Mean.Scn8 173.1 5.3 163.3 172.9 184.1 139.8 3.6 132.9 139.7 146.9
Mean.Scn9 183.1 5.0 173.7 183.0 193.2 198.7 4.6 189.7 198.6 207.8
Mean.Scn10 182.5 4.8 173.7 182.4 192.4 173.9 3.7 166.7 173.9 181.4
Mean.Scn11 157.1 5.6 146.5 157.0 168.2 134.4 4.5 125.8 134.3 143.3
Mean.Scn12 199.8 5.2 189.9 199.6 210.4 205.1 4.4 196.7 205.1 213.8
Mean.Scn13 141.4 4.9 132.2 141.2 151.2 110.0 3.7 102.9 109.9 117.5
Mean.Scn14 169.8 17.0 139.2 168.6 205.6 117.5 6.4 105.7 117.3 130.6
Mean.Scn15 249.4 9.9 230.9 249.2 269.5 198.7 8.3 183.0 198.5 215.7
Mean.Scn16 121.1 3.9 113.5 121.0 128.8 105.0 3.3 98.6 104.9 111.5
Mean.Scn17 180.8 12.0 158.5 180.4 205.2 224.1 10.8 203.9 223.8 246.2
Changes in the means of the scenarios when the growth rate is included or excluded
can be seen in Figure 4.7 for the Burr and the LN model. Under both models, posterior
estimates of the means of the scenarios are higher when the growth rate is taken into
account in the modelling. The significant difference between the means of Scenarios 8
& 9 and Scenario 1 disappears when growth is allowed in the model, under the Burr
distribution. These scenarios are related to the change in the settlement year. Here,
changing the settlement year to 1999 increases the estimated mean of Scenario 8 from
123 days to 173 days while for the most recent settlement year 2005 in Scenario 9,
the estimated mean is almost the same (181 days - 183 days). This is because in this
model we allow for business growth between years. By introducing weights to the
model by years, we are reducing the effect of the year on the delay as this effect can
partly be explained by the growth rate with this model. The significant increase in
the mean delay of Scenario 8 indicates that there is a positive growth for Office 11
which we already showed in Table 4.1. The weight assigned to the claims diagnosed
in 1999 for this office is around 1.75. Changing office to Office 6 (Scenario 14) can be
shown as another example of a big change. Introducing the growth rate to the Burr
model increases the estimated mean delay from 95 days to 170 days for this scenario.
The weight assigned to this office is approximately 5, meaning that office is growing
rapidly between successive years.
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Figure 4.6: Posterior estimates of the means (days) of the scenarios under the Burr
(black line) and LN model (red line) with growth rate. Bars show 95% credible
intervals and bullets show posterior means. Vertical lines show the posterior means
of the first scenarios under the two models.
Although the magnitudes of the mean scenarios are changed under the LN model,
there is no such dramatic change between the typical scenarios and the others when
we include the growth rate in the model. The difference between the typical scenario
is 27 days and for most of the scenarios the difference changes between 20 days and
34 days. Some exceptions are Scenarios 4, 11 and 13 with 17 days difference and
Scenarios 14 and 17 with 48 days and 40 days difference between the mean delays
excluding and including the growth rate in the analysis. As it is mentioned before,
the LN model is not as flexible as the Burr model in modelling the tail of the claim
distribution. Since the growth factor affects the longer delays more, this can not be
captured by the LN model.
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(b) LN Model
Figure 4.7: Posterior estimates of the means (days) of the scenarios under the Burr
and LN model with (red line) and without (black line) growth rate. Bars show 95%
credible intervals and bullets show posterior means. Vertical lines show the posterior
means of the first scenarios under the two models.
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Chapter 5
Selection of claim-specific
covariates
5.1 Introduction
In this chapter we perform variable selection among the available claim-related factors,
in order to obtain the most suitable model for describing and predicting the delay
between diagnosis and settlement of claims. Different prior distribution settings for
the model parameters are considered under the Bayesian approach. Here, we use
the methodology introduced by Dellaportas et al. (2002), Ntzoufras (2002, 2009) and
Ntzoufras et al. (2003). In particular, Gibbs variable selection methods are considered
in this part. Variable selection is also carried out with classical analysis and results
are compared.
In Section 5.2 claim specific covariates are selected in the absence of growth rate.
Gibbs variable selection (GVS) with three different prior sets is used and results
are confirmed using exact marginal likelihood findings and related Laplace approx-
imations. For the classical analysis, a maximum likelihood based method, namely,
stepwise regression, is employed. Growth rates are taken into account in Section 5.3.
To find a parsimonious model, a GVS method with two different sets of priors and
stepwise regression is used. For comparison purposes, a lognormal model is also fitted
and model assessment measures are provided.
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5.2 Selection of claim-specific covariates without
growth factor
To explain the delay between dates of diagnosis and settlement, we use p = 10 co-
variates related to claim or policyholder characteristics resulting in 210 = 1024 pos-
sible models when subsets of these covariates are used. For mt being the t
th model
(t = 1, . . . , 1024), given the marginal likelihood under mt, f(D|mt), and the prior
model probability, pi(mt), the posterior probability p(mt|D) can be calculated. From
Bayes theorem
p(mt|D) = f(D|mt)pi(mt)∑1024
t=1 f(D|mt)pi(mt)
.
Therefore two possible models can be compared using the so-called posterior-odds
ratio
PO =
p(mj|D)
p(mk|D) =
f(D|mj)
f(D|mk)
pi(mj)
pi(mk)
, j 6= k with j, k = 1, . . . , 1024
where
Bjk =
f(D|mj)
f(D|mk)
is the Bayes factor and pi(mj)
/
pi(mk) is the prior odds ratio (Kass and Raftery, 1995).
The Bayes factor is given as the ratio of two marginal likelihoods. These marginal
likelihoods can be obtained as
f(D|mt) =
∫
f(D|θt,mt)pi(θt|mt)dθt,
where θt is the parameter vector in model mt, f(D|θt,mt) is the likelihood function
under model mt and pi(θt|mt) is the prior density of the parameter vector θt (Kass
and Raftery, 1995).
5.2.1 Gibbs variable selection (GVS)
Let γ be a p× 1 indicator vector where γ ∈ {0, 1}p and p is the number of covariates
in the model. Introducing γ into the linear predictor for the models in (3.4) and
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(3.15) we obtain
η∗i = β0 +
8∑
j=1
γjβjzij + γ9β9,Officei + γ10β10,Causei .
In Bayesian model selection, the posterior model probabilities are highly dependent
on the choice of prior distributions of the model parameters. As the prior dispersion
increases, more parsimonious models will be suggested. This problem is known as the
Lindley-Bartlett paradox (Lindley, 1957; Bartlett, 1957). Therefore parameter prior
distributions must be chosen with care. We use the following priors
γj ∼ Bernoulli(0.5)
βj ∼ N(µj, σ2j ) (5.1)
where the parameters for the distribution of βj are considered in detail in the following
sections. We note that specific priors are chosen here to facilitate variable selection,
but are not used to obtain posterior estimates for the model parameters, and do not
represent real prior knowledge.
Independent priors
Let us first consider a mixture of independent normal prior distributions for (5.1)
(Dellaportas et al., 2002) given as follows:
µj = (1− γj)µ¯βj
σ2j = γjc
2 + (1− γj)σ¯2βj
where µ¯βj and σ¯
2
βj
are posterior estimates of the mean and variance of βj from a pilot
run with the full model and c2 is a constant .
Three different factors, c2 = 100, 1000 and c2 = n = 15860, are used for the prior
variance to demonstrate the Lindley-Bartlett paradox. In Tables 5.1 and 5.2 it can
be seen that as the prior variances increase, the inclusion probabilities of the vari-
ables, p(γ|D), decrease and thus simpler models are suggested. When we choose
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c2 = 100, posterior inclusion probabilities of the variables age, sex and smoker sta-
tus (γ1, γ2 and γ4) are less than 0.5 for both models (See Tables 5.1(a) and 5.2(a)).
Although the inclusion probabilities decrease with increasing c2, for the Burr model
the variables having less than 0.5 inclusion probability stay the same under three
different c2s. For the LN model, the inclusion probability of policy type (γ5) also goes
below 0.5 for c2 = 1000 and c2 = n. Note that the SD columns in the tables give the
standard deviations for the posterior distributions of the inclusion probabilities.
These results are consistent with the posterior model probabilities given in Tables 5.1
and 5.2. That is, model number 1013, which excludes variables age, sex and smoker
status is supported for all cases under the Burr model with decreasing posterior model
probabilities. The same model has the highest probability under the lognormal model
when c2 = 100. However, the posterior model probabilities of the top three models are
very close to each other with posterior odds close to 1. Since we use the same a-priori
probabilities for each possible model, the posterior odds will be equal to the Bayes
factor. The Bayes factor can be used to compare nested models. According to Kass
and Raftery (1995), the difference between models is negligible when the Bayes factor
is less than 3. Similarly, when c2 = 1000, the posterior odds of model 997 to model
1013 is m2/m1 = 2.82 < 3 and thus they are barely different from each other. For
the last case, model 997 has the highest posterior probability. This model excludes
policy duration as well as age, sex and smoker status.
In this example, we saw how the Lindley-Bartlett paradox is activated when these
independent priors are used. Since the posterior model probabilities are highly depen-
dent on the choice of the prior variance, this set of priors is not always useful. Here,
especially under the Burr distribution, we have consistent model selection results; this
is probably because we have a very large data set.
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Table 5.1: Parameter inclusion probabilities and model probabilities under the Burr
model with independent normal priors.
(a) Inclusion probabilities for various prior variances.
c2 = 100 c2 = 1000 c2 = n
Parameter p(γ|D) SD p(γ|D) SD p(γ|D) SD
γ1 0.0487 0.2152 0.0238 0.1525 0.0059 0.0766
γ2 0.0137 0.1162 0.0032 0.0562 0.0009 0.0300
γ3 0.9541 0.2093 0.8971 0.3038 0.6009 0.4897
γ4 0.0570 0.2318 0.0249 0.1558 0.0059 0.0766
γ5 0.9732 0.1614 0.9154 0.2783 0.6969 0.4596
γ6 1 0 1 0 1 0
γ7 0.9999 0.0082 0.9752 0.1554 0.9946 0.0731
γ8 1 0 1 0 1 0
γ9 1 0 1 0 1 0
γ10 1 0 1 0 1 0
(b) Posterior model probabilities - c2 = 100
Rank Model No Model f(m|D) PO(m1013/mt)
1 m1013 x3 + x5 + x6 + x7 + x8 + x9 + x10 0.8266 1.00
2 m1021 x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.0530 15.61
3 m1014 x1 + x3 + x5 + x6 + x7 + x8 + x9 + x10 0.0433 19.09
4 m1009 x5 + x6 + x7 + x8 + x9 + x10 0.0313 26.38
5 m997 x3 + x6 + x7 + x8 + x9 + x10 0.0151 54.63
6 m1015 x2 + x3 + x5 + x6 + x7 + x8 + x9 + x10 0.0120 68.88
7 m993 x6 + x7 + x8 + x9 + x10 0.0110 75.15
8 m1022 x1 + x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.0027 309.94
9 m1010 x1 + x5 + x6 + x7 + x8 + x9 + x10 0.0021 387.53
10 m1017 x4 + x5 + x6 + x7 + x8 + x9 + x10 0.0008 1033.25
(c) Posterior model probabilities - c2 = 1000
Rank Model No Model f(m|D) PO(m1013/mt)
1 m1013 x3 + x5 + x6 + x7 + x8 + x9 + x10 0.8052 1.00
2 m1009 x5 + x6 + x7 + x8 + x9 + x10 0.0493 16.34
3 m993 x6 + x7 + x8 + x9 + x10 0.0382 21.08
4 m997 x3 + x6 + x7 + x8 + x9 + x10 0.0318 25.34
5 m1021 x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.0232 34.75
6 m1014 x1 + x3 + x5 + x6 + x7 + x8 + x9 + x10 0.0201 40.06
7 m929 x6 + x8 + x9 + x10 0.0089 90.81
8 m949 x3 + x5 + x6 + x8 + x9 + x10 0.0088 91.50
9 m933 x3 + x6 + x8 + x9 + x10 0.0043 187.26
10 m1010 x1 + x5 + x6 + x7 + x8 + x9 + x10 0.0032 249.06
(d) Posterior model probabilities - c2 = n
Rank Model No Model f(m|D) PO(m1013/mt)
1 m1013 x3 + x5 + x6 + x7 + x8 + x9 + x10 0.5442 1.00
2 m993 x6 + x7 + x8 + x9 + x10 0.2476 2.20
3 m1009 x5 + x6 + x7 + x8 + x9 + x10 0.1422 3.83
4 m997 x3 + x6 + x7 + x8 + x9 + x10 0.0480 11.33
5 m1021 x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.0051 106.02
6 m929 x6 + x8 + x9 + x10 0.0045 120.05
7 m1014 x1 + x3 + x5 + x6 + x7 + x8 + x9 + x10 0.0027 199.12
8 m994 x1 + x6 + x7 + x8 + x9 + x10 0.0017 314.02
9 m1014 x1 + x5 + x6 + x7 + x8 + x9 + x10 0.0012 441.36
10 m945 x5 + x6 + x8 + x9 + x10 0.0007 816.26
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Table 5.2: Parameter inclusion probabilities and model probabilities under the LN
model with independent normal priors.
(a) Inclusion probabilities for various prior variances.
c2 = 100 c2 = 1000 c2 = n
Parameter p(γ|D) SD p(γ|D) SD p(γ|D) SD
γ1 0.3292 0.4699 0.0946 0.2926 0.0181 0.1332
γ2 0.0024 0.0493 0.0008 0.0289 0.0002 0.0129
γ3 0.9954 0.0679 0.9781 0.1462 0.9083 0.2886
γ4 0.2137 0.4099 0.0661 0.2485 0.0158 0.1248
γ5 0.6331 0.4819 0.2900 0.4538 0.0779 0.2680
γ6 1 0 1 0 1 0
γ7 1 0 0.9999 0.0082 0.9996 0.0192
γ8 1 0 1 0 1 0
γ9 1 0 1 0 1 0
γ10 1 0 1 0 1 0
(b) Posterior model probabilities - c2 = 100
Rank Model No Model f(m|D) PO(m1013/mt)
1 m1013 x3 + x5 + x6 + x7 + x8 + x9 + x10 0.2816 1.00
2 m997 x3 + x6 + x7 + x8 + x9 + x10 0.2524 1.12
3 m1014 x1 + x3 + x5 + x6 + x7 + x8 + x9 + x10 0.1999 1.41
4 m1021 x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.0803 3.51
5 m1022 x1 + x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.0692 4.07
6 m1005 x3 + x4 + x6 + x7 + x8 + x9 + x10 0.0521 5.40
7 m998 x1 + x3 + x6 + x7 + x8 + x9 + x10 0.0464 6.07
8 m1006 x1 + x3 + x4 + x6 + x7 + x8 + x9 + x10 0.0111 25.44
9 m993 x6 + x7 + x8 + x9 + x10 0.0022 128.00
10 m994 x1 + x6 + x7 + x8 + x9 + x10 0.0015 191.96
(c) Posterior model probabilities - c2 = 1000
Rank Model No Model f(m|D) PO(m1013/mt)
1 m997 x3 + x6 + x7 + x8 + x9 + x10 0.6112 0.35
2 m1013 x3 + x5 + x6 + x7 + x8 + x9 + x10 0.2168 1.00
3 m1014 x1 + x3 + x5 + x6 + x7 + x8 + x9 + x10 0.0484 4.48
4 m1005 x3 + x4 + x6 + x7 + x8 + x9 + x10 0.0390 5.56
5 m998 x1 + x3 + x6 + x7 + x8 + x9 + x10 0.0354 6.13
6 m1021 x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.0188 11.55
7 m993 x6 + x7 + x8 + x9 + x10 0.0180 12.06
8 m1022 x1 + x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.0051 42.24
9 m994 x1 + x6 + x7 + x8 + x9 + x10 0.0026 82.34
10 m1006 x1 + x3 + x4 + x6 + x7 + x8 + x9 + x10 0.0026 83.38
(d) Posterior model probabilities - c2 = n
Rank Model No Model f(m|D) PO(m1013/mt)
1 m997 x3 + x6 + x7 + x8 + x9 + x10 0.8062 0.09
2 m993 x6 + x7 + x8 + x9 + x10 0.0871 0.83
3 m1013 x3 + x5 + x6 + x7 + x8 + x9 + x10 0.0721 1.00
4 m1005 x3 + x4 + x6 + x7 + x8 + x9 + x10 0.0127 5.69
5 m998 x1 + x3 + x6 + x7 + x8 + x9 + x10 0.0115 6.25
6 m1014 x1 + x3 + x5 + x6 + x7 + x8 + x9 + x10 0.0034 21.00
7 m994 x1 + x6 + x7 + x8 + x9 + x10 0.0027 26.70
8 m1021 x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.0016 46.01
9 m1001 x4 + x6 + x7 + x8 + x9 + x10 0.0013 56.91
10 m1009 x5 + x6 + x7 + x8 + x9 + x10 0.0005 144.20
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Empirical priors
We use empirical priors following Ntzoufras (2009). Here, βj ∼ N(µj, σ2j ) and the
prior means and variances of the parameters are as follows
µj = µ¯βj , j = 1, . . . , p
σ2j = {γjn+ (1− γj)} σ¯2βj
where µ¯βj and σ¯
2
βj
are posterior estimates of the mean and variance of βj from a
pilot run with the full model. This set of priors can be considered as empirical priors
because the data we have already observed are used in the prior. However the observed
data count as one additional data point only, and therefore the double usage of the
data is low (see Ntzoufras (2009, page 408)).
Zellner’s g-prior
A prior based on Zellner’s g-prior is also considered. For a normal model, Zellner
(1986) suggested a Normal-Inverse Gamma conjugate prior for model m of the form
βm|σ2,m ∼MVN(µβm, c2(Z
′
mZm)
−1σ2) (5.2)
where Zm is the n × (pm + 1) standardised design matrix, βm is the (pm + 1) × 1
coefficient vector of model m with pm being the number of covariates involved in the
linear part of model m and c2 is a constant. Defining c2 = n, we can specify Zellner’s
g-prior for the parameter vector βm using the following multivariate normal prior
distribution
βm ∼MVN(µβm,S−1)
Here, µβm = µ0, . . . , µp is the prior mean vector with
µj = (1− γj)µ¯βj , j = 1, . . . , p
67
and the (j, k) element of the (p+ 1)× (p+ 1) matrix S is given by
Sj,k =
γjγk
nσ2
(Z
′
Z)jk + (1− γjγk)I{j = k}σ¯−2βj , j, k = 1, . . . , p.
with γ0 = 1 and µ¯βj , σ¯
2
βj
as before. For the Burr model on the other hand, (5.2) can
not be used directly. However, an approximation to (5.2) can be employed using the
information matrix as the unknown prior variance-covariance matrix to give
βm ∼ N(µβm, nΣˆ),
where Σˆ = (−D2l(βˆ))−1 is the estimated variance-covariance matrix with D2l(βˆ)
being the Hessian matrix of the log-likelihood evaluated at the maximum likelihood
estimate (Kass and Wasserman, 1995; Ntzoufras et al., 2003).
Model selection results
Inclusion and posterior model probabilities for empirical and Zellner priors are shown
in Tables 5.3 and 5.4 for Burr and LN models, respectively. Results under these two
prior sets are very close to each other. This is not surprising since both of these
priors considered here are ‘unit information priors’ which is introduced by Kass and
Wasserman (1995). They are very weakly informative given the size of the data and
the fact that they use information equivalent to that contained in a single data point.
Under the Burr model, the inclusion probability of sex (γ2) is around 0.08 with both
sets of priors implying that there is high probability of this variable being excluded
from the best models. On the other hand, inclusion probabilities of age and smoker
status (γ1 and γ4) are slightly under 0.5 (see Table 5.3(a)). As can be seen from Table
5.3(b) and 5.3(c), the highest posterior model probability is for model 1013 under
both prior sets which excludes all these three variables.
The same sets of priors are considered for the LN model with both giving almost
the same posterior model probabilities. The ten models with the highest posterior
model probabilities are given in Table 5.4. The only variable which has an inclusion
probability less than 0.5 is sex. The probability of this variable to be included in the
model is less than 0.02. Model 1022, which excludes this variable, has the highest
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posterior model probability.
Considering these results, it can be concluded that the best model under the Burr
distribution is model 1013 and under the lognormal distribution it is model 1022.
However the first four models under the Burr distribution, including model 1022,
have posterior odds less than 2. Therefore we can conclude that the best model under
the lognormal assumption is not inconsistent with the model selection under the Burr
distribution.
5.2.2 Variable selection using marginal likelihoods
Marginal likelihood for LN model
For normal regression models, the exact marginal likelihoods, and thus the model
probabilities, can be calculated analytically when conjugate distributions for the
model parameters are used. In this case, a Normal-Inverse Gamma conjugate prior
for model m, where m ∈ (m1, . . . ,m1024) is used.
The required marginal likelihood for the lognormal model has the form
f(D|m) =
∫
f(D|θm,m)pi(θm|m)dθm, (5.3)
where θm is the parameter vector of model m, including σ
2 and the (pm + 1) × 1
coefficient vector βm. The logarithm of the delay (log(D)) is distributed as
log(D)|βm, σ2,m ∼MVN(Zmβm, σ2In)
with In being the n× n identity matrix. In (5.3)
pi(θm|m) = pi(βm, σ2|m) ∝ pi(βm|σ2,m)pi(σ2)
with prior distributions
pi(βm|σ2,m) ∼ N(µβm, c2V mσ2)
pi(σ2) ∼ IGa(a, b)
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Table 5.3: Parameter inclusion probabilities and model probabilities under the Burr
model with empirical and Zellner’s g-priors.
(a) Inclusion probabilities for empirical priors and
Zellner’s g-prior.
Empirical Priors Zellner’s g-Prior
Parameter p(γ|D) SD p(γ|D) SD
γ1 0.4460 0.4971 0.4171 0.4931
γ2 0.0843 0.2778 0.0890 0.2847
γ3 0.9992 0.0277 0.9973 0.0519
γ4 0.4420 0.4966 0.4113 0.4921
γ5 1 0 1 0
γ6 1 0 1 0
γ7 1 0 1 0
γ8 1 0 1 0
γ9 1 0 1 0
γ10 1 0 1 0
(b) Posterior model probabilities - Empirical Priors
Rank Model No Model f(m|D) PO(m1013/mt)
1 m1013 x3 + x5 + x6 + x7 + x8 + x9 + x10 0.2847 1.00
2 m1014 x1 + x3 + x5 + x6 + x7 + x8 + x9 + x10 0.2180 1.31
3 m1021 x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.2120 1.34
4 m1022 x1 + x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.2002 1.42
5 m1015 x2 + x3 + x5 + x6 + x7 + x8 + x9 + x10 0.0377 7.55
6 m1023 x2 + x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.0193 14.75
7 m1016 x1 + x2 + x3 + x5 + x6 + x7 + x8 + x9 + x10 0.0171 16.62
8 m1024 x1 + x2 + x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.0101 28.10
9 m1010 x1 + x5 + x6 + x7 + x8 + x9 + x10 0.0003 949.00
10 m1018 x1 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.0002 1220.32
(c) Posterior model probabilities - Zellner’s g-Prior
Rank Model No Model f(m|D) PO(m1013/mt)
1 m1013 x3 + x5 + x6 + x7 + x8 + x9 + x10 0.3076 1.00
2 m1014 x1 + x3 + x5 + x6 + x7 + x8 + x9 + x10 0.2186 1.41
3 m1021 x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.2166 1.42
4 m1022 x1 + x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.1656 1.86
5 m1015 x2 + x3 + x5 + x6 + x7 + x8 + x9 + x10 0.0389 7.90
6 m1016 x1 + x2 + x3 + x5 + x6 + x7 + x8 + x9 + x10 0.0217 14.16
7 m1023 x2 + x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.0184 16.72
8 m1024 x1 + x2 + x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.0098 31.28
9 m1009 x5 + x6 + x7 + x8 + x9 + x10 0.0010 318.20
10 m1010 x1 + x5 + x6 + x7 + x8 + x9 + x10 0.0008 384.50
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Table 5.4: Parameter inclusion probabilities and model probabilities under the LN
model with empirical and Zellner’s g-priors.
(a) Inclusion probabilities for empirical priors and
Zellner’s g-prior.
Empirical Priors Zellner’s g-Prior
Parameter p(γ|D) SD p(γ|D) SD
γ1 0.8870 0.3166 0.8840 0.3203
γ2 0.0185 0.1349 0.0179 0.1327
γ3 0.9997 0.0173 0.9999 0.0100
γ4 0.7876 0.4090 0.7891 0.4079
γ5 0.9785 0.1449 0.9796 0.1415
γ6 1 0 1 0
γ7 1 0 1 0
γ8 1 0 1 0
γ9 1 0 1 0
γ10 1 0 1 0
(b) Posterior model probabilities - Empirical Priors
Rank Model No Model f(m|D) PO(m1022/mt)
1 m1022 x1 + x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.6808 1.00
2 m1014 x1 + x3 + x5 + x6 + x7 + x8 + x9 + x10 0.1760 3.87
3 m1021 x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.0780 8.72
4 m1013 x3 + x5 + x6 + x7 + x8 + x9 + x10 0.0254 26.83
5 m1024 x1 + x2 + x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.0120 56.88
6 m1006 x1 + x3 + x4 + x6 + x7 + x8 + x9 + x10 0.0096 70.67
7 m1005 x3 + x4 + x6 + x7 + x8 + x9 + x10 0.0047 143.84
8 m998 x1 + x3 + x6 + x7 + x8 + x9 + x10 0.0045 152.41
9 m1016 x1 + x2 + x3 + x5 + x6 + x7 + x8 + x9 + x10 0.0036 189.11
10 m997 x3 + x6 + x7 + x8 + x9 + x10 0.0021 319.17
(c) Posterior model probabilities - Zellner’s g-Prior
Rank Model No Model f(m|D) PO(m1022/mt)
1 m1022 x1 + x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.6828 1.00
2 m1014 x1 + x3 + x5 + x6 + x7 + x8 + x9 + x10 0.1737 3.93
3 m1021 x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.0787 8.68
4 m1013 x3 + x5 + x6 + x7 + x8 + x9 + x10 0.0269 25.35
5 m1024 x1 + x2 + x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.0110 62.07
6 m1006 x1 + x3 + x4 + x6 + x7 + x8 + x9 + x10 0.0092 74.48
7 m1005 x3 + x4 + x6 + x7 + x8 + x9 + x10 0.0049 140.29
8 m998 x1 + x3 + x6 + x7 + x8 + x9 + x10 0.0037 182.91
9 m1016 x1 + x2 + x3 + x5 + x6 + x7 + x8 + x9 + x10 0.0033 209.00
10 m1023 x2 + x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 0.0022 315.09
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where V m is the prior variance-covariance matrix, obtained from the pilot run. Then,
following Ntzoufras (2009), the exact marginal log-likelihood can be expressed as
log(f(D|m)) =− pm log(c) + 0.5
(
log(|Σ˜m|)− log(|V m|)
)
−
(0.5n+ a) log
(
0.5
(
(log(D))
′
log(D)− β˜
′
mΣ˜
−1
m β˜m + c
−2µβ
′
mV
−1
m µβm
)
+ b
)
+ κ−
n∑
i
log(Di)
(5.4)
where Σ˜ is the posterior variance-covariance matrix given by
Σ˜m =
(
Z
′
mZm + c
−2V −1m
)−1
and the posterior mean β˜ is written as
β˜m = Σ˜m
(
Z
′
mZmβˆ + c
−2V −1m µβm
)
with κ = a log(b) − log(Γ(a)) − 0.5n log(2pi) + log(Γ(0.5n + a)). Here βˆ denotes the
MLE of the coefficients.
Table 5.5 gives the ten highest marginal probability models using empirical priors.
Comparing this table with Table 5.4(c), it can be seen that the order of the first seven
models is the same, with very similar posterior model probabilities. Here, we also
conclude that the best model under the LN model is model 1022 which excludes age.
Table 5.5: Exact marginal likelihoods (EML) for the lognormal model.
Rank Model No Model Marginal Loglik p(m|D) PO(m1022/mt)
1 m1022 x1 + x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 -96214.18 0.6815 1.00
2 m1014 x1 + x3 + x5 + x6 + x7 + x8 + x9 + x10 -96215.54 0.1749 3.90
3 m1021 x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 -96216.34 0.0786 8.67
4 m1013 x3 + x5 + x6 + x7 + x8 + x9 + x10 -96217.45 0.0259 26.31
5 m1024 x1 + x2 + x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 -96218.24 0.0118 57.97
6 m1006 x1 + x3 + x4 + x6 + x7 + x8 + x9 + x10 -96218.43 0.0097 70.11
7 m1005 x3 + x4 + x6 + x7 + x8 + x9 + x10 -96219.22 0.0044 154.47
8 m1016 x1 + x2 + x3 + x5 + x6 + x7 + x8 + x9 + x10 -96219.35 0.0039 175.91
9 m998 x1 + x3 + x6 + x7 + x8 + x9 + x10 -96219.36 0.0038 177.68
10 m997 x3 + x6 + x7 + x8 + x9 + x10 -96219.96 0.0021 323.76
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Laplace approximation for the Burr model
Analytic computation of (5.3) may not be tractable for more complicated models.
In these cases, approximations such as Laplace’s method can be used to obtain an
adequate approximation for marginal likelihoods. Since this method relies on an un-
derlying normal distribution, the approximations will be more effective for symmetric
posterior distributions. However, in practice, for large sample sizes this method gives
reasonable approximations to marginal likelihoods (Gelman et al., 2000). A detailed
description of the method can be found in Kass and Raftery (1995). Here we only
give the resulting approximation, i.e.
fˆ(D|m) = (2pi)dm/2|Σ˜m|1/2f(D|θ˜m,m)pi(θ˜m|m)
where θ˜m is the vector of the posterior modes of the parameters under model m with
dimension dm, and Σ˜ = (−D2l(β˜))−1 is the covariance matrix where D2l(β˜) is the
Hessian matrix of the likelihood evaluated at the posterior modes of the parameters.
However, obtaining the covariance matrix at the posterior modes is not computa-
tionally easy. Thus, following Kass and Raftery (1995), we calculate the marginal
likelihoods with a variant of the Laplace approximation, using the covariance matrix
Σˆm which employs MLE estimates of the parameters to calculate the Hessian matrix.
That is
fˆ
MLE
(D|m) = (2pi)dm/2|Σˆm|1/2f(D|θˆm,m)pi(θˆm|m).
The approximated marginal likelihoods, fˆ
MLE
(D|m), for the Burr model are presented
in Table 5.6, together with the resulting posterior model probabilities p(m|D) and
posterior odds.
The results coincide with those obtained using the GVS method. Model 1013 has
again the highest approximated likelihood under both prior sets. When Tables 5.3
and 5.6 are compared it can be seen that the first five models are always the same.
The ordering of the second and the third model in the Laplace approximation using
empirical priors changes but the difference between the likelihoods is very small.
73
Table 5.6: Laplace Approximation for the Burr Model.
(a) Approximation with empirical priors.
Rank Model No Model fˆ
MLE
(D|m) p(m|D) PO(m1013/mt)
1 m1013 x3 + x5 + x6 + x7 + x8 + x9 + x10 -95319.67 0.2892 1.00
2 m1021 x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 -95319.94 0.2199 1.32
3 m1014 x1 + x3 + x5 + x6 + x7 + x8 + x9 + x10 -95319.97 0.2148 1.35
4 m1022 x1 + x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 -95320.08 0.1924 1.50
5 m1015 x2 + x3 + x5 + x6 + x7 + x8 + x9 + x10 -95321.74 0.0364 7.94
6 m1023 x2 + x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 -95322.40 0.0188 15.36
7 m1016 x1 + x2 + x3 + x5 + x6 + x7 + x8 + x9 + x10 -95322.56 0.0160 18.05
8 m1024 x1 + x2 + x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 -95323.03 0.0100 28.96
9 m1010 x1 + x5 + x6 + x7 + x8 + x9 + x10 -95325.72 0.0007 424.97
10 m1009 x5 + x6 + x7 + x8 + x9 + x10 -95326.08 0.0005 610.07
(b) Approximation with Zellner’s g-prior.
Rank Model No Model fˆ
MLE
(D|m) p(m|D) PO(m1013/mt)
1 m1013 x3 + x5 + x6 + x7 + x8 + x9 + x10 -95320.82 0.2847 1.00
2 m1014 x1 + x3 + x5 + x6 + x7 + x8 + x9 + x10 -95321.09 0.2182 1.30
3 m1021 x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 -95321.09 0.2178 1.31
4 m1022 x1 + x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 -95321.19 0.1967 1.45
5 m1015 x2 + x3 + x5 + x6 + x7 + x8 + x9 + x10 -95322.91 0.0355 8.03
6 m1023 x2 + x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 -95323.56 0.0184 15.44
7 m1016 x1 + x2 + x3 + x5 + x6 + x7 + x8 + x9 + x10 -95323.69 0.0161 17.68
8 m1024 x1 + x2 + x3 + x4 + x5 + x6 + x7 + x8 + x9 + x10 -95324.16 0.0101 28.20
9 m1010 x1 + x5 + x6 + x7 + x8 + x9 + x10 -95326.82 0.0007 404.12
10 m1009 x5 + x6 + x7 + x8 + x9 + x10 -95327.22 0.0005 598.82
5.2.3 Maximum likelihood based methods
Backward Stepwise Method: This method is based on the likelihood ratio test
(LRT). LRT = −2(l0−l1) where l0 and l1 denote the log-likelihood functions of the null
and the alternative model with df0 and df1 degrees of freedom, respectively. For large
number of observations (n), the distribution of LRT approaches the χ2 distribution
with df0 − df1 degrees of freedom (Miller and Miller, 2004). For the null hypothesis
H0 : xp = 0 where xp has 1 degree of freedom
∆BIC = −2(l0 − l1)− log(n)
= LRT − log(n).
The null hypothesis will not be rejected when LRT ≤ log(n) at some significance
level α. Here, log(n) ≈ 9.7 with n being 15860 and χ21 = 9.7 at α ≈ 0.002. This
significance level seems reasonable considering the size of the data set.
We note here that the forward stepwise method gives the same best models under
the Burr and LN distributions. Therefore we present only the results obtained by the
backward method.
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Tables 5.7 and 5.8 show log-likelihood and BIC values of different models under the
Burr and lognormal distributions, respectively. The LRT results for each step are
summarised in Table 5.9. Since this is a backward method, we start with the full
model, which is model 1024, and drop one variable at each step, unless there are no
variables to drop (reject the null hypothesis). For example, for the Burr distribution
(Table 5.7), the first step is to drop each one of the 10 covariates from the model
at a time and compare these 10 models with the full model, model 1024. Sorting
these models according to their BIC values, the model which excludes x2 (sex) has
the smallest BIC with LRT giving 3.8 for the hypothesis of x2 = 0 (see Table 5.9).
Since this is smaller than the critical value of 9.7, we conclude to drop this variable
from the model and continue to the second step. For this step our full model is model
1022, which excludes variable x2. From this model, we drop each of the remaining 9
variables (one at a time) and find their BIC values. Sorting them in ascending order
suggests that the model, 1014, which does not include variable x4 (smoker status) as
well as x2 is better than model 1022 (LRT = 9.3 < 9.7). Continuing to the third
step, we find that dropping x1 (age) from model 1014, gives a better model (model
1013) as LRT = 9.3 < 9.7 for the hypothesis of x1 = 0. On the fourth step, none of
the models excluding one of the remaining 7 variables from model 1013 give a smaller
BIC. The LRT for x3 = 0 (benefit type) hypothesis for the Burr model is rejected since
22.4 > 9.7. Similarly for the lognormal model, the hypothesis x4 = 0 (smoker status)
is rejected (LRT = 12.4 > 9.7, Table 5.9) on the second step after dropping sex (x2)
from the full model in the first step. Hence model 1013 under the Burr distribution
which excludes variables age (x1), sex (x2) and smoker status (x4) and model 1022
under the lognormal model which excludes sex (x2) are the best models. This result,
which is based on a maximum likelihood approach, agrees with the Bayesian variable
selection results given in Sections 5.2.1 and 5.2.2.
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Table 5.7: Variable selection with backward stepwise method for the Burr model.
Model No l BIC Drop Var
1022 −95160.2 190620.1 x2
1023 −95162.5 190624.9 x1
1016 −95162.7 190625.1 x4
1024 −95158.3 190626.1 NONE
1020 −95169.2 190638.2 x3
1008 −95172.2 190644.2 x5
960 −95175.0 190649.8 x7
896 −95273.2 190846.1 x8
992 −95281.7 190863.2 x6
768 −95435.3 191063.9 x9
512 −95429.8 191082.1 x10
Model No l BIC Drop Var (x2 and .)
1014 −95164.9 190619.9 x4
1021 −95164.9 190620.0 x1
1022 −95160.2 190620.1 NONE
1018 −95171.1 190632.4 x3
1006 −95174.1 190638.3 x5
958 −95177.9 190645.9 x7
894 −95275.3 190840.7 x8
990 −95284.3 190858.7 x6
766 −95437.8 191059.3 x9
510 −95430.5 191073.8 x10
Model No l BIC Drop Var (x2, x4 and .)
1013 −95169.5 190619.4 x1
1014 −95164.9 190619.9 NONE
1010 −95175.5 190631.4 x3
998 −95178.4 190637.2 x5
950 −95180.9 190642.2 x7
886 −95277.8 190836.1 x8
982 −95288.0 190856.4 x6
758 −95443.8 191061.6 x9
502 −95433.4 191070.0 x10
Model No l BIC Drop Var (x1, x2, x4 and .)
1013 −95169.5 190619.4 NONE
1009 −95180.7 190632.3 x3
997 −95181.7 190634.1 x5
949 −95183.2 190637.3 x7
981 −95291.0 190852.8 x6
885 −95295.6 190862.0 x8
501 −95437.6 191068.6 x10
757 −95466.4 191097.2 x9
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Table 5.8: Variable selection with backward stepwise method for the lognormal model.
Model No l BIC Drop Var
1022 −96060.9 192411.9 x2
1024 −96060.1 192420.1 NONE
1016 −96066.1 192422.3 x4
1023 −96066.7 192423.6 x1
1008 −96069.3 192428.7 x5
1020 −96074.5 192439.2 x3
960 −96084.2 192458.5 x7
992 −96174.2 192638.6 x6
768 −96247.2 192678.1 x9
896 −96260.0 192810.2 x8
512 −96373.3 192959.4 x10
Model No l BIC Drop Var (x2 and .)
1022 −96060.9 192411.9 NONE
1014 −96067.1 192414.7 x4
1021 −96067.9 192416.3 x1
1006 −96070.0 192420.4 x5
1018 −96075.3 192431.1 x3
958 −96085.9 192452.2 x7
990 −96175.6 192631.6 x6
766 −96248.2 192670.4 x9
894 −96261.3 192803.0 x8
510 −96374.5 192952.0 x10
Table 5.9: LRT values for each step given in Table 5.7 and 5.8.
Burr Lognormal
H0 : x2 = 0 x4 = 0 x1 = 0 x3 = 0 x2 = 0 x4 = 0
LRT: 3.8 9.3 9.3 22.4 1.6 12.4
The results obtained so far under different variable selection methodologies give very
close answers. Using Bayesian variable selection, marginal likelihoods or ML based
methods suggest the same model as the best model, i.e. m1013 under the Burr model
and m1022 under the LN model. DIC values of these models are shown in Table 5.10
and the lower DIC value for the Burr model again suggests that the selected model
under the Burr distribution has a better fit than the selected model under a lognormal
distribution. Therefore we will continue our analysis using model 1013 under the Burr
distribution. Previously, referring to the Bayes factor, we mentioned that under the
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Burr distribution we have 4 models (m1013,m1014,m1021 and m1022) that are barely
different from each other (see Tables 5.3 and 5.6). We select model 1013 instead of
the other 3 models because of parsimony. These models are not statistically different
from each other and model 1013 is a more parsimonious model compared to other
models as it includes less covariate(s) compared to them.
Table 5.10: DIC values of the selected models
D¯ = ̂−2 logL(θ) Dˆ = −2 logL(θˆ) pD DIC
Burr (m1013) 190367.6 190339.2 28.4 190396.0
LN (m1022) 192151.6 192121.8 29.8 192181.4
The posterior and ML estimates of the parameters of the selected model (m1013) under
the Burr model are given in Table 5.11.
The earlier comments on the effect of coefficients on the delay distribution are still
valid when using the selected model.
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Table 5.11: Estimates of the parameters under the selected Burr model (m1013).
MCMC MLE
Parameter Mean SD 2.5% 50% 97.5% Mean SD
β0 5.2980 0.0268 5.2470 5.2970 5.3490 5.2960 0.0280
β3 -0.0288 0.0061 -0.0409 -0.0288 -0.0167 -0.0288 0.0061
β5 0.0312 0.0063 0.0187 0.0313 0.0436 0.0311 0.0063
β6 0.1140 0.0071 0.1004 0.1139 0.1282 0.1143 0.0073
β7 -0.0332 0.0065 -0.0459 -0.0331 -0.0208 -0.0331 0.0064
β8 -0.1202 0.0074 -0.1346 -0.1202 -0.1057 -0.1201 0.0076
β9,1 0.2406 0.0234 0.1945 0.2404 0.2864 0.2396 0.0239
β9,2 0.1358 0.0210 0.0944 0.1354 0.1769 0.1345 0.0218
β9,3 -0.2149 0.0622 -0.3372 -0.2172 -0.0895 -0.2079 0.0611
β9,4 0.1322 0.0484 0.0408 0.1311 0.2288 0.1342 0.0496
β9,5 -0.1358 0.0359 -0.2054 -0.1363 -0.0640 -0.1398 0.0368
β9,6 -0.5528 0.0812 -0.7173 -0.5529 -0.3929 -0.5377 0.0835
β9,7 -0.2925 0.1270 -0.5539 -0.2841 -0.0520 -0.3003 0.1224
β9,8 0.0769 0.0213 0.0364 0.0765 0.1192 0.0762 0.0217
β9,9 -0.1974 0.0262 -0.2485 -0.1975 -0.1452 -0.1989 0.0267
β9,10 0.2371 0.0318 0.1726 0.2373 0.2976 0.2359 0.0327
β9,11 -0.0927 0.0193 -0.1300 -0.0930 -0.0541 -0.0942 0.0194
β9,12 0.1938 0.0253 0.1436 0.1938 0.2451 0.1928 0.0259
β9,13 0.4697 0.0778 0.3161 0.4733 0.6219 0.4656 0.0778
β10,1 -0.1523 0.0416 -0.2340 -0.1523 -0.0706 -0.1528 0.0410
β10,2 -0.0814 0.0208 -0.1211 -0.0817 -0.0402 -0.0808 0.0202
β10,3 -0.4840 0.0286 -0.5395 -0.4850 -0.4262 -0.4837 0.0281
β10,4 0.0002 0.0243 -0.0464 0.0002 0.0487 0.0005 0.0240
β10,5 0.1016 0.0783 -0.0521 0.1014 0.2548 0.0942 0.0803
β10,6 0.2451 0.1193 0.0190 0.2435 0.4862 0.2565 0.1221
β10,7 0.1237 0.0336 0.0572 0.1232 0.1898 0.1235 0.0339
β10,8 0.0167 0.0287 -0.0414 0.0173 0.0718 0.0165 0.0286
β10,9 0.2347 0.0300 0.1764 0.2342 0.2932 0.2355 0.0290
β10,10 -0.0044 0.0570 -0.1157 -0.0040 0.1079 -0.0096 0.0603
α 0.6193 0.0150 0.5910 0.6189 0.6485 0.6178 0.0168
τ 2.6280 0.0322 2.5680 2.6280 2.6880 2.6349 0.0382
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5.3 Selection of claim-specific covariates with growth
factor
In this section claim-specific covariates are selected with Gibbs based methods, using
empirical priors and Zellner’s g-prior as well as ML based methods under the Burr
distribution. We showed that the Burr distribution has a better fit than the LN model
in all of the cases we discussed so far. Therefore, here we do not give the full analysis
for the LN model but provide some comparisons.
Burr model
Gibbs-based methods:
Since we allow for growth in this section, we introduce γ in the model given in (4.2)
with the same linear predictor given in Section 5.2.1. That is
η∗i = β0 +
8∑
j=1
γjβjzij + γ9β9,Officek + γ10β10,Causel .
We also use the same priors we used in Section 5.2.1 for empirical and Zellner’s g-prior.
Posterior variable inclusion probabilities p(γ|D) and posterior model probabilities,
p(m|D), of 10 models having the highest probabilities with these two prior distribution
sets are given in Table 5.12 under the Burr model with growth factor. If we decide
to eliminate variables which have an inclusion probability less than 0.5, then age,
sex, smoker status and settlement year (x1, x2, x4 and x6) should be dropped from
the model with these two prior sets. This result is consistent with posterior model
probabilities, as model 981, which excludes these variables, has the highest probability
(see Tables 5.12(b) and 5.12(c)). The second highest model includes age (x1) and this
model (m982) is about 2.5 times less likely than the first model. The top 10 models
with both prior sets are exactly the same with changing order for the models which
have less than 5% posterior probabilities.
When model selection is carried out using a maximum likelihood based method, the
result agrees with the Bayesian variable selection results as model 981 is also found
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to be the best model under this approach.
The difference between model 981 and model 1013 is the settlement year. When
we did not take the growth factor into account the settlement year was found to
be important. However, as we explained in Chapter 4, the effect of settlement year
disappears when we allow for the growth between successive years. Since the effect of
the year on the delay is partly explained by the growth rate, this result is reasonable.
81
Table 5.12: Parameter inclusion probabilities and model probabilities under the Burr
model with empirical and Zellner’s g-priors when business growth is taken into ac-
count.
(a) Inclusion probabilities for empirical priors and
Zellner’s g-prior.
Empirical Priors Zellner’s g-Prior
Parameter p(γ|D) SD p(γ|D) SD
γ1 0.2879 0.4528 0.2987 0.4577
γ2 0.0841 0.2775 0.0772 0.267
γ3 0.8538 0.3533 0.8114 0.3912
γ4 0.256 0.4364 0.2378 0.4258
γ5 1 0 1 0
γ6 0.0857 0.28 0.0883 0.2837
γ7 1 0 0.997 0.0544
γ8 1 0 1 0
γ9 1 0 1 0
γ10 1 0 1 0
(b) Posterior model probabilities - empirical priors
Rank Model No Model p(m|D) PO(m981/mk)
1 m981 x3 + x5 + x7 + x8 + x9 + x10 0.3806 1.00
2 m982 x1 + x3 + x5 + x7 + x8 + x9 + x10 0.1429 2.66
3 m989 x3 + x4 + x5 + x7 + x8 + x9 + x10 0.1388 2.74
4 m977 x5 + x7 + x8 + x9 + x10 0.0624 6.10
5 m990 x1 + x3 + x4 + x5 + x7 + x8 + x9 + x10 0.0613 6.21
6 m983 x2 + x3 + x5 + x7 + x8 + x9 + x10 0.0404 9.41
7 m1013 x3 + x5 + x6 + x7 + x8 + x9 + x10 0.0314 12.13
8 m978 x1 + x5 + x7 + x8 + x9 + x10 0.0309 12.31
9 m1014 x1 + x3 + x5 + x6 + x7 + x8 + x9 + x10 0.0141 26.94
10 m985 x4 + x5 + x7 + x8 + x9 + x10 0.0120 31.64
(c) Posterior model probabilities - Zellner’s g-Prior
Rank Model No Model p(m|D) PO(m981/mk)
1 m981 x3 + x5 + x7 + x8 + x9 + x10 0.3644 1.00
2 m982 x1 + x3 + x5 + x7 + x8 + x9 + x10 0.1496 2.44
3 m989 x3 + x4 + x5 + x7 + x8 + x9 + x10 0.1170 3.11
4 m977 x5 + x7 + x8 + x9 + x10 0.0870 4.19
5 m990 x1 + x3 + x4 + x5 + x7 + x8 + x9 + x10 0.0523 6.97
6 m978 x1 + x5 + x7 + x8 + x9 + x10 0.0355 10.26
7 m983 x2 + x3 + x5 + x7 + x8 + x9 + x10 0.0349 10.43
8 m1013 x3 + x5 + x6 + x7 + x8 + x9 + x10 0.0304 11.99
9 m985 x4 + x5 + x7 + x8 + x9 + x10 0.0200 18.19
10 m1014 x1 + x3 + x5 + x6 + x7 + x8 + x9 + x10 0.0175 20.82
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When we performed model selection under the LN model, we saw that the best model
is not changed. Model 1022 which excludes only sex (x2) from the model is still the
best model under the LN distribution when growth rate is introduced. As mentioned
in Chapter 4, the importance of the settlement year under the LN model is not very
much affected by the introduction of the growth rates. The reason is that the growth
rates are affecting the earlier claims more, i.e. they are higher for earlier years for
almost all offices (see Table 4.1). Since these earlier claims have longer delays, the
higher weights on them increase the importance of modelling the tail. The relatively
shorter/inflexible tail of the LN distribution, on the other hand, is not able to model
them adequately.
To compare the Burr model with 6 covariates (model 981) with the lognormal model
which excludes sex (model 1022), log-likelihood values (l), degrees of freedoms (df)
and corresponding BIC values of these models are given in Table 5.13. The consider-
ably lower BIC of the Burr distribution, once again, suggest that it has a better fit.
Therefore we select this Burr model (model 981) as the best model when the business
growth is allowed in the model.
Table 5.13: Comparison of the Burr and LN models with growth rate.
Burr (m981) LN (m1022)
l -95610.1 -97146.7
df 28 31
BIC 191491.0 194593.2
We will use the selected model (m981) under the Burr distribution when we introduce
missing values in the analysis and for prediction. The posterior and ML estimates of
the parameters of this model are given in Table 5.14.
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Table 5.14: Estimates of the parameters under the best Burr model (m981) without
missing values with growth rate.
MCMC MLE
Parameter Mean SD 2.5% 50% 97.5% Mean SD
β0 5.4330 0.0333 5.3660 5.4340 5.4990 5.4389 0.0305
β3 -0.0227 0.0064 -0.0354 -0.0227 -0.0100 -0.0228 0.0063
β5 0.0351 0.0065 0.0222 0.0351 0.0478 0.0352 0.0065
β7 -0.0306 0.0066 -0.0434 -0.0307 -0.0179 -0.0303 0.0065
β8 -0.0985 0.0075 -0.1133 -0.0984 -0.0843 -0.0981 0.0075
β9,1 0.3238 0.0247 0.2751 0.3238 0.3714 0.3202 0.0239
β9,2 0.2665 0.0237 0.2209 0.2664 0.3129 0.2630 0.0225
β9,3 -0.2103 0.0640 -0.3399 -0.2076 -0.0872 -0.2046 0.0635
β9,4 -0.2726 0.0494 -0.3677 -0.2725 -0.1788 -0.2759 0.0510
β9,5 -0.0478 0.0373 -0.1223 -0.0477 0.0233 -0.0499 0.0380
β9,6 -0.1558 0.0891 -0.3110 -0.1600 0.0321 -0.1504 0.0923
β9,7 -0.1131 0.1403 -0.3911 -0.1181 0.1465 -0.0952 0.1255
β9,8 0.1556 0.0230 0.1090 0.1560 0.1995 0.1513 0.0224
β9,9 -0.3019 0.0281 -0.3550 -0.3026 -0.2493 -0.3068 0.0273
β9,10 0.2463 0.0347 0.1783 0.2462 0.3150 0.2427 0.0336
β9,11 -0.1137 0.0212 -0.1556 -0.1132 -0.0745 -0.1186 0.0200
β9,12 -0.1759 0.0278 -0.2305 -0.1758 -0.1228 -0.1816 0.0262
β9,13 0.3990 0.0744 0.2637 0.3984 0.5495 0.4058 0.0803
β10,1 -0.1547 0.0416 -0.2361 -0.1546 -0.0727 -0.1541 0.0420
β10,2 -0.0715 0.0206 -0.1136 -0.0715 -0.0329 -0.0723 0.0205
β10,3 -0.4673 0.0291 -0.5226 -0.4678 -0.4092 -0.4685 0.0286
β10,4 0.0019 0.0251 -0.0467 0.0019 0.0500 0.0019 0.0244
β10,5 0.1145 0.0788 -0.0415 0.1145 0.2666 0.1151 0.0819
β10,6 0.2548 0.1287 -0.0022 0.2574 0.5049 0.2582 0.1232
β10,7 0.1238 0.0355 0.0550 0.1240 0.1936 0.1241 0.0347
β10,8 0.0231 0.0293 -0.0340 0.0229 0.0803 0.0216 0.0292
β10,9 0.2438 0.0297 0.1859 0.2443 0.3021 0.2435 0.0296
β10,10 -0.0684 0.0602 -0.1870 -0.0664 0.0505 -0.0695 0.0606
α 0.5858 0.0156 0.5581 0.5866 0.6156 0.5840 0.0158
τ 2.6250 0.0378 2.5600 2.6200 2.7060 2.6283 0.0387
Discussion
In this chapter, the most relevant covariates affecting the delay distribution are chosen
first without considering business growth and then taking it into account. Sex is not
significant throughout the analyses under the Burr and LN models. On the other
hand, leaving age and smoker status out of the model is ambiguous since they have
relatively high posterior inclusion probabilities under the Burr model. We expect the
effect of year to diminish when office specific growth rates between successive years
are introduced in the model. Typically in life-related insurance practice, age and
smoking status are important policyholder characteristics and should probably also
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be taken into consideration when inception rates are calculated in CII. We note that
our model is developed here with the purpose of estimating and predicting delay in
claim settlement, also in the presence of non-recorded dates of diagnosis or settlement.
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Chapter 6
Modelling CDD III: Including the
missing values
6.1 Introduction
The data contain 19127 delay observations which have either the date of diagnosis or
the date of settlement recorded, with 15860 of them having both dates. Hence 17% of
the claims are excluded from the analysis when records with missing information are
not taken into account. However, in Bayesian analysis, the posterior distribution of
a parameter vector θ can be obtained by conditioning only on observed values Dobs
(Gelman et al., 2000). The aim of this chapter is to estimate the CDD taking account
of business growth and also missing values in the data set. This can then provide
estimates of non-recorded dates that are important for modelling claim inception
rates.
The growth rates are assigned to claims according to their diagnosis years. This
means that growth rates of 1752 claims (9.2%) which do not have date of diagnosis
recorded, can not be directly calculated. These claims are included in the analyses in
two steps. First, we estimate the dates of diagnosis from the model which assumes no
growth within offices between consecutive years. Here, we use the selected Burr model
derived in Section 5.2. This step is described in Section 6.2. Then, in the second step,
we use these dates to assign growth rates to the claims with missing dates of diagnosis
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and re-estimate the missing values allowing for the growth in the offices. The model
is developed in Section 6.3. In this second step, the selected Burr model concluded in
Section 5.3 is employed.
6.2 Including the missing values and assuming no
growth within offices
The dependent variable vector, D, can be written as D = (Dobs,Dmis) where Dobs
denotes the observed values andDmis denotes the missing values. So, the joint density
of the missing delay values conditional on the observed data can be given by
P (Dmis|Dobs) =
∫
P (Dmis,θ|Dobs) dθ
=
∫
P (Dmis|θ,Dobs)P (θ|Dobs) dθ
=
∫
P (Dmis|θ)P (θ|Dobs) dθ
= E
θ|Dobs
[P (Dmis|θ)] .
This suggests that the density of the missing values can be estimated using the simu-
lated θ values from the MCMC output. For each missing observation, values are drawn
from its posterior distribution. On the other hand, when we have missing observations
in the independent variables, full conditional distributions should be specified, i.e. we
need a distribution for those missing observations. By doing this, missing values will
be introduced as parameters to be estimated in WinBUGS (Ntzoufras, 2009).
In addition to dates of diagnosis (DoD) and settlement (DoS), we are also provided
with dates of commencement (DoC) of the policy, notification (DoN) and claim
admission (DoA) related to each claim. Since these dates are expected to be in
chronological order (see Figure 6.1), we use them to obtain natural upper and lower
limits when we impute the missing delay values, i.e.
Du ∼ Burr(α, τ, λu)I(LBu, UBu) (6.1)
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where u = 15861, ..., 19127, and LB and UB are lower and upper bounds, respectively.
DOC DOD DON DOA DOS
Figure 6.1: Chronological order of the dates relating to a claim.
The lower bound is determined as follows
du ≥ DoS −DoN when DoD is missing,
du ≥ DoA−DoD when DoS is missing,
du ≥ DoN −DoD when DoS and DoA are missing,
du > 0 when there is only DoD or DoS recorded.
The upper bound of the delay is determined by DoS−DoC ≥ du for the claims where
DoD is not recorded.
Due to missing dates of diagnosis, unobserved values of the covariate giving policy
duration until diagnosis must be imputed as well. We need to assign appropriate
distributions as follows
zPolDurv ∼ N(µPolDur, σ2PolDur)I(-1.22, 6.17)
µPolDur ∼ N(0, 1000)
σ2PolDur ∼ IGa(0.001, 0.001)
(6.2)
for v = 17376, ..., 19127. This means that we use a lower bound of zero days with an
upper bound of 7000 days resulting in the I(−1.22, 6.17) restriction for the standard-
ised covariate.
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We use the selected Burr model (m1013) in Section 5.2. The model has the same
structure given in (3.5), however, here we also introduce missing values in the model,
i.e.
Di ∼ Burr(α, τ, λi), i = 1, . . . , 15860
Du ∼ Burr(α, τ, λu)I(LBu, UBu), u = 15861, . . . , 19127
and for the model parameters, we use the prior distributions given in (3.10) but, here
we exclude age (x1), sex (x2) and smoker status (x4) from the full model. For the
unobserved values of policy duration, we use the distribution given in (6.2). The
estimated means of the standardised coefficients, their standard deviations and credi-
ble intervals are shown in Table 6.1, together with estimates of the parameters of the
policy duration distribution. Note that the definitions of the covariates corresponding
to β coefficients can be seen in Table 3.3.
We can compare the posterior estimates with those given in Table 5.11 and changes
can also be seen in Figures 6.2 and 6.3. These figures show the posterior densities of
the model parameters under the Burr model with and without missing values. Includ-
ing missing observations in the analysis leads to significant changes in the posterior
densities of some of the model parameters which means that for these covariates the
missing data are systematically different from the observed data. For example in-
cluding missing observations in the analysis decreases the positive effect of settlement
year (β6) on the delay. It might be because data are not provided for some settlement
years when the delay is shorter. The negative effect of Office 6 (β9,6) decreases when
the missing information is taken into account. The reason might be the office does
not provide data when the delay is longer. For cancer claims, on the other hand, the
data might not be provided when the delay is shorter, so that including the missing
data increases the negative effect of cancer (β10,2) on the delay. Other changes can be
interpreted in a similar way. The sign of the mean estimates of heart attack (β10,4) and
other causes (β10,8) changes from positive to negative. However in both cases these
coefficients are not significant in the models. The sign of TPD (β10,10) changes from
negative to positive when we include the missing observations in the model. Note
that this coefficient was negative with a very high standard deviation in the analysis
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without missing values. This might mean that for the TPD claims, data are provided
when the delays are shorter.
Table 6.1: Posterior estimates of parameters under the selected Burr model with
missing values (m1013).
Parameter Mean SD 2.5% 50% 97.5%
β0 5.3690 0.0277 5.3100 5.3690 5.4240
β3 -0.0314 0.0060 -0.0432 -0.0314 -0.0196
β5 0.0325 0.0063 0.0203 0.0326 0.0447
β6 0.0937 0.0072 0.0797 0.0936 0.1076
β7 -0.0329 0.0064 -0.0455 -0.0330 -0.0204
β8 -0.1151 0.0074 -0.1294 -0.1152 -0.0999
β9,1 0.2452 0.0228 0.2008 0.245 0.2903
β9,2 0.1553 0.021 0.1146 0.1552 0.1953
β9,3 -0.2221 0.0588 -0.3351 -0.2201 -0.1141
β9,4 0.1390 0.0488 0.0462 0.1381 0.2348
β9,5 -0.1812 0.0358 -0.2511 -0.1809 -0.1082
β9,6 -0.4045 0.0764 -0.5549 -0.4011 -0.2564
β9,7 -0.3327 0.1292 -0.5829 -0.3263 -0.0812
β9,8 0.0470 0.0213 0.0052 0.0472 0.0885
β9,9 -0.2182 0.0246 -0.2675 -0.2177 -0.1705
β9,10 0.1845 0.0317 0.1236 0.1841 0.2477
β9,11 -0.1370 0.0188 -0.1735 -0.1375 -0.0996
β9,12 0.1511 0.0244 0.1022 0.1513 0.1981
β9,13 0.5735 0.0513 0.4729 0.5746 0.6731
β10,1 -0.1602 0.0398 -0.2394 -0.1603 -0.0829
β10,2 -0.1269 0.0202 -0.1676 -0.1266 -0.0868
β10,3 -0.4576 0.0264 -0.5075 -0.4579 -0.4038
β10,4 -0.0471 0.0237 -0.0924 -0.0471 0.0001
β10,5 0.0848 0.0795 -0.0665 0.0845 0.2446
β10,6 0.2339 0.1163 -0.0002 0.2343 0.4572
β10,7 0.1324 0.0328 0.0682 0.1329 0.1954
β10,8 -0.0146 0.0288 -0.0696 -0.0153 0.0431
β10,9 0.1902 0.0277 0.1359 0.1898 0.246
β10,10 0.1652 0.0547 0.0538 0.1675 0.2666
α 0.6403 0.0181 0.6030 0.6415 0.6723
τ 2.5790 0.0367 2.5150 2.5750 2.6600
µPolDur 0.0188 0.0074 0.0043 0.0188 0.0333
(σ2PolDur)
−1 1.0260 0.0108 1.0050 1.0260 1.0480
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Figure 6.2: Comparison of posterior densities of model parameters (β1 − β9) under
the selected Burr model (m1013) with (red dashed line) and without (black solid line)
missing values.
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Figure 6.3: Comparison of posterior densities of model parameters (β10, α, τ) under
the selected Burr model (m1013) with (red dashed line) and without (black solid line)
missing values.
6.3 Considering the missing values and the growth
rate
In this section, both the missing values and the growth rates are handled in the delay
distribution. The modelling of the delay is performed in four steps. First, the missing
dates of diagnosis are filled with the estimated delays from the model in Section 6.2
(step 1). The estimate we use is the date of settlement minus the median of the delay
distribution corresponding to the characteristics of the claim. Then, using the year
of diagnosis, initial growth rates are assigned to the claims where the DoD is missing
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(9.2% of the claims) (step 2) and the delay is modelled using the selected model in
Section 5.3 (step 3). These 3 steps are repeated once more (starting from the model
estimated in step 3) to have the final growth rates and the final CDD (step 4). These
steps can be summarised in the following way
(1): Estimate year of diagnosis from the model without growth rate (given in Section
6.2).
(2): Assign growth rates based on (1).
(3): Fit CDD with growth rate from (2) with the selected model presented in Section
5.3.
(4): Repeat (1) - (3) starting from the model obtained in (3). (That is estimate year
of diagnosis from (3) and calculate growth rates based on this model. Fit CDD
with these growth rates using the model presented in Section 5.3.)
Out of 1752 claims, year of diagnosis (and hence the growth rate) is changed for 52
claims after this second iteration (step 4) either by going one year up or down. Here,
model m981 (excludes age, sex, smoker status and year of settlement) is used as it is
the selected model according to the variable selection in Section 5.3.
The probability model structure used here is the same as in (4.2). Here, we also
include the missing observations in the model. That is
Di ∼ Burr(α, τ, λwi), i = 1, . . . , 15860
Du ∼ Burr(α, τ, λwu)I(LBu, UBu), u = 15861, . . . , 19127
and prior distributions assigned to the model parameters are the same as in (4.3)
(note that we exclude age (x1), sex (x2), smoker status (x4) and settlement year (x6)
from the full model) and for the unobserved values of the policy duration covariate,
we use the distributions given in (6.2). Posterior estimates of the model parameters
are given in Table 6.2 for the Burr model.
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Table 6.2: Coefficients of the Burr model (m981) with missing values and with growth
rate.
Parameter Mean SD 2.5% 50% 97.5%
β0 5.4690 0.0250 5.4170 5.4690 5.5170
β3 -0.0234 0.0062 -0.0353 -0.0234 -0.0115
β5 0.0339 0.0063 0.0218 0.0340 0.0463
β7 -0.0320 0.0065 -0.0445 -0.0321 -0.0193
β8 -0.0977 0.0072 -0.1119 -0.0978 -0.0836
β9,1 0.3031 0.0215 0.2612 0.3030 0.3454
β9,2 0.2154 0.0196 0.1770 0.2153 0.2543
β9,3 -0.2052 0.0611 -0.3304 -0.2038 -0.0920
β9,4 -0.2487 0.0496 -0.3454 -0.2483 -0.1499
β9,5 -0.0899 0.0368 -0.1638 -0.0894 -0.0182
β9,6 -0.0504 0.0847 -0.2140 -0.0512 0.1142
β9,7 -0.1293 0.1182 -0.3741 -0.1240 0.0914
β9,8 0.1055 0.0205 0.0659 0.1055 0.1462
β9,9 -0.3154 0.0253 -0.3661 -0.3152 -0.2668
β9,10 0.2009 0.0329 0.1364 0.2012 0.2662
β9,11 -0.1576 0.0171 -0.1920 -0.1581 -0.1240
β9,12 -0.2089 0.0231 -0.2547 -0.2083 -0.1639
β9,13 0.5805 0.0470 0.4893 0.5799 0.6720
β10,1 -0.1452 0.0402 -0.2238 -0.1452 -0.0664
β10,2 -0.1009 0.0183 -0.1364 -0.1010 -0.0659
β10,3 -0.5419 0.0264 -0.5942 -0.5417 -0.4896
β10,4 -0.0288 0.0228 -0.0727 -0.0290 0.0162
β10,5 0.1287 0.0787 -0.0324 0.1289 0.2872
β10,6 0.1939 0.1163 -0.0398 0.1945 0.4142
β10,7 0.1523 0.0331 0.0868 0.1524 0.2162
β10,8 0.0063 0.0277 -0.0472 0.0061 0.0623
β10,9 0.2149 0.0271 0.1620 0.2145 0.2680
β10,10 0.1207 0.0564 0.0097 0.1211 0.2313
α 0.6179 0.0153 0.5930 0.6161 0.6520
τ 2.5700 0.0344 2.4940 2.5750 2.6250
µPolDur 0.0190 0.0074 0.0047 0.0190 0.0333
(σ2PolDur)
−1 1.0260 0.0108 1.0050 1.0260 1.0470
94
5.30 5.45 5.60
0
5
10
15
β0
Without MV
 With MV
−0.05 −0.02
0
20
40
60
β3
0.01 0.04 0.07
0
20
40
60
β5
−0.06 −0.02
0
20
40
60
β7
−0.13 −0.10 −0.07
0
20
40
60
β8
0.20 0.30 0.40
0
5
10
20
β9−1
0.15 0.25 0.35
0
5
10
20
β9−2
−0.4 −0.2 0.0
0
2
4
6
β9−3
−0.4 −0.2
0
2
4
6
8
β9−4
−0.25 −0.05 0.10
0
4
8
12
β9−5
−0.4 0.0
0
2
4
6
β9−6
−0.6 0.0 0.4
0.
0
1.
0
2.
0
3.
0
β9−7
0.00 0.10 0.20
0
5
10
20
β9−8
−0.45 −0.30
0
5
10
15
β9−9
0.05 0.20 0.35
0
4
8
12
β9−10
−0.25 −0.10
0
5
10
20
β9−11
−0.30 −0.15
0
5
10
15
β9−12
0.2 0.6
0
2
4
6
8
β9−13
Figure 6.4: Comparison of posterior densities of model parameters (β1 − β9) under
the selected Burr model (m981) including the growth rate, with (red dashed line) and
without (black solid line) missing values.
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Figure 6.5: Comparison of posterior densities of model parameters (β10, α, τ) under
the selected Burr model (m981) including the growth rate, with (red dashed line) and
without (black solid line) missing values.
Including missing observations and growth rates in the analysis has an effect on some
office (β9) and cause (β10) levels. Figures 6.4 and 6.5 show the differences in the pos-
terior densities of model parameters with and without missing values. According to
Figure 6.4, posterior densities of the effect of Office 13 (β9,13) are different from each
other. One of the reasons for this could be the percentage of missing observations
for this office, 86.4%, which is the highest among all the offices. Next, Office 2 and 3
come with 28.6% and 25.6% respectively. The posterior densities of Office 3 (β9,3) are
almost exactly the same when the missing values are included or excluded suggesting
the missing data provided from this office are ‘random’, i.e. the missing data are not
systematically different from the observed cases. For the causes, the highest missing
claims percentage is for death (β10,3) with 71.4% of the claims not recorded. Con-
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sidering the shapes of the posterior densities, there might be a systematic difference
between the observed data and the missing data for death. For TPD (β10,10) the
posterior densities are found to be different indicating the missing data might depend
on a factor. The data might not be provided when the delay is long for TPD claims.
Prediction
After the variable selection performed in Section 5.3, we decided to exclude age, sex,
smoker status and year of settlement from the model. Considering this result, Table
6.3 shows 11 illustrative scenarios and Table 6.4 shows details of the estimated claim
delay distribution for each of these scenarios under the Bayesian approach.
Table 6.3: Scenarios for prediction of the CDD under the selected Burr model (m981).
Scenario 1 2 3 4 5 6
Benefit Type FA SA FA FA FA FA
Joint/Single Life J J S J J J
Benefit Amount 50000 50000 50000 10000 250000 50000
Policy Duration 1460 1460 1460 1460 1460 365
Office Code 11 11 11 11 11 11
Cause of Claim Cancer Cancer Cancer Cancer Cancer Cancer
Scenario 7 8 9 10 11
Benefit Type FA FA FA FA FA
Joint/Single Life J J J J J
Benefit Amount 50000 50000 50000 50000 50000
Policy Duration 3650 1460 1460 1460 1460
Office Code 11 6 10 11 11
Cause of Claim Cancer Cancer Cancer Death TPD
The mean delay for a typical risk profile (Scenario 1) is estimated as 180 days. Includ-
ing missing observations in the analysis, the prediction becomes 174 days. Changing
the office in the typical scenario to Office 10 (Scenario 9) gives the highest posterior
mean delay among these 11 scenarios with 259 days (249 days when missing values
are included) while changing the claim cause to death (Scenario 10) gives the shortest
one with 121 days (112 days with missing values). Mean delays of the scenarios with
their 95% credible intervals for the cases where claims with missing information are
included or excluded from the model are given in Figure 6.6. Except for Scenarios 8
97
and 11, means of the delays considered here are shorter when missing values are taken
into account. Credible intervals of these scenarios are wider compared to the others.
Table 6.4: Posterior estimates of the mean of the delay distribution under different
scenarios given in Table 6.3 using the selected Burr model (m981) with growth rates.
Excluding Missing Data Including Missing Data
Mean SD 2.5% 50% 97.5% Mean SD 2.5% 50% 97.5%
Mean.Scn1 180.3 4.5 171.4 180.2 189.3 173.9 4.0 166.5 173.8 181.7
Mean.Scn2 168.1 5.3 157.9 168.0 178.9 161.7 4.8 152.7 161.7 171.3
Mean.Scn3 193.4 5.0 183.9 193.4 203.4 186.1 4.3 177.8 186.0 194.9
Mean.Scn4 184.2 4.7 175.1 184.2 193.4 177.8 4.1 170.2 177.8 186.0
Mean.Scn5 162.0 5.7 151.0 161.9 173.3 155.5 5.1 146.0 155.3 166.1
Mean.Scn6 202.1 5.1 192.0 202.0 212.2 194.7 4.4 186.5 194.7 203.5
Mean.Scn7 143.6 4.7 134.7 143.5 152.8 138.7 4.2 130.7 138.6 147.1
Mean.Scn8 173.6 17.3 145.8 171.5 212.6 194.3 17.8 161.6 193.5 230.9
Mean.Scn9 258.5 10.6 237.4 258.4 279.1 249.0 10.0 230.0 248.7 269.7
Mean.Scn10 121.4 3.8 114.2 121.3 128.9 111.9 3.2 105.7 111.8 118.5
Mean.Scn11 181.1 11.2 160.2 180.9 204.0 217.4 12.7 193.4 217.3 242.6
Discussion
Our principal application for this CDD model is to estimate the date of diagnosis (or
date of settlement) for a claim record where this is missing. If both dates are missing,
the claim record is omitted from the analysis. Hence, all our claim records will have
either actual or estimated dates of diagnosis and settlement. By estimating the date
of diagnosis, those claims can be used in calculation of inception rates. The effect
of using a point estimate (i.e. median) for the missing delays on the inception rates
might be argued. In Section 7.5, it is shown that the inception rates are not very
sensitive to how the missing dates are estimated.
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Figure 6.6: Comparison of posterior estimates of the mean delay under different
scenarios using the selected Burr model (m981) including (red solid line) and excluding
(black solid line) the missing information. Bars show 95% credible intervals and bullets
show posterior means.
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Chapter 7
Diagnosis inception rates I:
All-cause rates
7.1 Introduction
The objective of this chapter is to estimate the intensity of a diagnosis, denoted λ,
of a sickness at age x last birthday which will lead to a claim from any cause. This
intensity could be a function of some or all of the characteristics listed in Table 7.1.
For the analyses we restrict the age to 16− 80. By doing so, we exclude 8 cases out
of 587 177 different combinations of profiles where there is exposure at risk. Benefit
amount is modelled as a factor and the boundaries for the categories in Table 7.1 are
determined appoximately by the quartiles of this covariate. We use the corresponding
in force data, for which we have start of year and end of year information for 1999
to 2005 supplied by the CMI. This gave 24 132 215 policy-years of exposure. We
omitted approximately 5 million policy years of exposure from these data for various
reasons, in particular because some offices do not give information about both dates
of diagnosis and settlement for their claims and some policies have undefined smoker
status.
In Section 7.2 we explain how we calculated the exposure and present the model we
used to estimate the diagnosis inception rates. In Section 7.3 the diagnosis inception
rates are estimated under the best model after variable selection. The CMI gives the
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Table 7.1: Definitions of the covariates used in the modelling of the intensity rates.
Covariate Number of Levels Additional Information
θ1 Sex 2 (F & M) F is the base category
θ2 Benefit type 2 (FA & SA) FA is the base category
θ3 Smoker status 2 (N & S) N is the base category
θ4 Policy type 2 (Joint/Single life) J is the base category
θ5 Year Numerical (1999, . . . , 2005) Calendar year of exposure
Calendar year of diagnosis
θ6 Benefit amount 4 1, Benefit amount<25000
2, 25000<Benefit amount<50000
3, 50000<Benefit amount<75000
4, Benefit amount>75000
θ7 Policy duration 6 duration between the beginning of the year and
commencement of the policy
Duration 0, Policy Duration < 1 year
Duration 1, 1 year < Policy Duration ≤ 2 years
Duration 2, 2 years < Policy Duration ≤ 3 years
Duration 3, 3 years < Policy Duration ≤ 4 years
Duration 4, 4 years < Policy Duration ≤ 5 years
Duration 5+, Policy Duration > 5 years
θ8 Office 13
diagnosis inception rates for full accelerated policies only and the rates are separated
for sex, smoker status and policy duration. So, to compare our rates with CMI rates
presented in WP 43 (2010) we needed a model including these covariates. For this
purpose, we estimated inception rates with two other models. The details of the CMI
variables and difference between these two models are explained in Section 7.4 and for
different combinations of characteristics comparisons between the rates are presented.
Finally in Section 7.5, we performed a sensitivity analysis to see whether there is
a significant difference between the inception rates estimated by using the median
of the CDD obtained in Chapter 6 of the estimated delays rather than using other
percentiles of this distribution as a point estimate.
7.2 Modelling techniques
Exposure to risk calculation
The in force data we have are in census form, obtained at 1 January and 31 December
of each calendar year between 1999 and 2005. The total number of policies inforce may
be different for the end (31 December) of one year and beginning (1 January) of the
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next. Changes in participation of contributing offices across years are the main reason
for this. Also, for some years during their contribution periods, some of the offices
have different figures for the end of year and the start of the next year if the office
changes its portfolio of policies during its contribution period. However the effect of
the latter is relatively small. We also note that there are no gaps in submission, i.e.
there are no offices which stop contributing and then start again after a while.
The beginning and end of year in force data are counted for each calendar year for
different risk profiles. At the beginning of a year we count the lives at age x last
birthday at 1 January (E(0)(x,θ)) and at the end of a year we count the lives at
age x last birthday at 31 December (E(1)(x,θ)) for a given θ denoting a risk profile
involving specific characteristics given in Table 7.1. We assume linear change of
exposure between census dates and use a repeated Simpson’s Rule for approximation
as explained later in this section.
Estimation of the inception rates
Let
tθ8 denote the final calendar year in which the considered office (θ8) contributes
data, so that tθ8 is one of 1999, . . . , 2005
N(x,θ) denote the observed number of claims for all-causes at age x and risk
profile θ which are diagnosed in year θ5 and settled before the end of the last
contribution year of the considered office, tθ8
E(x, u;θ) denote the number of policies with age x last birthday and risk profile
θ, exposed at time u in the considered calendar year (θ5)
F (tθ8 − θ5 + 1− u;x,θ) denote the probability of settling a claim in time
(tθ8 − θ5 + 1 − u) at age x, given θ by the end of the last contribution year of
the considered office, tθ8 , starting from time u after the start of year θ5, where
θ5 = 1999, . . . , 2004, 2005 and tθ8 ∈ (θ5, θ5 + 1, . . . , 2005)
λ(x,θ) denote the intensity rate (hazard) for a claim diagnosis (all-causes) in
the respective year θ5 at age x last birthday given risk profile θ.
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Note that the risk profile, θ, includes office. Any claim settled before the end of the
last contribution year tθ8 which has a year of diagnosis θ5, where the associated office
did not contribute data, should be removed from N(x,θ). There are 900 such cases
which correspond to 4.7% of the claims data.
We assume the observed number of claim counts has a Poisson distribution given as
N(x,θ) ∼ Poisson(λ(x,θ)E∗(x, u;θ)) (7.1)
where
E∗(x, u;θ) =
∫ 1
u=0
E(x, u;θ)F (tθ8 − θ5 + 1− u;x,θ) du. (7.2)
Here E∗(x, u;θ) can be regarded as an ‘adjusted exposure’ where the cdf of the ap-
propriate CDD under the Burr model which takes business growth into account,
F (tθ8 − θ5 + 1 − u;x,θ), is used as an adjustment factor. The necessity of such
an adjustment is explained in Section 1.2. The fact that critical illness claims can
be subject to long delays between diagnosis and settlement, as discussed in earlier
chapters, makes it essential to use. Therefore, F (tθ8 − θ5 + 1 − u;x,θ) is used as
an adjustment factor. It eliminates the distortion caused by the addition of claims
diagnosed in contributing years of the office but settled in later years or yet to be
settled.
For a given year of diagnosis, θ5, and a very small interval du (du→ 0), the expected
number of diagnoses between u and u+ du is λ(x,θ)E(x, u;θ) du, and the expected
number of diagnoses between u and u+ du which will be settled before the end of tθ8
is
λ(x,θ)E(x, u;θ)F (tθ8 − θ5 + 1− u;x,θ) du.
Then the expected number of claims diagnosed in year θ5 and settled before the end
of year tθ8 is ∫ 1
u=0
λ(x,θ)E(x, u;θ)F (tθ8 − θ5 + 1− u;x,θ) du (7.3)
(see Figure 7.1).
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Under the Poisson distribution in (7.1) we obtain a raw/crude estimator for the in-
tensity (λˆraw(x,θ)), given by the MLE of λ as
λˆraw(x,θ) = N(x,θ)
/∫ 1
u=0
E(x, u;θ)F (tθ8 − θ5 + 1− u;x,θ) du (7.4)
whose standard error can be estimated as
√
N(x,θ)
/∫ 1
u=0
E(x, u;θ)F (tθ8 − θ5 + 1− u;x,θ) du. (7.5)
-
-ff
∫ 1
u=0
λ(x,θ)E(x, u;θ)F (tθ8 − θ5 + 1− u;x,θ) du
θ5 tθ8
-ff
N(x,θ)
Figure 7.1: Observed and expected number of claims.
The integral for calculating the adjusted exposure given in (7.2) is evaluated using
the repeated Simpson’s Rule with four steps. The raw rates produced by this proce-
dure can then be smoothed by specifying a model for the intensities and estimating
the parameters by maximum likelihood. A discussion of smoothing methodology for
mortality rates can be found in Forfar et al. (1988). Following that work, under
the Poisson model given in (7.1), we regress the intensity on covariates of interest
(defined in Table 7.1) for smoothing the crude diagnosis inception rates, λ(x,θ), in
the following way
λ(x,θ) = gr(x) + exp (fs(x) + βθ) , r, s = 0, 1, . . . (7.6)
where gr(x) =
∑r
i=1 κi x
i−1, fs(x) =
∑s
j=1 δj x
j−1, x is standardised age last birthday,
κ and δ are vectors of coefficients for age and β is a vector of coefficients for the
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covariates given in Table 7.1. Then the function given in (7.6) can be written explicitly
as
λ(x,θ) =
r∑
i=1
κi x
i−1 + exp
(
s∑
j=1
δj x
j−1 + βθ
)
. (7.7)
This model will be used in this chapter for the all-causes inception rates and in Chapter
8 for the cause-specific inception rates. Note that with r = 0, the formula reduces
to a GLM with Poisson errors and log-link function. When r > 0, we estimate the
model coefficients appearing in (7.7) by maximising the log-likelihood function using a
Newton-Raphson iterative method. Once the δ and κ coefficients are estimated, fitted
inception rates i.e. smoothed rates, λˆ(x,θ), or fitted number of claims, Nˆ(x,θ), can
be calculated. A similar model is used by Richards (2008), where he applies Cox-type
features to each parameter in his baseline model individually. Later in this chapter
and in Chapter 8 when modelling individual causes, it will be seen that in all cases
except one the best fit is obtained with r = 0. The one exception is for the cause-
specific inception rates relating to death, where a model with r = 1 gives the best fit.
In this case, the constant term, g0(x), presumably plays the same role as the constant
A in Makeham’s formula for the force of mortality: capturing deaths due to accidents,
which are not related to age or any of the covariates.
Variable selection
We use the following procedure to determine the best model:
1. Variable selection on the covariate vector θ is performed separately for each
fixed order s of the f function, starting from the first order polynomial, f2(x).
2. Fixing the order s and the covariates which are found important in the model, we
investigate whether adding a polynomial gr(x) to the model improves the model
fit. A polynomial is introduced in the model starting from order 0, g1(x) = 1.
If the fit is better, then we increase the order of r by 1 and continue searching;
if it is not, then we no longer investigate for higher order models. In previous
analyses using a subset of these covariates at earlier stages of this research, we
were able to select covariates under different gr(x) functions together with a
given fs(x) function. Although we have not been able to verify for this set
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of covariates (due to computing issues because of the size of the data), we
would like to mention that the selected covariates under the fs(x) model were
not different from those selected after introducing the linear polynomial, gr(x),
using the reduced set of covariates.
The significance of the year of diagnosis is being investigated in variable selection
through the covariate θ5. When θ5 is not part of the model, we add up the number
of claims and exposures over the diagnosis year.
7.3 All-cause rates without restriction
In this section, all the covariates given in Table 7.1 are incorporated to estimate
the intensity of diagnosis from all causes together with the interaction term between
smoker status and age. The reason we searched for this interaction is that CMI WP
43 (2010) indicates that there might be an interaction between these two variables
(see page 25). Considering that they are not using exactly the same data set, in
Figure 7.2 we plot male smoker crude rates against male non-smoker crude rates with
our data set. The graph we have is similar to the one in CMI WP 43 (2010). The
‘U-shape’ can be interpreted as the limited effect of smoking on health for younger
ages and various other risk factors independent of smoking for older ages.
Table 7.2 shows the log-likelihood and BIC values of the selected models under differ-
ent orders of gr(x) and fs(x) polynomials. According to this, including the g0(x), f2(x)
functions with the smoker status (θ3), policy duration (θ7), office (θ8) and age-smoker
status interaction (x×θ3) covariates is found to provide the best model. Although gen-
der is generally accepted as an important factor in diagnosis inception rates, we think
the reason for this covariate being dropped from the best model is the neutralising
effect of different individual causes for different genders.
The summary of the estimates of the best model is given in Table 7.3. Model coeffi-
cients suggest that age has a significant positive effect on the diagnosis inception rates
(Note here that age is standardised by subtracting the mean (39.75) and dividing by
the standard deviation (11.21)). All-cause rates are higher for smokers compared to
non–smokers. Up to curtate policy duration 4 years, the claim diagnosis rates are in-
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Figure 7.2: Male smoker crude inception rates divided by male non-smoker crude
inception rates.
Table 7.2: Selected covariates, log-likelihood values and BIC from fitting different
gr(x), fs(x) polynomials.
Polynomials Covariates l BIC
g0(x), f2(x) θ3, θ7, θ8, x× θ3 -67373.3 135025
g1(x), f2(x) θ3, θ7, θ8, x× θ3 -67372.7 135038
g0(x), f3(x) θ3, θ7, θ8, x× θ3, x2 × θ3 -67365.6 135037
creasing. This is what we expect, if there is no anti-selection. However, the coefficient
for policy duration 4 is less than for policy duration 3. This issue is also mentioned
by CMI in WP 43 (2010) and the problem is handled by putting a constraint on pol-
icy duration stating that the rates can not decrease with increasing duration unless
there is anti-selection. The combined effect of two competing forces of selection, i.e.
positive selection from health checks at the beginning of the policy and anti-selection
arising from insufficient underwriting (e.g. non-revelation of medical history), should
be investigated before forcing the data to overfit. In the CMI’s WP 43 (2010), the
combined effect is said to be not obvious but the constraint is applied in their work
assuming that there is a smooth progression of rates by policy duration. In this study
we are not forcing the rates to be higher. The other significant covariate is the Office
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variable. Among 13 offices, Office 7 has the lowest rates and Office 11 has the highest
rates. The coefficient of Office 8 gives the median effect. In the model, the age-smoker
interaction term is found to be significant with a positive effect on the inception rates.
Model fit is assessed using Pearson’s χ2 and the p-value is found to be 0.0174.
Table 7.3: ML estimates of parameters under the best model for all-cause rates.
Parameter Estimate Std. Error p-value
δintercept -6.6180 0.0224 < 2× (10−16)
δzage 0.8954 0.0109 < 2× (10−16)
βsmoker 0.3957 0.0185 < 2× (10−16)
βpoldur0 -0.1375 0.0166 < 2× (10−16)
βpoldur1 0.0080 0.0159 0.6159
βpoldur2 0.0505 0.0167 0.0025
βpoldur3 0.0681 0.0188 0.0003
βpoldur4 -0.0441 0.0233 0.0586
βpoldur5+ 0.0550 0.0174 0.0016
βoffice1 0.0970 0.0300 0.0012
βoffice2 0.1583 0.0274 < 8× (10−9)
βoffice3 -0.0923 0.0777 0.2348
βoffice4 -0.0065 0.0583 0.9116
βoffice5 0.0653 0.0494 0.1862
βoffice6 -0.0302 0.0900 0.7374
βoffice7 -0.5106 0.2070 0.0136
βoffice8 -0.00005 0.0291 0.9987
βoffice9 0.1150 0.0325 0.0004
βoffice10 -0.0608 0.0453 0.1793
βoffice11 0.3027 0.0253 < 2× (10−16)
βoffice12 0.2182 0.0310 < 2× (10−12)
βoffice13 -0.2562 0.0487 < 2× (10−7)
βzage×smoker 0.2044 0.0204 < 2× (10−16)
Monitoring the behaviour of the diagnosis inception rates especially at younger ages
is difficult on an actual scale. Therefore we change to a log scale in order to see
the details. Figures 7.3 to 7.8 show the inception rates against age on a log scale
for non-smokers – policy durations 0 to 5+ (NS0 to NS5+) and smokers – policy
durations 0 to 5+ (S0 to S5+), respectively. Note that y-axis is given in original
scale. In each graph, crude rates are shown with a dark blue line together with their
±2 standard errors (dotted blue lines). In these graphs, the crude rates (solid dark
blue line) and the smoothed rates (red line) are weighted averages for offices. Since
our model includes office as a covariate, the modelled inception rates will depend on
office as well as smoker status and policy duration. To obtain weighted smoothed
108
rates for offices we use (7.8).
∑13
i=1 λˆ(x; θ8,i; θ\θ8)E
∗(x; θ8,i; θ\θ8)∑13
i=1E
∗(x; θ8,i; θ\θ8)
(7.8)
Here θ8,i denotes Officei for i = 1, . . . , 13 and θ\θ8 denotes the other (fixed) character-
istics except office. In other words, to find weighted smoothed rates for offices (red
lines), we first obtain the inception rates from the best model (these inception rates
are office-specific rates) and then these office-specific inception rates are weighted
with office-specific exposures with the same characteristics and divided into the sum
of these exposures. If crude rates rather than modelled rates are used the weighted
average for crude rates will be obtained.
To see the effects of individual offices, we include three offices’ rates in the graphs.
These are Office 7, Office 11 and Office 8 which have the highest, the lowest and the
median coefficients in our model, respectively.
In most of the cases crude rates are provided until around age 65 as there are very few
data beyond this age. To obtain the weighted smoothed inception rates for offices the
lack of exposure after age 65 caused lack of smoothness on the smoothed rates after
that age. Therefore, we fixed the exposure for older ages by the exposure at age 65.
This problem also arises for younger ages as we have hardly any data for ages below
(about) 20. On the other hand, we have not fixed the exposure for these younger
ages. The lack of smoothness for these ages can be seen clearly in Figures 7.5 and 7.8
as long policy commitment is not very common at younger ages.
Note that in all figures weighted smoothed rates start closer to the median-effect office
(Office 8) and approach the office with highest rates (Office 11) with increasing age.
The reason for this is that its weight is higher for older ages as for this age range most
of the data are coming from this office whereas for younger ages data are coming from
all offices. The smoothed inception rates for the lowest rates office (Office 7) mostly
lie outside the lower bound of the confidence intervals for weighted crude rates for
offices. The reason for this is the small business volume of this office.
Overall, for all of the combinations of characteristics considered, smoothed rates ob-
tained from our analysis lie within the confidence interval of the crude rates.
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Figure 7.3: Graphs of diagnosis inception rates for non–smokers and durations 0 & 1.
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Figure 7.4: Graphs of diagnosis inception rates for non–smokers and durations 2 & 3.
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Figure 7.5: Graphs of diagnosis inception rates for non–smokers and durations 4 &
5+.
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Figure 7.6: Graphs of diagnosis inception rates for smokers and durations 0 & 1.
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Figure 7.7: Graphs of diagnosis inception rates for smokers and durations 2 & 3.
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Figure 7.8: Graphs of diagnosis inception rates for smokers and durations 4 & 5+.
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Modelled smoker rates against non–smoker rates are shown in Figure 7.9. Because
of the age - smoker interaction in the model the two lines cross below age 20. From
that age on, smoker rates are always higher than non-smoker rates, as expected. For
the ages below 20 the rates should be adjusted either by increasing the smoker rates
to the level of non-smokers rates or decreasing the non-smokers rates to the level of
smokers rate.
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Figure 7.9: Comparison of diagnosis inception rates for non–smokers vs smokers under
the best model for policy duration 0.
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7.4 All-cause rates including the CMI variables
In this section we compare the estimated rates from our analysis with the the claim
inception rates calculated by the CMI. We were kindly provided with these rates
by the CMI. Although the rates are provided from age 20 to 80, the CMI mentions
that outside the age range 25 - 65 the rates are only indicative due to lack of data.
These rates are presented in CMI WP 43 (2010). The rates are based on claims settled
between 1999 and 2004. Although this data set and our data set overlap considerably,
there are some differences between them mainly arising from different contributing
offices. In WP 43 (2010), all-cause rates are produced for each combination of sex,
smoker status and policy duration without examining the statistical significance of
these variables in the modelling. Also, the rates are given for full accelerated policies
only. In other words, the CMI variables are
sex
smoker status
policy duration
benefit type (for full accelerated policies).
The definitions of these variables are the same as the ones given in Table 7.1. How-
ever note that the age definition CMI uses is the ‘age nearest’ whereas our rates are
produced under the ‘age last birthday’ definition. This difference will shift each age
range for the inception rates by half a year.
Model 1:
To compare the CMI’s rates with these obtained here, we find the best model which
includes the CMI variables. To clarify, we force these four variables to stay in the
model and search for other possible covariates when they are in the model. Office is
the only variable added to these four covariates after a stepwise search. So the model
includes
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sex
smoker status
policy duration
benefit type (for full accelerated policies) and
office.
Table 7.4 shows selected models under different orders of age polynomials, together
with their log-likelihood and BIC values. Among these models, the one including
the g0(x), f2(x) functions with sex (θ1), benefit type (θ2), smoker status (θ3), policy
duration (θ7), office (θ8) and age - smoker status interaction (x × θ3) covariates is
found to be the best. The estimated parameters under this model are summarised
in Table 7.5. The difference between this model and the best model presented in
Section 7.3 is that this model involves sex and benefit type as covariates. This allows
us to find out how the inception rates are changing across the genders. According to
the coefficient, males have higher claim diagnosis rates than females (F is the base
category, see Table 7.1). In addition to that, stand alone policies have lower inception
rates than full accelerated policies (FA is the base category).
Table 7.4: Selected covariates, log-likelihood values and BIC from fitting different
gr(x), fs(x) polynomials.
Polynomials Covariates l BIC
g0(x), f2(x) θ1, θ2, θ3, θ7, θ8, x× θ3 -67363.6 135033
g1(x), f2(x) θ1, θ2, θ3, θ7, θ8, x× θ3 -67363.0 135045
g0(x), f3(x) θ1, θ2, θ3, θ7, θ8, x× θ3, x2 × θ3 -67356.0 135044
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Table 7.5: ML estimates of parameters under the best model which includes the CMI
variables for all-cause rates.
Parameter Estimate Std. Error p-value
δintercept -6.6360 0.0243 < 2× (10−16)
δzage 0.8937 0.0110 < 2× (10−16)
βsex 0.0543 0.0152 0.0004
βsmoker 0.3912 0.0185 < 2(10
−16)
βbentype -0.0631 0.0242 0.0091
βpoldur0 -0.1392 0.0166 < 2× (10−16)
βpoldur1 0.0069 0.0159 0.6667
βpoldur2 0.0501 0.0167 0.0027
βpoldur3 0.0686 0.0188 0.0003
βpoldur4 -0.0425 0.0233 0.0685
βpoldur5+ 0.0562 0.0174 0.0012
βoffice1 0.0892 0.0302 0.0031
βoffice2 0.1567 0.0275 < 2× (10−8)
βoffice3 -0.0935 0.0777 0.2290
βoffice4 -0.0074 0.0583 0.8989
βoffice5 0.0739 0.0495 0.1351
βoffice6 -0.0149 0.0902 0.8689
βoffice7 -0.5139 0.2070 0.0130
βoffice8 0.0031 0.0291 0.9149
βoffice9 0.1122 0.0325 0.0006
βoffice10 -0.0521 0.0453 0.2502
βoffice11 0.2949 0.0255 < 2× (10−11)
βoffice12 0.2104 0.0311 < 2× (10−16)
βoffice13 -0.2584 0.0488 < 2× (10−7)
βzage×smoker 0.2058 0.0204 < 2× (10−16)
Model 2:
We also fit a model using the four CMI variables only (i.e. sex, smoker status, policy
duration and benefit type). This means that office is excluded from the above model.
The log-likelihood and BIC values of the models under different age functions are
given in Table 7.6. As in the other cases, g0(x), f2(x) is found to give the best model.
The estimated parameters under this model are summarised in Table 7.7.
Table 7.6: Selected covariates, log-likelihood values and BIC from fitting different
gr(x), fs(x) polynomials.
Polynomials Covariates l BIC
g0(x), f2(x) θ1, θ2, θ3, θ7, x× θ3 -67508.1 135162
g1(x), f2(x) θ1, θ2, θ3, θ7, x× θ3 -67507.4 135174
g0(x), f3(x) θ1, θ2, θ3, θ7, x× θ3, x2 × θ3 -67498.9 135171
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Table 7.7: ML estimates of parameters under the model with the CMI variables for
all-cause rates.
Parameter Estimate Std. Error p-value
δintercept -6.5051 0.0130 < 2× (10−16)
δzage 0.9224 0.0107 < 2× (10−16)
βsex 0.0564 0.0152 0.0002
βsmoker 0.4023 0.0185 < 2× (10−16)
βbentype -0.1238 0.0235 < 2× (10−7)
βpoldur0 -0.1479 0.0162 < 2× (10−16)
βpoldur1 0.0043 0.0156 0.7831
βpoldur2 0.0498 0.0165 0.0026
βpoldur3 0.0707 0.0188 0.0002
βpoldur4 -0.0404 0.0233 0.0820
βpoldur5+ 0.0636 0.0156 < 5× (10−5)
βzage×smoker 0.2112 0.0204 < 2× (10−16)
Figures 7.10 to 7.21 show the inception rates with respect to age on a log scale for
combinations of sex, smoker status, and policy durations for full accelerated policies.
Note that y-axis is given in original scale. The letters of the captions of the figures
refer to sex (M or F), then the smoker status (NS or S) and then the benefit type (all
of them are FA) and final numbers are the policy durations from 0 to 5+. In each
graph, crude rates are shown with a dark blue line together with their ±2 standard
errors (dotted lines). These crude rates are the weighted averages for offices. The
red line shows the smoothed rates from model 1 when the weighted average of the
offices is taken (in the same way as in (7.8)). To show the smoothed rates for different
offices, the lowest (Office 7), the highest (Office 11) and the median (Office 8) offices
are represented on the graphs. Smoothed rates obtained by using model 2 are shown
by a black line. This model excludes the Office covariate from the analysis. As can
be seen from the graphs, the red lines and black lines are very close to each other.
The CMI rates are very close to the smoothed rates obtained from our analysis for
the age range between 30 and 60. This is the range where we have most of the data.
On the other hand when there is a big variability in the crude rates, the CMI rates
have a better fit. This is because the CMI rates are essentially estimated by adjusting
the crude rates by the help of base tables (e.g. CIBT02 (CI Trends Research Group,
2006)). See, for example, Figures 7.10 - 7.14 . In all of these graphs, for ages below 30,
the CMI rates capture the crude rates better. Although the smoothed rates obtained
from our analysis lie below the crude rates for males for this age range, they are still
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within two standard errors.
Confidence intervals are wider for younger and older ages due to lack of data for
these ages. When the number of observations is very small, the lower confidence
limit cannot be provided. For example for the upper graph of Figure 7.10, the lower
confidence limit could not be calculated for ages above 60 due to the small number of
observed claims at that age with the other characteristics. Having less data at older
ages for very short policy durations is not surprising. In a similar way, there are less
data at younger ages for long policy durations, since long policy commitments for
these ages are unusual (see e.g. Figures 7.12 , 7.15 , 7.18 and 7.21). In general, the
confidence intervals are narrower for the non–smoker graphs compared to smokers as
we have more data for non–smokers. On the upper graph of Figure 7.21 it is seen
that almost none of the lower bounds could be given, again due to lack of data for
female smokers with policy duration 4 years.
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Figure 7.10: Graphs of diagnosis inception rates for males, non–smokers, full acceler-
ated policies and durations 0 & 1.
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Figure 7.11: Graphs of diagnosis inception rates for males, non–smokers, full acceler-
ated policies and durations 2 & 3.
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Figure 7.12: Graphs of diagnosis inception rates for males, non–smokers, full acceler-
ated policies and durations 4 & 5+.
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Figure 7.13: Graphs of diagnosis inception rates for males, smokers, full accelerated
policies and durations 0 & 1.
125
20 30 40 50 60 70 80
MSFA2 Comparison
Age
In
ce
pt
io
n 
Ra
te
s
5e
−0
5
4e
−0
4
0.
00
3
0.
03
0.
2 Rates with CMI Var. (Exc. Office)
Weighted Rates with CMI Var. (Inc. Office)
CMI_Rates
Office7
Office8
Office11
20 30 40 50 60 70 80
MSFA3 Comparison
Age
In
ce
pt
io
n 
Ra
te
s
5e
−0
5
4e
−0
4
0.
00
3
0.
03
0.
2 Rates with CMI Var. (Exc. Office)
Weighted Rates with CMI Var. (Inc. Office)
CMI_Rates
Office7
Office8
Office11
Figure 7.14: Graphs of diagnosis inception rates for males, smokers, full accelerated
policies and durations 2 & 3.
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Figure 7.15: Graphs of diagnosis inception rates for males, smokers, full accelerated
policies and durations 4 & 5+.
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Figure 7.16: Graphs of diagnosis inception rates for females, non–smokers, full accel-
erated policies and durations 0 & 1.
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Figure 7.17: Graphs of diagnosis inception rates for females, non–smokers, full accel-
erated policies and durations 2 & 3.
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Figure 7.18: Graphs of diagnosis inception rates for females, non–smokers, full accel-
erated policies and durations 4 & 5+.
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Figure 7.19: Graphs of diagnosis inception rates for females, smokers, full accelerated
policies and durations 0 & 1.
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Figure 7.20: Graphs of diagnosis inception rates for females, smokers, full accelerated
policies and durations 2 & 3.
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Figure 7.21: Graphs of diagnosis inception rates for females, smokers, full accelerated
policies and durations 4 & 5+.
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Finally, we would like to see the effect of age–smoker interaction included in the
model for the inception rates. Modelled smoker rates against non–smoker rates for
males, policy duration 0 are shown in Figure 7.22. As in the best model case, up to
approximately age 20 the non-smoker rates are higher than the smoker rates. Since
there is very little data below age 20, this ordering is unlikely to be a real feature
and the rates should be adjusted for these ages. The adjustment might be increasing
the inception rates for smoker to the level of inception rates for non–smokers or vice
versa.
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Figure 7.22: Comparison of diagnosis inception rates for non–smokers vs smokers
using CMI variables for males and duration 0.
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7.5 Sensitivity of the inception rates to delay esti-
mates
In Sections 7.2 - 7.4, inception rates are calculated using the claims data for which
the missing dates are estimated using the median of the CDD obtained in Section
6.3. In this section, the effect of missing date estimation on the inception rates is
investigated. For different percentiles of the estimated missing delays, estimates of
inception rates will be different. To show how much they change, we replace the
missing delays with 2.5% and 97.5% percentiles as well as the mean of the CDD and
estimate the inception rates corresponding to each of these percentiles. With the help
of a confidence interval for the inception rates estimated by using the median of the
CDD, we investigate whether there is a significant difference between the inception
rates estimated by using the median of the CDD and the inception rates estimated
using other percentiles of the CDD. The confidence interval is obtained by using a
bootstrap methodology which is discussed in Section 7.5.1.
7.5.1 Sensitivity analysis
In Sections 7.2 - 7.4 we assumed the number of claim counts has a Poisson distribution
with mean λE∗ (see (7.1)) and we used three different models for smoothing. In this
section we perform the sensitivity analysis using the best model obtained in Section
7.3. Since we use a logarithmic link function, the linear predictor of the model is in
the form
log E(N) = δint+δzagex+βsmokerθ3+βpoldurθ7+βofficeθ8+βzage×smokerx×θ3+log(E∗).
(7.9)
We would like to mention that the reason we use different subscripts for the β co-
efficients from the θ covariates is convenience. Once the δ and β coefficients are
estimated, fitted inception rates, i.e. smoothed rates, λ˜, or fitted number of claims,
N˜ , can be calculated. In the bootstrap method we use, the number of claims can be
simulated from a Poisson distribution with the fitted rates
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N sim ∼ Poisson(λ˜E∗)
and we can regress N sim on the covariates
log(E(N sim)) = δint+δzagex+βsmokerθ3+βpoldurθ7+βofficeθ8+βzage×smokerx×θ3+log(E∗)
and repeat this to obtain a confidence interval for the inception rates (Efron and
Tibshirani, 1993). We simulate 500 empirical samples with this procedure. For each
of these samples, N˜ sim and λ˜sim are calculated.
We would like to note that an alternative way of doing this is to assume that the esti-
mated δ and β coefficients in (7.9) have multivariate normal distributions (asymptot-
ically) and to simulate coefficients from this distribution as explained by Forfar et al.
(1988) in section 11. However, this bootstrap method uses more assumptions, such
as asymptotic normality of the estimated coefficients, and it gives slightly narrower
confidence intervals than the first method. We prefer to use the first method since we
do not need to assume asymptotic normality.
The confidence intervals are given for the risk profiles in Section 7.3 under the best
model. However, we use the age range 20 to 65 here since there are very limited or
no data for some risk profiles outside of this range.
Figures 7.23 - 7.25 demonstrate the confidence intervals of the inception rates, es-
timated by using the median of the CDD, of the risk profiles shown previously in
Figures 7.3 – 7.8 under the best model. In the figures, IR denotes the smoothed
diagnosis inception rates while 2.5pc, median, 95pc and 97.5pc denote the 2.5%,
50%, 95% and 97.5% percentiles of the CDD, respectively. Missing delays are esti-
mated using the mean of the CDD when inception rates are denoted by IR.(mean).
IR.(boot.ci.median) is the confidence interval of the IR.(median) obtained by the
bootstrap method. These inception rates and confidence intervals are given as a ratio
of the inception rates based on the median in order to see the changes clearly. The
inception rate, as estimated by using the median of the CDD, is taken to be equal to
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1 i.e.
IR.(median) = λ˜/λ˜
and the other percentiles and the confidence intervals are shown as a ratio of it. For
example
IR.(mean) = λ˜mean/λ˜
or
IR.(boot.ci.median) = λ˜sim/λ˜.
In general, the confidence intervals mostly lie within 10-15% of λˆ. Especially for
younger and older ages, the confidence intervals for smokers (Figures 7.26 - 7.28) are
wider than for non-smokers (Figures 7.23 - 7.25).
In some of the figures we see that the rates are not very smooth for younger and
older ages (see e.g. IR.(97.5pc) in Figure 7.23 or in Figure 7.27). The reason is that
we use a weighted average for offices using their exposures as explained previously in
this chapter and for these ages the exposure figures are not very homogeneous since
we do not have enough data. This is also the reason for getting wider intervals for
these ages. For example, there is a lack of smoothness in the rates at around age 20
starting from policy duration 3 (see the lower graph in Figure 7.24, graphs in Figure
7.25, the lower graph in Figure 7.27, graphs in Figure 7.28). This is because at that
age a long policy duration is unusual. Therefore at around this age the confidence
interval gets slightly wider and this becomes more obvious for longer policy durations
such as 4 years, 5 years or more (see Figures 7.25 and 7.28). The same effect can
also be seen for older policyholders with short policy durations (see Figures 7.23 and
7.26). Since we have less data for smokers, the rates are less smooth for older and
younger policyholders with this risk profile.
In the upper graphs of Figures 7.23 and 7.26, which correspond to policyholders with
policy duration less than a year, inception rates estimated by using the 97.5% point of
the CDD lie outside of the confidence interval of IR.(median), whereas they lie inside
when they are calculated using the 95% point of the CDD. The reason for that is the
long tail of the Burr distribution. Note that the percentiles we use in estimation of
the missing delays affect not only the missing dates of diagnosis. Since we calculate
137
policy duration and age at the time of diagnosis, the estimated delays also affect these
variables. Because of the heavy tail of the Burr distribution, the estimated missing
delays are very long using the 97.5% percentile. The average missing delay with this
percentile is 645 days (with standard deviation 289.1), whereas it drops to 456 days
(209.8) when the 95% point is used. Although it is still long compared to the median
(115 days (83.3)) or the mean (174 days (98.6)) of the distribution, it is significantly
less extreme than the 97.5% percentile. This means that, when the date of diagnosis
is missing, it is estimated to be very early if the 97.5% point is used. This, in turn,
means very short policy durations for these claims, where many of them fall in the less
than 1 year policy duration category and it appears that most of the missing dates
have policy duration less than a year.
In all graphs, the inception rates that are estimated by using the mean or 2.5%
percentile are very close to those estimated by using the median of the CDD. For
longer policy durations, the inception rates based on the 97.5% percentile of the CDD
are closer to the other inception rates estimated using other CDD percentiles.
From the sensitivity analysis in this section, we can conclude that the inception rates
are not very sensitive to the point estimate used to obtain the missing dates. Since
using a reasonable percentile of the CDD (between 2.5% and 95%) for the missing
dates will give an inception rate within the 95% confidence interval of IR.(median),
the median of the CDD can be safely used to estimate the missing dates.
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Figure 7.23: Graphs of relative diagnosis inception rates with different missing delay
estimates and confidence intervals of the inception rates based on the median of the
CDD (as a ratio of inception rates based on the median of the CDD) for non–smokers
and durations 0 & 1.
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Figure 7.24: Graphs of relative diagnosis inception rates with different missing delay
estimates and confidence intervals of the inception rates based on the median of the
CDD (as a ratio of inception rates based on the median of the CDD) for non–smokers
and durations 2 & 3.
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Figure 7.25: Graphs of relative diagnosis inception rates with different missing delay
estimates and confidence intervals of the inception rates based on the median of the
CDD (as a ratio of inception rates based on the median of the CDD) for non–smokers
and durations 4 & 5+.
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Figure 7.26: Graphs of relative diagnosis inception rates with different missing delay
estimates and confidence intervals of the inception rates based on the median of the
CDD (as a ratio of inception rates based on the median of the CDD) for smokers and
durations 0 & 1.
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Figure 7.27: Graphs of relative diagnosis inception rates with different missing delay
estimates and confidence intervals of the inception rates based on the median of the
CDD (as a ratio of inception rates based on the median of the CDD) for smokers and
durations 2 & 3.
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Figure 7.28: Graphs of relative diagnosis inception rates with different missing delay
estimates and confidence intervals of the inception rates based on the median of the
CDD (as a ratio of inception rates based on the median of the CDD) for smokers and
durations 4 & 5+.
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Chapter 8
Diagnosis inception rates II:
Cause-specific rates
In this chapter we derive the intensity rates of a diagnosis of a sickness at age x last
birthday with characteristics θ which will lead to a claim from particular cause c. This
intensity is denoted by λc(x,θ). The same characteristics vector, θ, given in Table
7.1 is used. Again, we restrict the age to 16− 80 for the analyses. Also, the effect of
the age - smoker interaction is investigated for the same reason stated in Section 7.3.
The rates are provided for the main claim causes, i.e. CABG, cancer, death, heart
attack, kidney failure, major organ transplantation, MS, Stroke and TPD, and for
other causes. Variable selection is performed in the same way as described in Section
7.2. Note that we start model selection with g0(x), f2(x) function. Here, we do not
force the first order exponential age term to stay in the model but it stays in models
for almost all causes as age is an important factor for the morbidity rates. On the
other hand, if it drops from the model (e.g. MOT, MS), we select the best model
between models with g0(x), f1(x) and g1(x), f1(x) functions.
For some causes for male-non–smokers and different policy durations we show the
CMI rates presented in WP 43 (2010) for comparison purposes. Although the CMI
rates are provided from age 20 to 80, they mention that for the specific causes the
rates outside the age range 31 and 60 are only indicative.
Goodness of fit of models is assessed using Pearson’s χ2. For almost all causes, p-
values were found above 1%. Two exceptions are cancer (p-value = 4.88× 10−6) and
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death (p-value = 1.15 × 10−11). We note that goodness of fit is not easily achieved
when the aim is to obtain smoothed diagnosis inception rates, especially in large data
sets.
The structure of the model is explained in Section 8.1 and in Section 8.2 the best
models for individual causes are presented. In Section 8.3 these individual causes are
compared to the all-cause rates obtained in Chapter 7.
8.1 Structure of the model
We define N c(x,θ) as the observed number of claims for cause c at age x and risk
profile θ which are diagnosed in year θ5 and settled before the end of the last con-
tribution year of the considered office, tθ8 , and we assume a Poisson distribution so
that
N c(x,θ) ∼ Poisson(λc(x,θ)E∗c(x, u;θ)) (8.1)
where λc(x,θ) denotes the intensity for a claim diagnosis in the respective year θ5
from cause c at age x last birthday and risk profile θ, and the adjusted exposure
E∗c(x, u;θ) is
E∗c(x, u;θ)) =
∫ 1
u=0
E(x, u;θ)F c(tθ8 − θ5 + 1− u;x,θ) du. (8.2)
In (8.2), the adjustment factor, F c(tθ8 − θ5 + 1 − u;x,θ), denotes the probability of
settling a claim in time (tθ8 − θ5 + 1 − u), at age x last birthday, given risk profile
θ and cause c by the end of year tθ8 starting from time u after the start of year θ5,
where θ5 = 1999, . . . , 2004, 2005 and tθ8 ∈ (θ5, θ5 + 1, . . . , 2005) and the exposure,
E(x, u;θ), is calculated in the same way as explained in Section 7.2. The integral is
approximated for each cause seperately by using a four-step Simpson’s Rule.
Under the Poisson distribution given in (8.1), the crude estimator for the intensity
and the standard error of the estimate is given in (8.3) and (8.4), respectively.
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λˆraw,c(x,θ) = N c(x,θ)
/
E∗c(x, u;θ) du (8.3)
sd(λˆraw,c(x,θ)) =
√
N c(x,θ)
/∫ 1
u=0
E∗c(x, u;θ) du. (8.4)
For smoothing the crude rates we use the same function given in (7.7) with Poisson
errors.
8.2 Best models for specific causes
Coronary artery bypass graft (CABG)
The two risk factors for coronary heart diseases that one can not change are aging
and being male. Smoking is also known as a serious risk factor for heart diseases
(Chatterjee et al., 2009). Under different age polynomials for CABG, the gender
and smoking status covariates are always found to be important after model selection
using stepwise regression where BIC is used as a selection criterion. The models we
have considered can be seen in Figure 8.1. This figure also shows the path we used in
model selection.
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Figure 8.1: Model selection for CABG.
The smallest BIC is obtained under the quadratic exponential polynomial for age
(g0(x), f3(x)) with the sex (θ1) and smoking status (θ3) covariates. The function given
in 8.5 is used to smooth the CABG rates
λCABG = exp
(
δint + δzagex+ δzage2x
2 + βsexθ1 + βsmokerθ3
)
(8.5)
and parameter estimates are given in Table 8.1. As expected, males and smokers have
higher CABG rates compared to the base categories of females and non–smokers. Age
has a positive effect on the intensity rates, however the negative coefficient of age2
indicates a decreasing age effect for older ages (Note here that age is standardised
by subtracting the mean (39.75) and dividing by the standard deviation (11.21) as
stated in Chapter 7).
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Table 8.1: ML estimates of parameters under the best model for CABG.
Parameter Estimate Std. Error p-value
δintercept -12.8404 0.2148 < 2× (10−16)
δzage 5.6621 0.8185 4.6× (10−12)
δzage2 -3.1830 0.6858 3.5× (10−6)
βsex 1.7691 0.1696 < 2× (10−16)
βsmoker 0.5814 0.1174 7.4× (10−7)
Figures 8.2 and 8.3 show the smooth and crude rates for CABG. Note that, in this
chapter, the rates are provided in the log scale in figures, in order to be able to see
the details, especially for younger ages and the y-axis is presented in original scale.
Therefore, intervals between labels are not equally spaced.
In the graphs it can be seen that rates are almost flat after age 65. Like all surgical
operations, CABG has a risk of complications. Some serious risks such as stroke
and heart attack are more likely for elderly people (NHS, 2010). Also, comorbidity is
more common for older people which increases the chance of developing complications.
Therefore, in the literature, it is controversial to operate on elderly people (see e.g.
MacDonald et al. (2000), Bowling et al. (2001), Bradshaw et al. (2001)). It appears
that more cautious approaches to treatments are considered for these people, such as
medical treatments rather than surgical ones (Stone et al., 1996; Bowling et al., 2001),
and this might be one of the reasons for lower surgical rates at older ages. In Figure
8.2, for non–smokers, the CMI rates in WP 43 (2010) are also provided. Decreasing
CABG rates for older ages can be seen from these rates as well.
We also mention that there are very few CABG claims for females as can be seen
from Figure 8.3. Therefore none of the lower bounds of the confidence interval could
be provided.
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Figure 8.2: Graphs of diagnosis inception rates for CABG for males, non–smokers
(MNS) and smokers (MS).
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Figure 8.3: Graphs of diagnosis inception rates for CABG for females, non–smokers
(FNS) and smokers (FS).
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Cancer
As stated before, cancer claims form almost half (49%) of the claims data. This is
not surprising, considering the statistics given by Cancer Research UK (2010) which
states that more than one in three people in the UK will suffer from cancer during
their lives.
After model selection under different age polynomials, sex, smoker status and year
covariates have remained in the models. The age - smoker interaction term, found to
be important for the model with g0(x), f2(x) age function, dropped from the model
with g0(x), f2(x) age function. Figure 8.4 summarises the models we have considered
for smoothing the cancer rates.
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Figure 8.4: Model selection for cancer.
We started with a model with a first order exponential age function (g0(x), f2(x)).
Adding a linear intercept term to this model (g1(x), f2(x)), or the model obtained after
increasing the exponential order of age by one (g0(x), f3(x)) did not give a better BIC
value. We use the model given in (8.6) for smoothing the cancer rates. The estimates
of the model parameters are presented in Table 8.2. The effect of age and smoking
are found to be positive. The intensity for males is lower than females, probably
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because of high breast cancer rates for females. Finally the effect of diagnosis year
is found to be important and positive, implying higher cancer rates for more recent
years (note that year is standardised by subtracting the mean (2002.36) and dividing
by the standard deviation (1.86)). This fact is also noted by Cancer Research UK
(2010). According to that study, it is mentioned that although the rates have not
changed very much within the last decade, cancer rates in the UK increased by 25%
between 1978 and 2007. This rise is 14% for men and 32% for women. The effect of
age - smoker interaction will be shown in Figure 8.8 later.
λCancer = exp (δint + δzagex+ βsexθ1 + βsmokerθ3 + βzyearθ5 + βzage×smokerx× θ3)
(8.6)
Table 8.2: ML estimates of parameters under the best model for cancer.
Parameter Estimate Std. Error p-value
δintercept -6.8689 0.0153 < 2× (10−16)
δzage 0.9357 0.0143 < 2× (10−16)
βsex -0.5595 0.0217 < 2× (10−16)
βsmoker 0.0703 0.0287 0.0142
βzyear 0.0514 0.0119 < 1.5× (10−5)
βzage×smoker 0.1201 0.0326 0.0002
Figure 8.5 shows the crude and modelled cancer rates for males, non-smokers. These
rates are the weighted average over year. Since year is an important covariate in the
model, cancer rates depend on it. However, we would like to produce cancer rates
independent of the year. Therefore, we use a weighted average where the rates are
weighted by exposure (similarly to what we have done in Chapter 7 to find weighted
rates for offices, see (7.8)).
To find weighted smoothed rates for year (red lines in Figures 8.5 - 8.7), after obtaining
the year-specific inception rates from the model given in (8.6) we weight these rates
with year-specific exposures with the same characteristics and divide by the sum of
these exposures. This can be expressed as
∑2005
i=1999 λˆ(x; θ5,i; θ\θ5)E
∗(x; θ5,i; θ\θ5)∑7
i=1E
∗(x; θ5,i; θ\θ5)
(8.7)
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where θ5,i denotes yeari for i = 1999 . . . 2005 and θ\θ5 denote the remaining charac-
teristics found important for cancer except year. We have used the same procedure
to find the weighted crude rates.
In Figure 8.5, the weighted crude and smoothed rates for males - non–smokers are
presented together with CMI rates for different policy durations. Figures 8.6 and 8.7
show the smooth and crude rates for cancer for other combinations of gender and
smoking status. In these figures we also show the smoothed rates for individual year
effects for years 1999 (lowest effect) and 2005 (highest effect) to see the effect of the
years. The weighted rates are closer to year 2005 compared to 1999 since we have
more data for the recent years.
The confidence intervals are wider for ages below 30 and above 60 as we have less data
compared to the age range 30–60. Also, since we have more data for non–smokers
the confidence intervals (upper graphs of Figures 8.6 and 8.7) are tighter than the
confidence intervals of smokers (lower graphs of Figures 8.6 and 8.7).
154
20 30 40 50 60 70 80
MNS − Cancer
Age
In
ce
pt
ion
 R
at
es
1.
7e
−0
5
0.
00
01
2
0.
00
09
1
0.
00
67
0.
05 Weighted Rates
Crude Rates (CR)
CR +(−) 2SE
CMI_Durn0
CMI_Durn1,2,3,4
CMI_Durn5+
Figure 8.5: Graphs of diagnosis inception rates for cancer for males, non–smokers
(MNS) together with CMI rates.
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Figure 8.6: Graphs of diagnosis inception rates for cancer for males, non–smokers
(MNS) and smokers (MS).
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Figure 8.7: Graphs of diagnosis inception rates for cancer for females, non–smokers
(FNS) and smokers (FS).
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Modelled smoker rates against non–smoker rates for males are shown in Figure 8.8 to
see the effect of age - smoker interaction. From about age 32 the incidence rates for
smokers are higher than for non–smokers, as expected. Thus below age 30 the model
fit is poor as we do not expect smoker rates to be lower than non–smoker rates. One
possible reason for this might be lack of data for this age range. In general, we do not
have much data for younger ages and this is more evident for individual causes.
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Figure 8.8: Graphs of diagnosis inception rates for cancer for males, non–smokers vs
smokers.
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Death
Since the death claims are covered only in fully accelerated policies, we work with
a subset of data which has 359 587 different combinations of characteristics. Sex
(θ1), smoker (θ3) and age - smoker interaction (x × θ3) are found to be the most
important covariates in modelling the mortality rates for each of the different age
polynomials. Unlike all other causes, introducing a linear constant to the model
improves the fit significantly. This age-independent linear constant corresponds to
the Makeham constant and captures external causes of deaths such as accidents. The
model selection procedure is described in Figure 8.9.
The model with (g1(x), f3(x)) age polynomials has the smallest BIC value and is in
the form
λDeath = κint+exp
(
δint + δzagex+ δzage2x
2 + βsexθ1 + βsmokerθ3 + βzage×smokerx× θ3
)
.
(8.8)
The estimates of the model parameters are given in Table 8.3. According to this
model, males have higher mortality rates than females. The death rates for smokers
are increasing by age. The mortality rates increase considerably at older ages.
Table 8.3: ML estimates of parameters under the best model for death.
Parameter Estimate Std. Error p-value
κintercept -0.0002 2.4× (10−5) 1.8× (10−14)
δintercept -7.7712 0.0409 < 2× (10−16)
δzage -0.9999 0.0945 < 2× (10−16)
δzage2 1.5207 0.0973 < 2× (10−16)
βsex 0.4423 0.0225 < 2× (10−16)
βsmoker 0.4859 0.0270 < 2× (10−16)
βzage×smoker 0.3519 0.0296 < 2× (10−16)
Figures 8.10 and 8.11 show the smooth and crude death rates for the four combinations
of gender and smoker status. It can be seen that until age 27 the mortality rates are
slightly decreasing for non-smokers (see the upper graphs of Figures 8.10 and 8.11).
We think that this is because of the accident hump which is observed for younger
adults. This decrease is less obvious for smokers and lasts until age 18 (see the lower
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graphs of Figures 8.10 and 8.11). However this effect might not be significant for
smokers as there are very few data.
To see the effect of the age–smoker interaction in the model, we plot inception rates
of non–smokers and the inception rates of smokers against age. This graph can be
seen in Figure 8.12. The two lines cross at around age 25 and again, the lack of data
below age 30 might have caused this effect.
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Figure 8.9: Model selection for death.
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Figure 8.10: Graphs of diagnosis inception rates for death for males, non–smokers
(MNS) and smokers (MS).
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Figure 8.11: Graphs of diagnosis inception rates for death for females, non–smokers
(FNS) and smokers (FS).
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Figure 8.12: Graphs of diagnosis inception rates for death for males, non–smokers vs.
smokers.
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Heart attack
For heart attack inception rates, Figure 8.13 shows that the smallest BIC is obtained
for the model with a quadratic age polynomial (g0(x), f3(x)). For each different age
polynomial we have tried, sex and smoker status are found to be important. When
the order of the polynomial is greater than 3, the age - smoker interaction stays in
models as well. Our best model includes an age2 - smoker interaction term.
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Figure 8.13: Model selection for heart attack.
The function we use to smooth the heart attack rates is given in (8.9), and parameter
estimates are shown in Table 8.4. Males and smokers have higher heart attack rates.
These two, i.e being a male and a smoker, are known to be the two major risk factors
of cardiac diseases (see Chatterjee et al. (2009)).
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λHA = exp
(
δint + δzagex+ δzage2x
2 + βsexθ1 + βsmokerθ3 + βzage2×smokerx
2 × θ3
)
(8.9)
Table 8.4: ML estimates of parameters under the best model for heart attack.
Parameter Estimate Std. Error p-value
δintercept -11.1938 0.0895 < 2× (10−16)
δzage 5.4266 0.3232 < 2× (10−16)
δzage2 -3.3297 0.2801 < 2× (10−16)
βsex 1.9150 0.0750 < 2× (10−16)
βsmoker 1.5299 0.0586 < 2× (10−16)
βzage2×smoker -0.2798 0.0589 2.1× (10−6)
Figures 8.14 and 8.15 show the smooth and crude heart attack inception rates for
the four combinations of gender and smoker status. The CMI produced heart attack
inception rates for males, non-smokers for different policy durations. These rates are
shown in the males and non-smokers graph (upper graph in Figure 8.14). There is
a decrease above age around 65 because of the negative coefficients of age2 and age2
- smoker interaction. Generally for the inception rates of cardiac diseases a decrease
with age is not expected. Since we have hardly any heart attack data after age 65, the
inception rates after this age are based on extrapolation from the function and this
might be the possible reason of this unexpected decrease after this age. For females
we have less heart attack data compared to males (see Figure 8.15). Hence we could
not provide the ‘crude rates −2 standard errors’ for most of the cases.
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Figure 8.14: Graphs of diagnosis inception rates for heart attack for males, non–
smokers (MNS) and smokers (MS).
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Figure 8.15: Graphs of diagnosis inception rates for heart attack for females, non–
smokers (FNS) and smokers (FS).
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Kidney failure
In the modelling of kidney failure, the exponential age term was not significant and
was dropped from the model. Between the g0(x), f1(x) and g1(x), f1(x) models, the
former is selected due to its lower BIC value. Sex is found to be the only significant
covariate in smoothing the crude rates. Log-likelihood and BIC values of these models
are given in Figure 8.16.
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Figure 8.16: Model selection for kidney failure.
The smoothing function is shown in (8.10) and the estimates of the model parameters
are given in Table 8.5. The positive coefficient for sex indicates a higher kidney failure
rate for males.
λKF = exp (δint + βsexθ1) (8.10)
Table 8.5: ML estimates of parameters under the best model for kidney failure.
Parameter Estimate Std. Error p-value
δintercept -12.7364 0.2582 < 2× (10−16)
βsex 1.5805 0.2811 1.9× (10−8)
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Figure 8.17 shows the crude and smoothed inception rates for kidney failure. Since we
do not have many claims for this cause, especially for women, there is a large number
of zero crude rates across ages. Thus the rates are given in the actual scale rather
than the log scale.
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Figure 8.17: Graphs of diagnosis inception rates for kidney failure for males (M) and
females (F).
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Major organ transplantation
None of the considered covariates, including age, were significant in modelling the
rates for major organ transplant. As can be seen from Figure 8.18, g0(x), f1(x) has
the lowest BIC value. Thus, for this cause we simply use an exponential intercept
term in the modelling (see (8.11)) where the estimated coefficient is given in Table
8.6.
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Figure 8.18: Model selection for major organ transplant.
λMOT = exp (δint) (8.11)
Table 8.6: ML estimates of parameters under the best model for major organ trans-
plantation.
Parameter Estimate Std. Error p-value
δintercept -12.7501 0.1741 < 2× (10−16)
Figure 8.19 shows the crude and modelled MOT rates. The graph is given in the
actual scale due to zero crude rates at various ages.
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Figure 8.19: Graph of diagnosis inception rates for major organ transplant for all
population.
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Multiple sclerosis (MS)
We started searching for the best model for multiple sclerosis with a first order expo-
nential age polynomial (g0(x), f2(x)). However the age term was found to be insignif-
icant in the model and dropping it gave a model with lower BIC value (g0(x), f1(x)).
Including a linear intercept in the model did not improve the model fit and we ended
up using a g0(x), f1(x) function. The log-likelihood and BIC values for these models
are given in Figure 8.20. The effects of sex, smoking status and policy duration on
multiple sclerosis were found to be important.
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Figure 8.20: Model selection for multiple sclerosis.
The function we use to smooth the multiple sclerosis rates is given in (8.12) and
parameter estimates are shown in Table 8.7. As can be seen from the table, males
have lower MS rates than females and smokers have higher rates than non-smokers. In
Chapter 3 we mentioned that there is a 6-months waiting period for this disease before
a claim is admitted. We can see the effect of this waiting period on the coefficient of
the first year policy duration: it is considerably lower than for the other durations.
λMS = exp (δint + βsexθ1 + βsmokerθ3 + βpoldurθ7) (8.12)
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Table 8.7: ML estimates of parameters under the best model for multiple sclerosis.
Parameter Estimate Std. Error p-value
δintercept -9.2773 0.0508 < 2× (10−16)
βsex -0.7460 0.0760 < 2× (10−16)
βsmoker 0.3935 0.0847 3.4× (10−6)
βpoldur0 -0.8727 0.0944 < 2× (10−16)
βpoldur1 -0.0607 0.0732 0.4069
βpoldur2 0.1876 0.0746 0.0119
βpoldur3 0.2174 0.0873 0.0127
βpoldur4 0.1512 0.1092 0.1661
βpoldur5+ 0.3772 0.0750 4.9× (10−7)
Figures 8.21 and 8.22 show the crude and modelled multiple sclerosis rates for the four
combinations of gender and smoking status. These rates (both crude and modelled)
are the weighted averages of policy durations. Inception rates can be obtained for
an average policy duration by weighting the duration-specific inception rates with
duration-specific exposures in a similar way as in (7.8) and (8.7). In the figures we
also show inception rates for specific durations, Duration 0 and Duration 5+. The
reason for the weighted rates being close to rates with policy duration 5+ is that
most of the MS claims have long policy durations. Most of the lower bounds of the
confidence intervals for the crude rates could not be shown for smokers as there are
very few data (the lower graphs in Figures 8.21 and 8.22).
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Figure 8.21: Graphs of diagnosis inception rates for multiple sclerosis for males, non-
smokers (MNS) and smokers (MS).
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Figure 8.22: Graphs of diagnosis inception rates for multiple sclerosis for females,
nonsmokers (FNS) and smokers (FS).
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Other Causes
In modelling other causes, the model with an exponential first degree age polynomial
(g0(x), f2(x)) has a better fit compared to the model with a quadratic age polyno-
mial (g0(x), f3(x)) or compared to the model which includes a linear intercept term
(g1(x), f2(x)). BIC values can be seen in Figure 8.23.
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Figure 8.23: Model selection for other causes.
The best model includes sex, benefit type and office covariates and is given by equation
(8.13). For Office 7 we do not have any other-cause claims. Therefore, the analysis
is performed excluding this office from the analysis. The estimated parameters of the
model are presented in Table 8.8. Other-cause rates are higher for males and stand
alone policies. The coefficient of Office 1 is the median of office coefficients. Office
6 has the highest coefficient and thus claims from this office are associated with the
highest rates and those from Office 12 with the lowest rates.
λOther = exp (δint + δzagex+ βsexθ1 + βbentypeθ2 + βofficeθ8) (8.13)
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Table 8.8: ML estimates of parameters under the best model for other diseases.
Parameter Estimate Std. Error p-value
δintercept -9.7664 0.0727 < 2× (10−16)
δzage 0.8427 0.0371 < 2× (10−16)
βsex 0.6769 0.0641 < 2× (10−16)
βbentype 0.3822 0.0752 3.7× (10−7)
βoffice1 0.0054 0.1028 0.9579
βoffice2 0.4897 0.0773 < 2.4× (10−10)
βoffice3 -0.4387 0.3274 0.1802
βoffice4 0.4308 0.1778 0.0154
βoffice5 -0.4789 0.2345 0.0411
βoffice6 0.8111 0.2077 < 9.4× (10−5)
βoffice7 - - -
βoffice8 0.6979 0.0747 < 2× (10−16)
βoffice9 0.1077 0.1074 0.3160
βoffice10 -0.6450 0.2113 0.0023
βoffice11 0.0827 0.0821 0.3138
βoffice12 -1.0341 0.1704 < 1.3× (10−9)
βoffice13 -0.0285 0.1635 0.8614
Figures 8.24 and 8.25 show crude and smooth rates for other causes for the combina-
tions of gender and benefit type. These rates are the weighted average over the offices
(calculated in a similar way as in (7.8)). We also show the rates for the individual
offices (Office 12, Office 1 and Office 6) in the figures. We are using office specific
exposures to weight the rates. It is mentioned previously that we have very few and
irregular exposures below age 20 and above age 65 for individual offices and therefore
we observe lack of smoothness below age 20 and above age 65 when we weight the
rates. Here, for older ages we fix the exposure at age 65 as explained in Chapter 7.
Although the same can be applied to younger ages, we have not fixed the exposure
below age 20. Therefore, in the graphs it is seen that there is lack of smoothness in
the weighted smoothed rates below age 20.
Especially for full accelerated policies, the weight of Office 1 for older ages is high (see
upper graphs in Figures 8.24 and 8.25). Therefore the weighted rates become almost
the same as for Office 1. For male, stand alone policies, on the other hand, other
offices are also contributing and thus the weighted rates do not approach the rates for
Office 1 (see the lower graph in Figure 8.24). Note that we could not provide any of
the lower bounds of the confidence interval for female stand alone policies as we have
very limited observed numbers of claims (see the lower graph in Figure 8.25).
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Figure 8.24: Graphs of diagnosis inception rates for other diseases for males, full
accelerated (MFA) and stand alone policies (MSA).
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Figure 8.25: Graphs of diagnosis inception rates for other diseases for females, full
accelerated (FFA) and stand alone policies (FSA).
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Stroke
Stroke is modelled by using a first order exponential age polynomial (g0(x), f2(x)) due
to its lower BIC value compared to the other models considered. These models are
shown in Figure 8.26 together with the best covariates under different age functions
and their log-likelihood and BIC values.
g0(x), f2(x); (θ1, θ3, x × θ3)
BIC=12673
l=-6303.1
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g0(x), f3(x); (θ1, θ3, x× θ3)
BIC=12686
l =-6303.0
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Figure 8.26: Model selection for stroke.
The selected model includes sex, smoker status and age - smoker interaction. The
smoothing function is given in (8.14) and the estimated parameters are presented in
Table 8.9. The positive coefficient for sex indicates that stroke rates are higher for
males. Being a smoker also increases the inception rates. This effect increases with
increasing age.
λStroke = exp (δint + δzagex+ βsexθ1 + βsmokerθ3 + βzage×smokerx× θ3) (8.14)
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Table 8.9: ML estimates of parameters under the best model for stroke.
Parameter Estimate Std. Error p-value
δintercept -9.7228 0.0605 < 2× (10−16)
δzage 1.0440 0.0467 < 2× (10−16)
βsex 0.3764 0.0684 3.1× (10−10)
βsmoker 0.5236 0.0832 3.8× (10−8)
βzage×smoker 0.4137 0.0845 9.8× (10−7)
Figures 8.27 and 8.28 show the crude and smooth stroke rates for the subsets of gender
and smoker status. In the males, non-smokers plot, rates produced by the CMI are
also included. The CMI rates are fixed at age 60, due to lack of data after this age.
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Figure 8.27: Graphs of diagnosis inception rates for stroke for males, nonsmokers
(MNS) and smokers (MS).
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Figure 8.28: Graphs of diagnosis inception rates for stroke for females, nonsmokers
(FNS) and smokers (FS).
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The effect of the interaction term can be seen in Figure 8.29 which shows the non–
smoker rates against the smoker rates. These two lines intersect at about age 25
meaning that the fit of the model is poor below age 25. As stated before, the possible
reason for this is extrapolating from the function when the data is sparse.
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Figure 8.29: Graphs of diagnosis inception rates for stroke for males, nonsmokers vs
smokers.
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Total and permanent disability (TPD)
In terms of BIC, the model with age function g0(x), f2(x) is found to give a better
fit than the models with g0(x), f3(x) and g1(x), f2(x) age functions (see Figure 8.30).
The selected models under different age functions include year and policy duration.
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Figure 8.30: Model selection for TPD.
The smoothing function is given in (8.15) and the estimated parameters are shown
in Table 8.10. For TPD claims, insurance companies generally wait at least 6-months
before the settlement to make sure the effect of the cause is permanent. This period
may change for different causes of TPD (e.g. mental illness, accidents, etc.) and each
office applies its own rules to accept and settle policies as TPD claims. Moreover,
due to imprecise definition of TPD, the recorded date of diagnosis is not consistently
determined across offices and across TPD claims.
λTPD = exp (δint + δzagex+ βzyearθ5 + βpoldurθ7) (8.15)
187
Table 8.10: ML estimates of parameters under the best model for total and permanent
disability.
Parameter Estimate Std. Error p-value
δintercept -10.3321 0.0637 < 2× (10−16)
δzage 0.8815 0.0630 < 2× (10−16)
βzyear -0.2564 0.0553 3.6× (10−6)
βpoldur0 -1.1459 0.1753 6.3× (10−11)
βpoldur1 -0.6855 0.1513 5.9× (10−6)
βpoldur2 0.1294 0.1206 0.2830
βpoldur3 0.0650 0.1415 0.6460
βpoldur4 0.6046 0.1319 4.6× (10−6)
βpoldur5+ 1.0324 0.0886 < 2× (10−16)
Figures 8.31 to 8.33 show the crude and modelled TPD rates for different policy
durations. These rates are weighted averages over years (see (8.7)). The effect of lack
of exposure on the weighted smoothed inception rates can be seen in the values before
age 20. Individual years (1999 and 2005) are also shown in these graphs. Finally, the
modelled rates by CMI are included in the figures. We should mention that the CMI
rates are for males and non-smokers and they are the same for policy durations 1 to
4. Therefore the CMI rates shown in the lower graph in Figure 8.31 are considerably
higher than the crude rates. Note that the CMI rates are provided until age 65 for
this cause. This is because most of the insurance companies restrict the age to 65
for TPD claims. However this is not a uniform practice and different companies use
different upper limits. In our model, we extend the rates until age 80 as for the other
diseases.
Because of the waiting period for this cause as explained above, there are almost no
cases in the first year of the policy (see the upper graph in Figure 8.31). The number
of claims are considerably higher for the long policy durations, and therefore only in
the lower graph in Figure 8.33 are we able to give the lower bound of the confidence
interval for the crude rates. This is because the acceptance of a TPD claim as a valid
claim is subjective and changes from office to office and claim to claim. As explained
earlier, the ABI set some standards for the definition of this disease in 2010, however
the experience used in this study does not cover these adjustments.
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Figure 8.31: Graphs of diagnosis inception rates for TPD for policy durations 0 (PD0)
and 1 (PD1).
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Figure 8.32: Graphs of diagnosis inception rates for TPD for policy durations 2 (PD2)
and 3 (PD3).
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Figure 8.33: Graphs of diagnosis inception rates for TPD for policy durations 4 (PD4)
and 5+ (PD5+).
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8.3 Comparison of cause-specific rates with the all-
causes rates
In this section we give a comparison between the smoothed all-cause rates (calculated
in Section 7.3) and the cause-specific rates derived in this chapter. This is useful
for verifying our modelling since the cause-specific rates should sum to the all-cause
rates, theoretically. This is because the sum of Poisson distributed random variables
also follows a Poisson distribution with parameter given by the sum of the individual
parameters if the random variables are independent. Here we have two issues. First,
we can not guarantee that the numbers of claims for individual causes are independent
from each other. For example heart attack and death might not be independent if
there are people who suffer from heart attack and do not claim but die afterwards,
resulting in a death claim. Secondly, even if we assume independence, the sum of
cause-specific intensity rates will not be precisely equal to the all-cause rates, since
we adjust exposures for each cause separately. However, we still expect the sum of
all-cause rates to be close to the all-cause rates.
One problem we have encountered with these comparisons is non-matching covariates
in the best models. To overcome this problem, we took all the covariates appearing
in the smoothing functions so far into account, i.e. sex (θ1), benefit type (θ2), smoker
status (θ3), year (θ5), policy duration (θ7) and office (θ8). We consider different
combinations of these covariates. As an example, the best model obtained in Section
7.3 includes smoker, policy duration and office covariates. So, for different sex or
benefit types or years the rates will not change. For TPD, the best model includes year
and policy duration, which means these rates will change only with these covariates.
On the other hand, for MOT the rates will not change for different risk profiles as
the smoothing function only includes an intercept term. Similar comments can be
made for all individual causes. Hence, the sum of cause-specific rates is simply the
arithmetic sum of individual rates at each age.
Here we consider four different risk profiles, male - non-smokers, female - non-smokers,
male - smokers and female - smokers, where we take full accelerated policies, year 2003,
policy duration 3 and Office1 as given.
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The first risk profile we look at is males - non-smokers. In Figure 8.34, we show
contributions of individual causes over age. Here we demonstrate the rates for ages
20 to 65 since most of the policies cease at age 65. The upper grey area shows the
difference between the all-cause rates (we use the best model obtained) and the sum
of the cause-specific rates. According to the figure, below age 30, death, afterwards
cancer, has the biggest contribution to the all-cause rates for male - non–smokers.
At older ages death rates increase significantly. A comparison between the all-cause
rates and the sum of cause-specific rates is provided in Figure 8.35(a) for the given
risk profile. To be able to make a direct comparison with Figure 8.34, the age range
20 to 65 is used in this graph. To give a broader perspective, Figure 8.35(b) shows
the logarithm of the difference for ages 16 to 80. Note that in this plot the rates are
given in log scale, the y-axis is in original scale. It seems that for this specific risk
profile, the sum of cause-specific rates is higher than all-cause rates after age 50. As it
is mentioned, we do not expect them to be exactly equal to each other, partly because
of the problems with independence or different adjustment factors. However the most
important reason is probably the use of different smoothing functions for each of the
individual causes and the all-cause rates. The main purpose of this section is to see if
there is any particular bias in our modelling. Seeing that the two lines intersect each
other, we conclude that there is no particular bias in our modelling.
We have inspected the same risk profile given above for females. Figures 8.36 and
8.37 demonstrate the comparison of all-cause rates and cause-specific rates for female
- non-smokers this time. As we are using the best model for the all-cause rates, we
have the same rates for males and females since this variable is not used in the model.
However when we look at individual causes we see that cancer’s contribution to female
rates is greater. On the other hand, heart attack and death rates are higher for males.
Both Figures 8.35 and 8.37 indicate that we have reasonable models for cause-specific
rates. The cause-specific rates cross the all-cause rates at two points, indicating no
particular bias in the modelling.
The two other risk profiles we have checked are smokers for two genders. Figures 8.38
and 8.40 show the contribution of individual causes for male - smokers and female
-smokers, respectively. For both risk groups, cancer and death contribute most to the
inception rates. For males, heart attack rates also add significantly to the rates. The
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difference between the smoothed all-cause rates and cause-specific rates is shown in
Figure 8.39 for male - smokers. Except for ages 30 to 40, the sum of cause-specific
rates is greater than the all-cause rates. On the contrary, for female - smokers the
sum of the cause-specific rates is smaller between ages 30 and 70 (see Figure 8.41(b)).
Although there are no substantial differences between the two rates, they are larger
compared to the non-smoker rates. The reason for this might be having less data for
smokers. In both cases (for males and females), the difference is higher at younger
and older ages where we have significantly less data.
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Figure 8.34: Contribution of individual causes for males, full accelerated policies,
non-smokers, year 2003, policy durations 3 and Office1.
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Figure 8.35: Comparison of all-cause rates and summation of cause-specific rates for
males, full accelerated policies, non-smokers, year 2003, policy duration 3 and Office1.
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Figure 8.36: Contribution of individual causes for females, full accelerated policies,
non-smokers, year 2003, policy durations 3 and Office1.
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Figure 8.37: Comparison of all-cause rates and summation of cause-specific rates
for females, full accelerated policies, non-smokers, year 2003, policy duration 3 and
Office1.
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Figure 8.38: Contribution of individual causes for males, full accelerated policies,
smokers, year 2003, policy durations 3 and Office1.
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Figure 8.39: Comparison of all-cause rates and summation of cause-specific rates for
males, full accelerated policies, smokers, year 2003, policy durations 3 and Office1.
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Figure 8.40: Contribution of individual causes for females, full accelerated policies,
smokers, year 2003, policy durations 3 and Office1.
201
20 30 40 50 60
0.00
0
0.00
5
0.01
0
0.01
5
0.02
0
0.02
5
0.03
0
0.03
5
Age
Ince
ption
 Rat
e
All−Causes Rates
Sum of Cause−Specific Rates
(a) In actual scale from age 20 to 65.
20 30 40 50 60 70 80
Age
Ince
ption
 Rat
e
All−Causes Rates
Sum of Cause−Specific Rates
0.00
012
0.00
12
0.01
1
0.11
1
(b) In log scale from age 16 to 80.
Figure 8.41: Comparison of all-cause rates and summation of cause-specific rates for
females, full accelerated policies, smokers, year 2003, policy duration 3 and Office1.
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Chapter 9
Conclusions and Further Research
9.1 Conclusions
One of the main contributions of this thesis is that this is the first statistical model
for estimating diagnosis inception rates for CII in the UK, or elsewhere.
The two recent studies by the CMI, WP 43 (2010) and WP 50 (2011), adjust the initial
rates for CII by using a base table. Moreover, to analyse specific characteristics, they
split the data into subgroups. This approach is limited to providing the inception
rates only for the combinations of characteristics where there is a significant amount
of data. For all-cause rates, separate rates can be produced for different combinations
of sex, smoker status and policy durations. For cause-specific rates, on the other hand,
these combinations are generally restricted to males - non–smokers. Apart from these
limitations, a main disadvantage of this model is that uncertainty measures (e.g.
confidence intervals) can not be provided for inception rate estimates as they are not
based on proper statistical modelling. Our approach can provide such measures, as
demonstrated for example through the bootstrap confidence intervals in Section 7.5.
In this thesis, we started with modelling the delay between dates of diagnosis and
settlement as long delays may distort the results by exposure year. In modelling this
delay, both Bayesian and classical methods were used. A three-parameter Burr distri-
bution showed a good fit. However, not being a standard distribution for statistical
packages makes it more difficult to use in practice. Therefore we compared the results
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with a widely used, standard lognormal model. We showed that this two-parameter
distribution gives a poor fit especially in the tail of the observed delay and therefore
it is more appropriate to employ a distribution which is more flexible in modelling
strongly right-skewed data, such as the Burr distribution.
The effects of settlement year, policy duration, office, death and stroke on the delay
were found to be strong when we did not consider missing values or business growth
in Chapter 3. When growth rate was introduced in the model in Chapter 4, the
strong positive effect of the settlement year disappeared under the Burr model. This
is what we expect, as the effect of the settlement year is partly explained by the
growth factor as explained in this chapter. Also, with the growth rate in the model,
the coefficients for office changed. Again, this is not surprising because we allowed for
business growth within each office. However, under the lognormal model, the effect of
the settlement year on the delay was not affected. The reason is that the growth rate
is mostly affecting the earlier claims since these are given more weight. These earlier
claims have longer delay periods because of the nature of the data (data include claims
settled between 1999 and 2005). Regarding that, growth rates mostly affect the tail
of the distribution which, in this case, was not modelled adequately by the lognormal
distribution.
We performed Bayesian variable selection in Chapter 5 in order to obtain the most
suitable model to estimate the delay between dates of diagnosis and settlement. As
far as we are aware, this is the first study which shows how to perform variable
selection under the Bayesian context using a Burr distribution. This is important
since the Burr distribution is very appropriate for actuarial analysis as insurance data
is generally strongly right-skewed (e.g. claim amounts, number of claims). In model
selection, different prior distributions for the model parameters were used. We showed
how the Lindley-Bartlett paradox is activated if the priors are not chosen cautiously
in Section 5.2. Then, with the empirical and Zellner’s g-priors, the best model was
determined. While the model excluding age, sex and smoker status was supported
without growth rates (in Section 5.2), the model excluding age, sex, smoker status
and settlement year was supported when the growth rates were included under the
Burr model (in Section 5.3). On the other hand, the model which excludes only sex
was found to be the best model with and without growth rates under the lognormal
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model. These results were confirmed with Laplace approximation for the Burr model
and exact marginal likelihoods for the LN model. We also obtained the same answers
from the maximum likelihood based methods as a result of using lots of data and
uninformative priors. We note that sex was never found significant under the two
models including or excluding the growth rate. However exclusion of age and smoker
status was not as certain as sex due to relatively high inclusion probabilities for these
variables. In life-related insurance practice, age, sex and smoking status are important
policyholder characteristics and when we calculate the inception rates in Chapters 7
and 8 these variables were also included in the analyses. Nevertheless, in Chapter 5
our purpose is to estimate and predict delay in claim settlement, also in the presence
of non-recorded dates of diagnosis or settlement. Note that models including age
or smoker status were not statistically different from the highest probability model
which excludes these variables. However, because of model parsimony we chose to
work with the model which excludes these variables. The selected Burr model was
used to estimate the missing dates in the data set as it provided a considerably better
fit.
Including missing observations in the analysis of the CDD in Chapter 6 changed the
posterior densities of some of the model parameters significantly (e.g. some offices,
death, TPD). For these variables we have concluded that the missing data mechanism
might be systematic rather than random and therefore excluding missing observations
from the analyses may lead to bias in the estimation as they may depend on some
factors. For example, without including the missing observations, the effect of TPD
on the delay is always found to be insignificant with a negative coefficient. However,
after taking the missing observations into account this coefficient turned out to be
significant with a positive coefficient. This result is reasonable since it is well known
that TPD claims take time to be settled. In the CMI’s WP 33 (2008, Appendix A),
for TPD claims it is mentioned that
“...(TPD claims) are notoriously difficult to settle, due to delays in establishing the
permanence of the disability”.
We think that the reason for the ambiguity of this coefficient in our analyses is due
to the unclear definition of TPD. There are various different causes of TPD claims
including back disorder (24%), mental illness (18%), arthritis (12%) and accidents
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(10%) (ABI, 2009). For a TPD claim to be successful, either the claimant should
be unable to return to their own or any other occupation, or should not be able
to carry out the number of daily living activities as defined in the policy. However,
every insurance company applies its own interpretation to assess whether the diagnosis
meets the criteria for a TPD claim. This causes problems in CII; approximately 55%
of TPD claims are not accepted because the required conditions are not satisfied (see
ABI (2009)). Due to these different definitions and the huge range of causes from
accidents to mental illnesses, the entered date of diagnosis changes across offices and
across TPD claims (e.g. some offices apply a waiting period to some TPD claims and
then accept it as the diagnosis date, while some of them accept it as date of diagnosis
immediately but wait for some period before they accept it as a claim).
Finally we provided the diagnosis inception rates for all-cause rates (combined) and
for 10 individual causes in Chapters 7 and 8, respectively. The observed number of
claims was assumed to have a Poisson distribution and the rates were modelled using a
similar model to that described in Forfar et al. (1988). All-cause rates were modelled
under the best model obtained after variable selection in Section 7.3. We concluded
that the all-cause diagnosis inception rates mostly depend on age, smoker status,
policy duration and office. For general practice we need to provide ‘all-office’ rates.
Here, our approach was weighting the intensity rates with the exposure of each office.
At first sight, sex being non-significant in the best model may seem unusual; however
we think that the reason is that the high rates for different causes for different sexes
cancel each other. In fact, in Chapter 8 it can be seen that for most of the individual
causes sex is an important covariate, as expected.
The effects of estimation of missing delays on the inception rates is discussed in Section
7.5. Here it is seen that the inception rates based on other percentiles (from 2.5% to
95%) or the mean of the CDD lie within the confidence interval of the inception rates
based on the median of the CDD. This lack of sensitivity is important in practice, since
it provides confidence in using estimated inception rates, under possible departures
from assumptions used regarding missing values. At this point, we note that this
sensitivity analysis could be achieved as a result of obtaining estimates of the CDD
under a Bayesian modelling framework. However, obtaining the Bayesian estimates
for the inception rates would be computationally very challenging (especially using
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WinBUGS) considering the size of the data set.
The sum of individual rates should give the all-cause rates, in theory. Since we used
different smoothing models, this will not be satisfied precisely. However to determine
if there is any bias in the modelling we compared the sum of the cause-specific rates
with the all-cause rates in Chapter 8. As an example, for a specific characteristic, the
difference between the sum of cause-specific rates and all-cause rates was compared
for four different combinations of sex and smoker status. The results were encouraging
as the cause-specific rates and all-cause rates cross each other at least at two points.
For the age range where we have most of the data these rates are very close to each
other whereas the difference is bigger for younger and older ages due to lack of data.
9.2 Further research
The reason for providing diagnosis inception rates is to estimate the future cash flow
of a CI policy and determine the liability of the insurance company more accurately.
So, a natural extension of this thesis would be calculation of these expected cash
flows, as these can be used in reserving and pricing.
It is important to model the inception rates for older ages since the rates are higher
for these ages. One of the approaches in the future might be to compare the incidence
rates from our analysis (from insured data) with population statistics. By determining
the relationship between these two, we could provide more reliable rates for the ages
where we have less data.
Another interesting research topic would be the projection of morbidity rates to future
calendar years for different causes for CII.
As mentioned earlier, the claim inception analyses in Chapters 7 and 8 could be
performed under a full Bayesian approach so that the entire posterior distribution can
be estimated after incorporating observations with missing dates. This would provide
proper measures of parameter uncertainty, including corresponding standard errors
and credible intervals. We note that this would be computationally very challenging
due to the amount of data we have. This problem would require the use of considerably
more powerful programming tools than those provided in WinBUGS (e.g. C++).
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In this thesis we could not separate different types of cancers. Although we have
enough data to analyse some of the cancers on their own (e.g. breast cancer), con-
sultation with the CMI revealed that for many cancer claims cause is recorded as
‘cancer - site not specified’ by offices and providing any specific cancer rates would
underestimate the true rates for specific cancer types. If the site of the cancer can be
specified for each claim in the future, then inception rates for specific cancers can be
provided.
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